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The lung is a highly specialised organ that facilitates the uptake of oxygen and the 
release of carbon dioxide. Due to its unique structure, which provides enormous sur-
face area to outside ambient air, it is continuously exposed to numerous pathogens 
and toxicants that are inhaled from air polluted with, for instance, cigarette smoke, 
automobile exhaust, diesel, etc., which makes the lung susceptible to varying degrees 
of injury. To combat these unrelenting physical, chemical and biological insults, the 
respiratory epithelium is covered with a thin layer of lining fluid containing several 
antioxidants and surfactants, serving as a first line of defence. Nonetheless, inhalation 
of such toxic air pollutants and microorganisms can result in lung injury and the gen-
eration of reactive oxygen/nitrogen species (ROS/RNS), which in turn leads to a cas-
cade of signalling events that trigger the inflammatory response by the release of 
proinflammatory cytokines and chemokines [1]. 
 Inflammation is the primary reaction of a tissue to eliminate pathogenic insults 
and injured tissue components in order to restore normal physiological functions or 
replace the irreparable tissue with scar tissue. A key component of this innate defence 
mechanism of the lung is the influx and accumulation of inflammatory phagocytes, 
namely polymorphonuclear neutrophils (PMN) and alveolar macrophages. These cells 
play a pivotal role in eliminating the pathogen or other biological intruders through the 
generation of various ROS. The most significant and important ROS generating cell 
system in the lung is the pool of inflammatory neutrophils. In the course of their de-
fence activities, they produce a vast amount of oxidants, including superoxide (O2·-), 
hydrogen peroxide (H2O2), hypochlorous acid (HOCl) and nitric oxide (NO·). This 
spectrum of different oxidants can be attributed to the action of four different en-
zymes, respectively NADPH oxidase, superoxide dismutase, myeloperoxidase (MPO) 
and nitric oxide synthase, catalysing different reactions [for review, see chapter 2]. 
These reactive species help in killing the pathogen, and the inflammation often sub-
sides after the insulting agent is removed or following the completion of the repair 
process. However, repeated tissue damage and regeneration due to persistent inhala-
tion of toxic agents, such as by smoking cigarettes, may result in increased macro-
phage recruitment, delayed neutrophil clearance and increased ROS/RNS production. 
This may ultimately lead to chronic inflammation and lung injury. In contrast to the 
protective effects, such overwhelming ROS production by inflammatory cells may 
damage macromolecules (DNA, lipids, proteins) in proliferating lung epithelial cells. 
This may ultimately result in permanent genomic alterations, such as point mutations, 
deletions or rearrangements [2]. In this way, chronic inflammation provides a micro-
environment, which is rich in inflammatory cells, ROS/RNS, recurring DNA damage 
and growth factors; thereby further facilitating malignant transformation in the lung [3]. 
 
The functional relationship between inflammation and cancer is not a novel concept. 
As early as in the 19th century, it was observed that tumours often arose at sites of 
chronic irritation [4]. More recently, a large number of epidemiological studies have 
confirmed that chronic inflammation in selected organs predisposes for cancer. Also 
in pulmonary pathologies, such as chronic obstructive pulmonary disease (COPD) 
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and cancer induced by exposure to cigarette smoke, inflammation is considered as a 
major precursor or “hallmark” for cancer development [5]. 
 The communalities in smoking, COPD and lung cancer begin with profound alte-
rations induced by cigarette smoke, which contains known carcinogens as well as 
high levels of ROS. The induction of ROS after tobacco smoke exposure leads to the 
impairment of epithelial and endothelial cell function as well as inflammation. The 
ongoing inflammatory processes in COPD may persist after smoking cessation and 
have been related to disease progression and lung cancer risk [6, 7]. As COPD 
progresses, the percentage of the airways that contains neutrophils, macrophages 
and T cells increases [6]. This prominent presence of neutrophils associated with 
COPD, suggest a significant role of the ongoing neutrophilic inflammation in the carci-
nogenic response [8]. 
 Neutrophils are the major source of oxidants in the inflamed lung. The constant 
release of ROS by these cells provides a plausible mechanism by which inflammatory 
processes and pulmonary carcinogenesis might be related; ROS cause genetic alte-
rations in the lung epithelium, which may promote cancer development [9]. At this 
moment, it is indeed generally accepted that the carcinogenic capacity of neutrophils 
is at least partly attributable to the generation of DNA damaging and mutagenic ROS. 
Additionally, considering the exposure to inhaled carcinogens as well as the simulta-
neous presence of inflammatory neutrophils in the lung of smokers, neutrophils are 
also implicated in pulmonary genotoxicity via the MPO mediated peroxidative meta-
bolic activation of inhaled chemical carcinogens, thereby generating highly DNA reac-
tive and mutagenic compounds [for review, see chapter 2]. Furthermore, it should be 
noted that the induction of DNA damage and mutagenesis alone does not cause can-
cer and that neutrophil derived ROS may also be implicated in a wide variety of other 
processes that could contribute to tumourigenesis. Apart from inducing oxidative DNA 
damage, oxidising species could also be implicated in modifying DNA repair capacity 
of target cells [for review, see chapter 2]. Such an inhibitory effect on DNA repair 
could provide an additional contribution of neutrophil derived ROS to the mutagenic 
environment during chronic inflammation. Moreover, neutrophils may also have an 
impact on a variety of other (pre-)neoplastic processes besides cell proliferation, such 
as angiogenesis and metastasis, by generating a prooxidant environment, as well as 
by releasing defensins, proteases or growth factors. 
AIMS and OUTLINE of the thesis 
Because pulmonary inflammation plays an important role in the pathogenesis of lung 
cancer, a thorough understanding of lung cancer pathogenesis requires consideration 
of the tumour microenvironment and the inflammatory pathways cooperative in carci-
nogenesis. 
 Presently, there is convincing evidence indicating a crucial role of neutrophils in 
pulmonary carcinogenesis by their genotoxic capacity. This is mainly thought to occur 
through the release of mutagenic ROS leading to oxidative DNA damage. On the 
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other hand, the metabolic activation of chemical carcinogens is known to be promoted 
via the neutrophil derived enzyme MPO, resulting in DNA adducts. These DNA le-
sions may be converted to mutations due to mispairing during DNA replication, unless 
they are repaired by DNA repair processes. Apart from inducing oxidative DNA dam-
age, neutrophil derived ROS have also been implicated in modifying the DNA repair 
capacity of target cells. Moreover, several oxidising species are reported to act as 
endogenous inhibitors of nucleotide excision repair (NER), the most important DNA 
repair process involved in the removal of bulky DNA adducts. This provides a possible 
additional explanation for the association between neutrophils and lung cancer risk in 
subjects exposed to DNA adduct forming chemicals. Nevertheless, there are only 
limited data available on a potential role of the major neutrophil derived oxidant HOCl 
in the pathophysiology of inflammation related carcinogenesis. Therefore, the central 
aim of the present thesis was to investigate mechanisms of neutrophil induced geno-
toxicity and to elucidate the specific role of the neutrophil derived enzyme MPO and 
its product HOCl herein. 
 
This thesis will highlight three distinct pathways of neutrophil induced genotoxicity in 
lung epithelial cells: 
- Genotoxic effects of neutrophils and HOCl; 
- DNA repair inhibition by neutrophils and HOCl; 
- Neutrophil induced inflammatory pathways and gene expression changes 
in the lung microenvironment. 
 
The studies described in this thesis primarily focus on epithelial cells (type II) that line 
the respiratory tract, since these are considered to be a specific target for smoking 
associated carcinogenesis. Both in vitro and in vivo models were used. Since current 
in vivo models are not well suited to distinguish between the different cell types inte-
grated into the lung tissue, the in vitro models were applied to determine specific 
mechanisms underlying the influence of neutrophils and HOCl on lung epithelial target 
cells. 
 As a general overview, the scientific literature on the DNA damaging and muta-
genic capacity of neutrophils is reviewed in chapter 2, as well as a discussion of the 
implication of these processes in pulmonary carcinogenesis. 
 With respect to direct neutrophil induced genotoxicity, in chapter 3, the DNA 
damaging and mutagenic capacity of HOCl in epithelial lung cells in vitro is studied. 
Moreover, to extend the in vitro observations into the whole organism, HOCl induced 
DNA damaging effects were assessed in the mouse lung, using an acute lung in-
flammation model in combination with neutrophil depletion. 
 Considering the widespread exposure to inhaled DNA adduct forming carcino-
gens, as well as the simultaneous presence of neutrophils in the inflamed lung, in 
chapter 4, the reduction of NER by neutrophils and their product HOCl (produced by 
MPO) is proposed as a significant contributory factor in the development of inflamma-
tion related pulmonary mutagenesis and carcinogenesis. The effect of activated neu-
trophils on the NER capacity of lung target cells was studied using a coincubation 
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model of neutrophils and type II epithelial cells. Based on initial in vitro findings, the 
effect of neutrophil inflammation on NER was investigated in the mouse lung following 
acute inflammation (chapter 5). The causal role of MPO and neutrophils in this in vivo 
effect was addressed respectively in MPO knockout mice and mice depleted of circu-
lating neutrophils. 
 Another way to explore the relation between lung inflammation and cancer, and 
the role of neutrophils herein is a gene expression profiling of airway epithelial cells 
using microarray technology. Chapter 6 describes the normal airway transcriptome of 
mice and the neutrophil induced alterations following inflammation to define pathogen-
ic changes in the microenvironment that could contribute to tumour development. 
Finally, chapter 7 comprises a summary of the results and a general discussion. 
General introduction 
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Abstract 
Inflammation has been recognised as an important factor in cancer development. For 
the lung, experimental studies with rats, as well as molecular epidemiological studies 
in humans have provided evidence that the influx of neutrophils into the airways may 
be an important process linking inflammation with carcinogenesis. Currently, it is be-
lieved that the genotoxic capacity of neutrophils is a crucial etiological factor in this 
carcinogenic response. In the present review, we discuss two major pathways of 
neutrophil induced genotoxicity: i) Induction of oxidative DNA damage through release 
of reactive oxygen species (ROS), and ii) Myeloperoxidase related metabolic activa-
tion of chemical carcinogens. So far, direct evidence for a role of neutrophils in pul-
monary genotoxicity has largely been derived from in vitro studies using cocultures of 
activated neutrophils and target cells. Current evidence from in vivo studies is primari-
ly indirect and additional animal studies are needed to substantiate causality. A further 
challenge will be to extrapolate results from such studies to humans. Taken together, 
this will provide a better insight into the role of neutrophils in pulmonary carcinogenici-
ty, and may hence lead to novel approaches for cancer prevention strategies. 
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Introduction 
The association between chronic inflammation and the development of cancer has 
been recognised for a long time [1, 2]. In fact, as early as the late 1800’s, Rudolf Vir-
chow described the appearance of tumours developed at sites of chronic irritation [3]. 
Currently, there is a large number of clinical data confirming these early observations. 
Colon carcinomas are for example closely associated with chronic inflammatory bowel 
diseases, including colitis ulcerosis [4]. Similarly, patients with chronic infections, such 
as osteomylitis or decubitus ulcers, can develop very aggressive carcinomas [5] and 
urinary bladder cancer is frequently found in patients who suffer from urinary tract 
infection [6]. Also in the lung, chronic inflammatory diseases, such as sarcoidosis, 
fibrosis and chronic obstructive pulmonary disease (COPD), have been associated 
with a higher risk of cancer development [2, 7-10]. In addition, other studies demon-
strated that human lung cancer risk can be modified by polymorphisms in proinflam-
matory genes, such as IL-1β and TNF-α [11, 12]. The strongest support for the in-
volvement of chronic inflammation in carcinogenesis, however, is possibly derived 
from studies showing that long-term users of anti-inflammatory drugs may be at a 
reduced risk of cancer development [13]. 
 Within the lung, many sources of inflammation may be effective in accelerating 
carcinogenesis, including inflammatory reactions caused by air pollution particles (e.g. 
cigarette smoke, diesel, quartz) [for review: 14, 15]. Inflammatory processes in the 
lung are characterised by the influx of neutrophils into the airways and it is generally 
accepted that these cells are crucially involved in the pathogenesis of various chronic 
pulmonary diseases. The pulmonary vasculature represents the largest reservoir of 
circulating polymorphonuclear neutrophils (PMN) in the human body. The concentra-
tion of neutrophils within the pulmonary capillary blood is 35-100x greater than within 
the large vessels of the systemic circulation, thereby providing a pool of rapidly re-
cruitable neutrophils [16]. Neutrophils are a major source of oxidants in the inflamed 
lungs, and the constant release of reactive oxygen species (ROS) by these cells pro-
vides a plausible mechanism by which inflammatory processes and pulmonary carci-
nogenesis might be related: ROS cause genetic alterations in the lung epithelium, 
which may promote cancer development [17]. In this paper, we provide a review of 
the DNA damaging and mutagenic capacity of neutrophils as well as a discussion of 
the implications of these processes for pulmonary carcinogenesis. We will specifically 
focus on the lung, as the concept of neutrophil infiltration in relation to tumour devel-
opment is largely derived from studies investigating the pulmonary pathogenicity of 
inhaled particles [review: 14, 15, 18]. This review will highlight two distinct pathways of 
neutrophil induced genotoxicity: i) Oxidative DNA disturbances caused by neutrophil 
derived ROS and ii) Myeloperoxidase (MPO) mediated metabolic activation of inhaled 
chemical carcinogens. It should be realised that induction of DNA damage and muta-
genesis alone does not cause cancer and that neutrophils, for instance by generating 
a prooxidant environment, as well as by releasing defensins [19], proteases or growth 
factors may have an impact on a variety of other neoplastic processes, including cell 
proliferation, metastasis and angiogenesis. However, these topics are beyond the 
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scope of this paper, and are discussed in several excellent reviews [e.g. 1, 2, 17 and 
others].  
Pulmonary neutrophils: friend or foe? 
Inflammation is a normal response of tissues to ‘inactivate’ invading microbial, chemi-
cal or physical agents. A key component in the inflammatory reaction is the transport 
and accumulation of phagocytes into the injured tissue. The role of neutrophils in host 
defence was first discovered in the late 1800’s by Elie Metchnikoff, who observed that 
‘wandering’ cells crowded around sharp thorns which he had pierced into transparent 
starfish larvae [20]. In the lung, the recruitment of neutrophils upon inhalation of in-
flammogenic agents largely depends on an elaborate network of cytokines [21]. In this 
process, resident alveolar macrophages have a pivotal role. In normal conditions, 
alveolar macrophages clear most of the invading microorganisms or particles. How-
ever, when macrophages are overwhelmed by the intrinsic inflammogenic activity of 
the pathogens, they will be activated to release a wealth of cytokines and chemo-
kines, eliciting a rapid inflammatory reaction. In general, neutrophil recruitment is 
characterised by three subsequent steps: adherence, extravasation and migration [22, 
23]. The adherence of PMN to the vascular endothelium is mediated by specific ad-
hesion molecules [22]. Subsequent processes of pulmonary neutrophil recruitment 
(extravasation and migration) are controlled by chemokines, including IL-8 [24-26]. 
For a more detailed description of the processes involved in neutrophil trafficking into 
the airways, readers are referred to other reviews [e.g 16, 22, 27-29]. Once migrated 
into the lung, the PMN will be activated to release a myriad of products dedicated to 
kill invading pathogens. Currently, more than fifty neutrophil derived toxins have been 
identified, including proteolytic enzymes and bactericidal proteins [for extensive re-
view: 27, 30]. A hallmark of neutrophil activation, however, is their respiratory burst. 
This is characterised by an increased consumption of oxygen that is used to generate 
large amounts of ROS. This process ultimately leads to the conversion of H2O2 into 
hypochlorous acid (HOCl) by the neutrophilic enzyme MPO. HOCl is a very strong 
oxidant which plays a crucial role in actual killing of inhaled pathogens by migrated 
neutrophils [31]. 
 In contrast to their protective role in innate immunity, PMN are also implicated in 
the pathogenesis of a variety of acute or chronic inflammatory pulmonary diseases, 
including chronic obstructive pulmonary disease [32, 33], idiopathic pulmonary fibrosis 
[34] and the adult respiratory distress syndrome [35]. In these diseases, neutrophils 
are associated with several pathogenic processes. For instance, PMN derived oxi-
dants and proteolytic compounds are implicated in a great variety of injurious effects, 
including lung matrix degradation, killing of pulmonary epithelial and vascular endo-
thelial cells and inducing detachment of these cells from their matrix support [36, 37]. 
Furthermore, oxidants released by neutrophils might have a role in deregulation of the 
airway smooth muscle function, disturbing its contractile response [38]. Finally, neu-
Neutrophils and respiratory tract DNA damage 
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trophil derived ROS cause oxidative DNA damage that may provoke mutagenesis in 
pulmonary target cells. 
Neutrophils as a source of ROS 
The most significant and important ROS generating system in the lung is constituted 
by the pool of inflammatory neutrophils. In the course of their defence activities, they 
produce a vast amount of oxidants. The whole spectrum of oxidants generated by 
neutrophils is more or less due to the action of four different enzymes, catalysing 
different reactions (summarised in Table 1). NADPH-oxidase is the enzyme by which 
the oxidant generation is initiated. It is a membrane-bound enzyme, which is dormant 
in resting cells, but comes into action when the cell is activated by phagocytosis of 
invading microorganisms or particles. NADPH-oxidase is composed of a number of 
subunits, which are distributed in the cytosol and the membranes of intracellular ve-
sicles and organelles. Upon activation, the cytosolic subunits migrate to the mem-
branes where they bind to membrane-bound subunits, assembling the active oxidase. 
The intracellular organelles then fuse with the plasma membrane resulting in the re-
lease of O2•- into the extracellular environment or into phagocytic vesicles [39]. This 
O2•- is a substrate for the enzyme superoxide dismutase (SOD), which catalyses the 
formation of H2O2 from O2•- [40]. H2O2 is relatively stable and is known for its capacity 
to diffuse and to cross cellular membranes. As such, this provides a phagocyte the 
possibility to ‘act at a distance’. In neutrophils, however, most of the hydrogen perox-
ide (up to 70%) is consumed by the enzyme MPO [41]. MPO is the most abundant 
protein in neutrophils and catalyses the conversion of H2O2 into HOCl [31]. In addition, 
neutrophils are also able to produce reactive nitrogen species (RNS), which is facili-
tated by inducible nitric oxide synthase (iNOS), catalysing the production of NO• from 
L-arginine, oxygen and NADPH [42]. However, the ability of neutrophils to yield NO• is 
much less compared to macrophages [43, 44], and studies on the activity of iNOS in 
isolated blood neutrophils have yielded contradictory results [45, 46]. 
 
 
 
 
The enzymes as listed in Table 1 give rise to the four oxidants initially generated by 
activated neutrophils, O2•-, H2O2, HOCl, NO•. Because of their reactivity, these prod-
ucts will constantly interact with each other, causing the formation of a myriad of oxi-
dants (see Fig. 1), among which the hydroxyl radical is recognised as being the most 
DNA reactive compound by far [47, 48]. 
 
Enzymes Reactions Product
NADPH oxidase 2O2 + NADPH Æ 2O2•- + NADP+ + H+ O2• -
Superoxide dismutase 2O2
•- + 2H+Æ O2 + H2O2 H2O2
Myeloperoxidase Cl- + H2O2 Æ HOCl + OH- HOCl
Nitric oxide synthase L-arg + O2 + NADPH Æ NO• + L-citrulline + NADP+ NO•
Table 1: Enzymes and rections involved in oxidant generation by neutrophils
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Oxidant induced genotoxicity by neutrophils 
Genotoxic processes may lead to irreversible changes in the structure of the genetic 
material of cells. This effect is considered as an important process in cancer devel-
opment. The term ‘genotoxic’ has been used for the first time in 1973 by Hermann 
Druckrey during a conference on ‘Evaluation of genetic risks of environmental chemi-
cals’ in Sweden. He stated: “In order to describe the components of chemical interac-
tion with genetic material, the term genotoxic is proposed as a general expression to 
cover toxic, lethal and heritable effects to karyotic and extracaryotic genetic material 
in germinal and somatic cells” [49]. At this moment, it is generally accepted that the 
carcinogenic capacity of neutrophils is at least partly attributable to the generation of 
DNA damaging and mutagenic ROS. However, it should be realised that neutrophilic 
ROS may be implicated in a wide variety of other processes that could all contribute 
to tumourigenesis (Fig. 2). 
 In the past, a variety of genotoxic properties of phagocyte derived ROS have 
been investigated, including their capacity to induce DNA damage, DNA mutations, 
and chromosomal aberrations. Before discussing the mechanisms by which neutro-
phils may cause oxidative damage to target cellular DNA, some background informa-
tion about the processes by which neutrophil derived ROS per se may damage DNA 
is provided in the next paragraph. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Schematic overview of the generation and interaction of reactive oxygen species produced by 
neutrophils. Three different pathways for the generation of •OH are indicated (A,B,C). 
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Modification of DNA by ROS 
A major development in carcinogenesis research in the past 20 years has been the 
discovery of DNA damage induced by ROS derived from both endogenous and ex-
ogenous sources [50]. In the mid 1980’s, Ames and coworkers discovered that oxi-
dised DNA bases were abundantly present in tissues of both humans and rodents 
[51]. At the same time, it became evident that ROS induced DNA damage was likely 
to be involved in carcinogenesis. Many of the ROS indeed have characteristics which 
indicate that they are possible carcinogens [52] (also see Fig. 2). Generally, the reac-
tions contributing to ROS induced DNA damage are oxidation, nitration, depurination, 
methylation and deamination. The reactivity of the various ROS towards the DNA is 
extremely variable. For instance, superoxide and hydrogen peroxide are thought not 
to react with DNA at all [52]. The hydroxyl radical on the other hand, is the most DNA 
reactive ROS, which generates a multiplicity of products from all 4 bases [53]. The 
best studied DNA lesion caused by hydroxyl radical attack is 8-
hydroxydeoxyguanosine (8-oxo-dG), which is produced by a hydroxylation of the C-8 
position of the guanine derivative of the DNA [54]. Currently, there is a consensus that 
the presence of 8-oxo-dG, which is in fact a premutagenic lesion, is associated with 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Overview of a variety of processes by which neutrophil derived ROS may promote tumour 
development. The present review specifically focuses on the processes involved in neutrophil induced DNA 
damage and mutagenesis. 
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the carcinogenic process [55]. In addition to 8-oxo-dG, numerous other kinds of •OH 
modified DNA bases have been described, including 5-hydroxymethyluracil, 5-
hydroxyuracil, 5-hydroxyadenine, 8-hydroxyadenine, 2,6-diamino-4-hydroxy-5-
formamidopyrimidine [52]. However, in contrast to 8-oxo-dG, the biological implica-
tions and significance of these lesions for carcinogenesis are often less well unders-
tood. 
 Although •OH causes the most significant and abundant DNA base lesions in 
mammalians, other neutrophil derived ROS may also interact with DNA. HOCl for 
instance, which is one of the major oxidants produced by neutrophils, is shown to 
react with DNA, thereby inducing DNA-protein crosslinks, chlorination of DNA bases, 
as well as pyrimidine oxidation products [56-58]. One specific nucleobase damage 
product that is formed by treatment of naked DNA as well as cellular DNA with HOCl 
is 5-chlorouracil, which is also suggested to act as a fingerprint of DNA damage by 
HOCl [56, 59, 60]. Due to its extreme cytotoxic activity, HOCl induced DNA damage in 
target cells is often associated with cell death. Therefore, the consequence of such 
DNA damage with regard to mutagenicity in competent proliferating cells is still con-
troversial. Peroxynitrite is also suggested to damage DNA bases, likely by deamina-
tion or nitration [61, 62]. Neutrophil derived ROS may also indirectly damage DNA 
through production of lipid hydroperoxides. In this process, a variety of very reactive 
side-products can be generated, such as epoxides or aldehydes. Among these, ma-
londialdehyde and 4-hydroxynonenal are extensively studied and are shown to be 
highly DNA reactive [63, 64] and mutagenic [65]. In addition to oxidising DNA bases, 
ROS may cause DNA strand breakage due to free radical attack of the DNA sugar-
phosphate backbone [66]. DNA strand breaks can be categorised as either single-
strand or double-strand breaks, and may cause mutagenic and clastogenic effects. 
 A large amount of knowledge about the DNA reactivity of various ROS as de-
scribed above is obtained from incubations of purified ROS with naked DNA. Howev-
er, the relevance of such a-cellular assays with respect to the mechanism of ROS 
induced genotoxicity by neutrophils can be questioned, because the kinetics of ROS 
production by neutrophils and subsequent availability of these ROS to damage target 
cellular DNA are totally different. Therefore, mechanistic in vitro analysis of genotoxic 
effects of neutrophils should ideally involve cocultures of neutrophils and target cells, 
since this more closely mimics the real life situation. 
Neutrophil induced oxidative genotoxicity 
Evidence from cocultures with target cells 
In Table 2, a historical overview of studies reporting oxidant induced genotoxic effects 
of activated phagocytes, mostly of PMN, is listed. The general concept of these stu-
dies is that they all use cocultures of phagocytes and specific target cells. In these 
experiments, the phagocytic oxidative burst is generally initiated by addition of phorbol 
esters, like PMA, to trigger protein kinase C mediated activation of NADPH-oxidase. A 
variety of genotoxic endpoints is then assessed in cocultured bacteria or specific 
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mammalian target cells. The first observation of phagocyte induced genotoxicity and 
the crucial role of ROS herein was reported by Weitzman and Stossel in 1981 [67]. 
They found that the ability of peripheral blood leukocytes to induce mutations in bacte-
ria was markedly attenuated when cells were used from a patient with chronic granu-
lomatous disease (CGD). In CGD, neutrophils have a defect in the NADPH-oxidase 
mediated generation of O2•-, and are thus unable to generate ROS. The first study on 
leukocyte mediated genotoxic (clastogenic) effects in mammalian cells was published 
by Weitberg et al. in 1983, describing leukocyte induced sister chromatide exchanges 
(SCE’s) in hamster ovary cells [69]. Further studies from Weitzman and Stossel 
(1984), describing the induction of mutations in mammalian cells by phagocytes [71], 
finally led to a publication from the same group showing the development of tumours 
in athymic mice injected with fibroblasts which were previously exposed to activated 
human neutrophils [73]. This was a rather important finding, since it provided a causal 
link between neutrophil activity, ROS release and carcinogenesis. Mechanisms were 
then further elucidated by the discovery of oxidative DNA base damage induced by 
neutrophils, first in naked DNA [87, 88] and later also in target cellular DNA [79, 83]. 
Such oxidised DNA bases, including 8-oxo-dG are premutagenic and could possibly 
explain the reported mutagenic effects of neutrophils. In other studies, neutrophils 
were also found to induce target cellular DNA strand breakage [e.g. 75-77, 86]. Fur-
ther crucial observations with regard to effects in the lung were published by Driscoll 
and coworkers [82, 89], who demonstrated that neutrophils, obtained by bronchoal-
veolar lavage (BAL) from particle exposed rats, were mutagenic to alveolar epithelial 
cells in vitro. 
 The specific role of ROS in phagocyte induced genotoxicity was not only con-
firmed by using PMN from chronic granulomatous disease patients, but also by the 
use of a variety of specific antioxidants [81, 82]. This approach, and more specifically, 
the use of catalase, has led to a consensus that hydrogen peroxide is the major ROS 
that is mediating genotoxic processes induced by activated phagocytes [75, 76, 82, 
90]. Indeed, by using various target cells in vitro, it was shown that reagent hydrogen 
peroxide was able to induce base damage and strand breakage in nuclear DNA [75, 
83, 86, 91, 92]. Furthermore, it has been established that the type of DNA base mod-
ifications as detected in target cells exposed to reagent H2O2 is highly comparable 
with the damage induced by activated neutrophils. In general, these reflect hydroxyl 
radical specific DNA modifications, indicating that neutrophil derived H2O2 acts as a 
progenitor of the hydroxyl radical, which then ultimately attacks cellular DNA [76, 79, 
88, 92]. This is further illustrated by own observations showing that activated neutro-
phils cause induction of hydroxyl radical mediated 8-oxo-dG in pulmonary epithelial 
cells [83]. In addition, other studies revealed that hydroxyl radical scavengers were 
effective in reducing neutrophil induced sister chromatide exchanges [72], mutations 
[93] and DNA strand breakage [76] in target cells. Now, based on these collaborate 
findings, it is hypothesised that neutrophil derived H2O2, which is relatively stable, 
diffuses through the plasma membrane towards the nucleus where it reacts with DNA 
bound transition metals to form hydroxyl radicals via the Fenton reaction. We ob-
served that close contact between target cells and activated neutrophils is a prerequi-
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site for this process to occur, as supernatants from activated neutrophils were unable 
to induce cellular DNA damage, likely since H2O2 is consumed by neutrophilic MPO or 
catalase [85]. But even when close contact between neutrophils and target cells is 
allowed (e.g. in coculture systems), there will be a constant balance between the 
consumption of H2O2 by MPO, versus the capturing of diffusible H2O2 by the neigh-
bouring target cells [94]. This is possibly illustrated by recent experiments in which we 
observed that neutrophil induced DNA strand breakage in cocultured pulmonary tar-
get cells was increased upon inhibition of MPO activity, suggesting an increased 
availability of diffusible and DNA breaking H2O2 [86]. 
 
 
 
 
Although the studies as described above contribute to a concept of H2O2 induced 
genotoxicity by neutrophils, also H2O2 independent mechanisms of neutrophil induced 
genotoxicity should be considered. For instance, Gera and Lichtenstein (1991) dem-
onstrated that neutrophil derived defensins were able to induce DNA strand breaks in 
target cells [95]. The possible role of neutrophil derived ROS beside H2O2, is further 
illustrated by the observation that the mutational spectrum induced by activated neu-
trophils was different from the one induced by reagent H2O2 alone [81]. One likely 
alternative candidate ROS would be HOCl. As described above, HOCl may induce a 
variety of mutagenic DNA base lesions, and studies have revealed the presence of 
HOCl related DNA modifications in human and experimental animal inflammatory 
tissues [59, 60]. 
 Apart from inducing oxidative DNA damage, neutrophil derived ROS have also 
been implicated in modifying DNA repair capacity of target cells. In vitro studies have 
for instance shown that neutrophils are able to inhibit poly(ADP-ribose) polymerase 
and DNA strand break repair in neighbouring cells by virtue of their HOCl generating 
capacity [96, 97]. Others showed that nitric oxide is a potent inhibitor of human Ogg1, 
 
Target Genotoxic endpoint Reference
Salmonella Mutations Weitzman and Stossel, 1982 [67]
Photobact. Fischeri Mutations Baker et al. , 1983 [68]
Chinese hamster ovary cells Sister chromatid exchanges Weitberg et al. , 1983 [69]
Salmonella Mutations Fulton et al. , 1984 [70]
Chinese hamster ovary cells Mutations (Hprt ) Weitzman and Stossel, 1984 [71]
Chinese hamster ovary cells Sister chromatid exchanges Weitberg et al. , 1985 [72]
Mouse fibroblasts Malignant transformation Weitzman et al. , 1985 [73]
E. Coli Mutations De Togni et al. , 1988 [74]
Human lymphocytes Strand breaks and PARP activity Schraufstätter et al. , 1988 [75]
Plasmacytoma cellline DNA strand breaks Shacter et al. , 1988 [76]
Tumour cells DNA strand breaks Chong et al. , 1989 [77]
Tumour cells DNA strand breaks Shacter et al. , 1990 [78]
Human Ad293 cells DNA base modifications Dizdaroglu et al. , 1993 [79]
Mononuclear leukocytes DNA strand breaks Van Staden et al. , 1993 [80]
Human Ad293 cells Mutations (frequency and spectrum) Akman et al. , 1996 [81]
Alveolar epithelial cells Mutations (HPRT ) Driscoll et al. , 1997 [82]
Alveolar epithelial cells 8-oxo-dG Knaapen et al. , 1999 [83]
Chinese hamster ovary cell line Mutations (Gpt ) Kim et al. , 2003 [84]
Alveolar epithelial cells DNA strand breaks Knaapen et al. , 2005 [85]
of phagocytes (neutrophils and macrophages) in a variety of target cells
Table 2: Chronological overview of in vitro coculture studies showing (oxidant mediated) genotoxic properties
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a glycosylase that is involved in the repair of 8-oxo-dG lesions [98]. Although these 
observations need to be confirmed in vivo, they support the concept that an inhibitory 
effect on DNA repair is an additional contribution of neutrophil derived ROS to the 
mutagenic environment of chronic inflammation. 
Evidence from in vivo studies 
A large body of evidence for a role of neutrophils in pulmonary ROS mediated geno-
toxicity has been derived from rat studies investigating toxicity of inhaled particles [for 
review: 14, 15, 18]. By the use of these animals, it has been demonstrated that chem-
ical and physical differences between various poorly soluble particles (e.g. coal dust, 
carbon black, titanium dioxide) may not be the only factors predicting the lung tumour 
response, since patterns of tumour formation were not associated with any inherent 
genotoxic activity of such particles [99]. This suggests that there must be a common 
mechanism by which high doses of both toxic (e.g. quartz, diesel soot) and non-toxic 
particles (e.g. titanium dioxide, carbon black) induce carcinogenesis in the rat. By 
considering such a mechanism, it is currently hypothesised that high particle doses 
induce a chronic inflammatory response, mainly caused by impairment of particle 
clearance by alveolar macrophages. Consequently, it is proposed that tumour forma-
tion is only found at particle doses eliciting a certain minimal level of phagocyte influx 
with associated ROS release, at levels that overwhelm pulmonary antioxidant and 
DNA repair protection systems. The constant release of ROS by activated inflamma-
tory phagocytes is indeed assumed to be a crucial event, since ROS may cause ge-
notoxic effects in the lung epithelium as described above. These genetic alterations, 
together with increased and chronic target cell proliferation and tissue remodelling, 
are now considered to be crucial components in the particle induced carcinogenic 
response of the rat lung [9, 18, 99-101] (also see Fig. 2). 
 The inflammatory response in a particle exposed rat lung is characterised by an 
influx of neutrophils. For instance, in addition to an overall increase in inflammatory 
cells found in the bronchoalveolar lavage fluid, the percentage of neutrophils has 
been reported to increase from 3-4 % in healthy non-exposed rats, up to levels above 
50 % after acute or subchronic exposure to particles, such as quartz, particulate mat-
ter or titanium dioxide [82, 89, 102-105]. Regarding a role of neutrophils in pulmonary 
genotoxicity, it has been established that in vivo mutagenicity in rat alveolar type II 
cells, isolated after particle exposure, was paralleled by a neutrophilic inflammation 
[82, 89]. Specifically, we and others demonstrated that the association between neu-
trophil numbers in bronchalveolar lavage and Hprt mutation or DNA strand breakage 
in pulmonary epithelial cells shows a threshold, suggesting that endogenous protec-
tion mechanisms (e.g. DNA repair, antioxidant capacity) first need to be overwhelmed 
by neutrophil derived ROS in order to cause significant genotoxicity [101, 106]. A 
further confirmation of the neutrophils’ role in particle induced tumour formation in the 
rat was obtained by the observation that BAL derived neutrophils from quartz exposed 
rats were mutagenic (Hprt) to alveolar type II cells in vitro, whereas no direct effect of 
quartz was found in the same system. Notably, these in vitro effects of neutrophils 
were attenuated by the use of catalase, indicating that the crucial role of H2O2 in neu-
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trophil induced genotoxicity, as described above for in vitro cocultures is also valid for 
the in vivo situation [82]. Importantly, in the studies from Driscoll and coworkers, the 
capacity of alveolar macrophages to induce ex vivo mutagenesis was found to be 
significantly lower than the capacity of neutrophils, which is in line with observations 
describing an increased ROS generating capacity of neutrophils compared to macro-
phages or monocytes [107, 108]. Further indications that neutrophils are indeed in-
volved in early stages of particle induced carcinogenicity are found in studies showing 
that levels of DNA strand breakage, as well as 8-oxo-dG in lungs of acute and chronic 
quartz exposed rats, were associated with the intensity of neutrophil influx [106, 109-
111]. 
 Table 3 provides an overview of in vivo studies, showing a relation between neu-
trophil influx and pulmonary genotoxicity in experimental animals. However, evidence 
obtained from such particle exposure studies is primarily associative, and no causal 
relationship between the presence of neutrophils and the induction of genotoxicity can 
be inferred from these studies. In fact, with respect to particle toxicology, there is still 
a lack of solid evidence that neutrophils are the true driving force behind particle in-
duced pulmonary genotoxicity in the rat. Indeed, in the last few years, various con-
trasting results have been published. For instance, despite a massive neutrophil in-
flux, we did not observe increased 8-oxo-dG levels in rat lungs seven days after silica 
exposure. In parallel, we found a significant induction of APE/Ref-1, which led us to 
suggest that the absence of steady-state 8-oxo-dG increases under conditions of 
persistent neutrophilic inflammation may result from a compensatory base excision 
repair [115]. In another study, differential mutagenic effects were observed in rats 
which were exposed to crystalline or amorphous silica, both titrated at exposure levels 
to result in similar neutrophil influx. Despite these similar neutrophil ‘doses’, increased 
mutations in the Hprt gene were only found in rats exposed to crystalline silica [116]. 
In addition, others observed that DNA strand breaks in BAL cells from carbon black 
exposed mice were independent of neutrophil infiltration [117]. 
 
 
 
 
Rather simple approaches to test the causality between neutrophil influx and pulmo-
nary genotoxicity would be either to use animals that are systemically depleted from 
neutrophils, for instance by administration of anti-PMN antibodies, or to use animals in 
which pulmonary influx of neutrophils is prevented by depletion of alveolar macro-
phages or by treatment with anti-chemokine antibodies [112, 118]. At present, we are 
 
Species Exposure Genotoxic endpoint Reference
Rat Quartz/carbon black (i.t.) Mutagenesis (Hprt ) Driscoll et al. , 1997/1996 [82, 89]
Rat Quartz (i.t.) DNA strand breaks Knaapen et al ., 2002 [106]
Rat Quartz (i.t.) 8-oxo-dG Nehls et al .,1997 [110]
Rat Quartz (i.t.) 8-oxo-dG, p53 mutations Seiler et al ., 2002 [111]
Rat Hyperoxia 8-oxo-dG Auten et al ., 2002 [112]
Rat Carbon black (inhalation) 8-oxo-dG Gallagher et al. , 2003 [113]
Mouse Diesel (inhalation) 8-oxo-dG, DNA strand breaks Dybdahl et al. , 2004 [114]
(no increased mutagenesis)
Table 3: In vivo studies showing an association between neutrophil influx and oxidant related genotoxicity
in the lung
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only aware of one single study that addressed pulmonary pathogenicity (unfortunately 
not genotoxicity) of particles in rats that were depleted from PMN. Interestingly how-
ever, this study showed that the recruitment of PMN to the alveolar region is not nec-
essarily linked with silica induced pulmonary toxicity [119]. In contrast, in a more re-
cent and similar study, systemic depletion of neutrophils was shown to protect against 
airway pathogenicity induced after a 4 week inhalation challenge with LPS [120]. Still, 
there is a lack of studies that have used such approaches to elucidate the causal role 
of neutrophils on pulmonary genotoxicity specifically. One crucial example is a study 
by Auten and colleagues, which showed that blocking of neutrophil influx by treatment 
with anti-CINC antibodies caused a significant reduction of pulmonary oxidative DNA 
damage (8-oxo-dG and DNA nicking) in hyperoxia exposed newborn rats [112]. So 
far, this is the only study providing solid evidence for a causal role of neutrophils in 
eliciting pulmonary oxidative DNA damage in vivo. It is, however, questionable wheth-
er this approach, i.e. blocking neutrophil influx into the lung, can be applied in studies 
that focus on chronic effects of pulmonary neutrophilic inflammation. With regard to 
tumour formation, for instance, it must be realised that neutrophils might play a dual 
role in later stages of the carcinogenic process. On the one hand, PMN infiltration into 
tumours might stimulate tumour progression by facilitating tumour growth, metastasis 
and angiogenesis through the release of a variety of proteases and growth factors like 
vascular endothelial growth factor [1], as well as by contributing to genetic instability 
of the tumour cells through release of ROS [121]. In line with this, it has been shown 
that tumour growth can be inhibited by the elimination of circulating PMN [122]. On 
the other hand, PMN have also been identified as potent anti-tumour cells and studies 
suggest that neutrophil infiltration into some tumours is associated with a favourable 
prognosis [123]. Paradoxically, this inhibitory role largely depends on the same wea-
ponry of neutrophils, e.g. release of cell damaging ROS, which is assumed to mediate 
their tumour promoting activity. 
Implications for the human situation 
The major question to be answered is whether the concept of in vitro and in vivo neu-
trophil induced pulmonary oxidative DNA damage and mutagenicity, as described 
above, can be extrapolated to humans. Current knowledge concerning the relation 
between neutrophils and pulmonary genotoxicity or carcinogenicity is largely obtained 
from high particle dose exposures using rats, which is recognised as a highly sensi-
tive species with regard to particle induced tumour formation. In humans, however, 
neutrophil influx is generally much less compared to (particle exposed) rats: e.g. total 
cell numbers in the rat lung lavage can be increased more than 10-fold, with neutro-
phils exceeding 50%. In contrast, heavy smokers, for instance, show a total cell re-
covery in bronchoalveolar lavage of about 4-5x greater than from non-smoking 
healthy individuals, with increases of neutrophils up to 10-30% [124, 125]. In addition, 
in humans that are chronically exposed to crystalline silica, the inflammatory response 
in the lung is mainly characterised by an influx of lymphocytes and macrophages 
rather than neutrophils [9], suggesting that neutrophils only play a minor part. Never-
theless, more recent data on effects of pulmonary instillation of particulate matter in 
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human volunteers indicate that neutrophils might have a role in the more acute phase 
of particle exposure, with BAL neutrophil percentages up to 40% [126]. However, 
even if such a profound neutrophil influx occurs in humans, it remains unclear whether 
this could lead to oxidant induced genotoxicity. For instance, up to now there is still a 
lack of studies that tried to assess pulmonary oxidative DNA damage in lung diseases 
that are specifically characterised by neutrophil influx, such as chronic obstructive 
pulmonary disease or acute respiratory distress syndrome. An indication of the possi-
ble role of neutrophils in human pulmonary genotoxicity could be provided by previous 
studies from our own laboratory, where we focussed on the nose as a more easily 
accessible part of the respiratory tract to evaluate respiratory neutrophil induced DNA 
damage. To our own surprise however, we could not find a relation between neutro-
phil numbers present in nasal lavage and 8-oxo-dG formation in nasal epithelial cells, 
although the presence of neutrophils was closely associated with epithelial cell prolife-
ration [85]. Although one should be cautious by interpreting these data, they indicate 
that the presence of neutrophils is not necessarily linked to oxidative DNA damage in 
the human respiratory tract. This would probably point to highly efficient antioxidant or 
DNA repair responses in humans, as opposed to the rat. 
 In considering the validity of the rat neutrophil model of pulmonary genotoxicity for 
the human situation, assessment of species specific host factors may provide useful 
information. In contrast to the rat, exposure of mice and hamsters to high lung particle 
doses has been much less associated with development of lung tumours, which is 
directly related to a less pronounced inflammatory response in these animals [15]. 
Regardless of the actual numbers of neutrophils that enter the airways, the inherent 
capacity of neutrophils to generate ROS, as well as the differential ability of species 
and/or target cells to counteract the adverse effects of ROS may be further crucial 
factors in defining the resulting neutrophil induced genotoxic effect. For instance, 
studies showed that the ROS releasing capacity of pulmonary neutrophils obtained 
from particle exposed hamsters was much less in comparison with cells obtained from 
the rat [127]. In addition, the hamster appeared to be far more effective at sustaining 
its antioxidant defences, suggesting a further explanation of the increased resistance 
of this species towards inflammation induced carcinogenicity [128]. 
Metabolic activation of chemical carcinogens by neutrophils 
By inhalation of polluted air (e.g. diesel exhaust, cigarette smoke, etc.), the human 
respiratory tract is exposed to a variety of environmental chemical carcinogens. Cur-
rently, it is largely accepted that in addition to the direct genotoxic effects of ROS, 
neutrophil derived oxidants are also implicated in pulmonary genotoxicity via the pro-
motion of metabolic activation of such inhaled chemicals, thereby generating highly 
DNA reactive and mutagenic compounds. For instance, neutrophils are able to trans-
form aromatic compounds, such as benzene, into more carcinogenic metabolites 
through oxidant mediated hydroxylation and nitration reactions [129]. In addition, 
neutrophil derived nitrite was associated with increased formation of mutagenic N-
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nitrosamines in the presence of nitrosatable amine precursors [130], whereas others 
showed that neutrophil derived oxidants are able to activate heterocyclic amines, such 
as 2-amino-3,8-dimethylimidazo[4,5-f]quinoxaline (MeIQx), into mutagenic electrophil-
ic products [131]. However, probably the most relevant pathway by which neutrophils 
may enhance metabolic activation of chemical carcinogenesis is a myeloperoxidase 
mediated peroxidative metabolism. A selection of studies showing neutrophil me-
diated metabolic activation of chemical carcinogens is listed in Table 4. 
 
 
 
 
At present, there is accumulating evidence that MPO gene polymorphisms are asso-
ciated with lung cancer risk [e.g.: 146-151]. One of the most frequently occurring po-
lymorphisms is a –463 G→A transition in the promoter region of MPO. Early studies 
showed that the presence of the A allele is associated with decreased MPO gene 
(mRNA) and protein expression in primary acute myeloid leukaemia cells, indicating a 
possible functionality of this polymorphism [152]. Consequently, a number of case-
control studies showed that persons carrying the mutant AA genotype have an up to 
40-70% reduced risk for lung cancer [146-151], although other studies could not con-
firm these results [153, 154]. Nonetheless, since pulmonary MPO is largely derived 
from recruited neutrophils [155], these studies further suggest an involvement of neu-
trophils in human pulmonary carcinogenesis. 
 Considering the role of MPO in the generation of HOCl, it would be expected that 
the possible protective effect of the –463 A allele is mediated through a reduced pro-
duction of HOCl. Although HOCl formation has been linked to induction of DNA dam-
age in vitro and in vivo, as we discussed above, there is currently no evidence in 
support of a causal role of HOCl in pulmonary carcinogenesis. On the contrary, there 
is growing evidence that the protective effect of the A allele is predominantly observed 
in smokers, mainly suggesting an interaction between neutrophils, MPO and cigarette 
smoke constituents [148, 149]. This is further supported by data showing that the 
protective effect of the MPO polymorphism was found to be strongest for small cell 
lung cancer specifically, which is a type of lung cancer strongly associated with ciga-
rette smoking [150]. Cigarette smoke is a potent source of chemical carcinogens, and 
at present, it is believed that the association between MPO and pulmonary carcinoge-
nesis can be explained by the involvement of neutrophil derived MPO in metabolic 
activation of inhaled chemical carcinogens, including aromatic amines [156-158] and 
heterocyclic amines [132]. However, MPO activity has most frequently been linked to 
 
Parent compound Mutagenic/carcinogenic product or effect Proposed mechanism Ref.
Amines N-nitrosamines Nitrosation mediated by NO release by PMN 130
N-arylhydroxamic acids Formation of 2-nitroso-fluorene (2-NOF) MPO mediated peroxidation 132
Aromatic amine (ABZ) Formation of ABZ-DNA adducts MPO mediated peroxidation 133
Aromatic amine (ABZ) Formation of 3'-Nitro-ABZ Nitrosation, catalysed by MPO in presence of nitrite 134
2-Aminofluorene (2-AF) 2-AF-DNA adducts MPO catalysed 135
Mutagenesis (Ames test) MPO catalysed 136
Benzene Formation of phenol and p-nitrophenol Peroxynitrite mediated hydroxylation and nitration 129
Heterocyclic amines (MeIQx) Formation of electrophilic mutagenic products one electron oxidation mediated by ROS 131
Heterocyclic amines (MeIQx) Formation of N-nitroso-compounds MPO catalysed nitrosation 137
Heterocyclic amines (IQ) Formation of IQ-DNA adducts MPO catalysed 138, 139
Aromatic Amine (3-ABA) Formation of 3-ABA-DNA adducts MPO catalysed 140
PAH (B[a]P) B[a]P-DNA adducts peroxyl/peroxide dependent epoxidation 141-145
Table 4: Examples of neutrophil or MPO mediated activation of environmental chemicals into genotoxic metabolites
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the metabolism of carcinogenic polycyclic aromatic hydrocarbons (PAH) [117, 138-
141]. 
 PAH account for a large group of structurally related, widespread environmental 
pollutants that are formed during incomplete combustion processes. In the western 
world, PAH are produced by, for example, power plants and combustion engines. The 
most potent source for human exposure however, is smoking. Benzo[a]pyrene (B[a]P) 
is the best studied PAH, and has widely been used as a prototype PAH to reveal the 
relationship between metabolic activation processes and chemical carcinogenesis 
[159-162]. Briefly, the activation of B[a]P involves a specific sequence of enzymatic 
reactions, resulting in the generation of bay region diol-epoxide (BPDE), which can 
form a covalent adduct with the exocyclic aminogroup of guanine in DNA [159-163] 
These BPDE-DNA adducts are mutagenic to bacteria as well as mammalian cells 
[164], elicit the transformation of cells in culture and are carcinogenic in several tis-
sues including the lung [165, 166]. 
Activation of PAH by neutrophil derived MPO 
The capacity of neutrophils to metabolise PAH to their DNA binding metabolites was 
already described in the 1980’s by in vitro and in vivo studies from Trush et al. [145] 
and Kensler et al. [144]. In these studies, they found that the interaction of the B[a]P 
metabolite B[a]P-7,8-dihydrodiol with phorbol ester activated neutrophils, but not al-
veolar macrophages (which lack MPO), resulted in the generation of a metabolite, 
which covalently binds to added calf thymus DNA. This effect could be ameliorated by 
the addition of the heme enzyme inhibitor sodium azide, suggesting the involvement 
of MPO [145]. In addition, activated PMN were shown to enhance the mutagenicity of 
B[a]P-7,8-dihydrodiol in the S. typhimurium strain TA100 [145]. These initial in vitro 
observations were also confirmed in vivo, by showing that recruitment and activation 
of PMN caused a 50% increase in covalent binding of B[a]P-7,8-dihydrodiol metabo-
lites to epidermal DNA in the skin of CD-1 mice [144]. The specific role of MPO was 
further revealed by showing that the B[a]P metabolite (±)-B[a]P-7,8-diol may serve as 
a substrate for MPO, thereby generating (+)-anti-benzo[a]pyrene diol epoxide (BPDE), 
which is the highly DNA reactive and most mutagenic metabolite of B[a]P [141, 142]. 
Specifically, by stereochemical analysis of tetrol products, it was shown that PMA 
activated PMN, as well as an in vitro MPO-H2O2 system, primarily generated anti-
diolepoxides with an anti/syn ratio > 5. Such ratios indicate that MPO epoxidises 
B[a]P-7,8-diol via a peroxyl/peroxide dependent activation mechanism [141]. The 
consequences of these processes for pulmonary neutrophilic inflammation have been 
described by studies demonstrating that bronchoalveolar lavage neutrophils, obtained 
from mice exposed to bacteria by inhalation, were able to transform B[a]P-7,8-diol to a 
DNA binding metabolite ex vivo. Again, this effect was shown to be MPO dependent 
[142]. More recently, these observations were confirmed by studies in our laboratory, 
showing that activated neutrophils enhance BPDE-DNA adduct formation in cocul-
tured alveolar epithelial target cells that were exposed to B[a]P-7,8-dihydrodiol [143]. 
 A major link between these mechanistic studies describing the role of MPO in the 
activation of chemical carcinogens, and the epidemiological studies indicating an 
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association between MPO and pulmonary carcinogenesis in smokers is possibly pro-
vided by a study in which we found a strong relationship between the MPO –463 
G→A polymorphism and PAH-DNA adduct levels in skin of atopic dermatitis patients 
treated with PAH containing coal tar ointments [167]. With regard to the situation in 
the lung, support is provided by our observation that the MPO –463 G→A polymor-
phism was indeed associated with a reduced MPO enzyme activity in bronchoalveolar 
lavage of smoking individuals. This was accompanied by a significant reduction in 
PAH-DNA adduct levels in pulmonary cells [125]. Since the formation of PAH-DNA 
adducts is considered as a crucial process in smoking related carcinogenesis [168], 
these observations provide a first indication of the possible causal relation between 
neutrophils, MPO and pulmonary carcinogenesis in humans. Overall, these related 
studies further define a role of neutrophils in human pulmonary carcinogenesis in 
addition to their capacity to release ROS: they can enhance metabolism of environ-
mental mutagenic carcinogens through release of MPO. 
Neutrophils and pulmonary genotoxicity: gaps and needs 
The association between chronic inflammation and the carcinogenic process has 
been observed for considerable time. However, the causal mechanisms that can 
explain for this association are still unclear. In the current review, we have focussed 
on one possible candidate mechanism, i.e. the contribution of neutrophils to genotox-
icity, with special reference to respiratory tract (Fig. 3). In vivo studies with rats have 
revealed a concept indicating that chronic neutrophilic inflammation upon high particle 
dose exposures may initiate and promote tumour growth in the lung. This seems to be 
largely facilitated by genotoxic processes through the release of DNA damaging ROS, 
as well as by inducing cell proliferation. It should be clear, however, that the causal 
role of neutrophils in ROS mediated DNA damage and mutagenesis is still primarily 
described by in vitro experiments. In vivo experiments using experimental animals 
have mainly provided indirect evidence, and additional research is needed to further 
test the relationship between neutrophils and ROS induced genotoxicity in the respira-
tory tract. Systemic depletion of neutrophils, or blocking neutrophil influx into the lung 
by treatment with specific antibodies seems to be a promising approach to further 
reveal the effect of neutrophils in animals acutely exposed to inflammatory agents 
(inhaled particles, microorganisms, hyperoxia) [e.g. [112]]. Such studies should ideally 
be performed by evaluating genotoxicity in target cells relevant for neoplastic out-
comes, instead of evaluating DNA damage in whole lung homogenates or in inflam-
matory cells obtained by BAL. We showed that isolation of pulmonary epithelial cells 
provides an opportunity to tackle neutrophil induced in vivo genotoxicity in a ‘multiple-
marker’ approach, since the contribution of various factors, including inflammatory cell 
influx, antioxidant status and cytotoxicity can be evaluated within a single animal . 
 The major question that remains to be answered is whether in vitro and in vivo 
observations in experimental animals can be extrapolated to humans. So far, it is still 
unclear whether neutrophils really cause ROS induced genotoxicity in the inflamed 
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human respiratory tract. On the other hand, recent molecular epidemiological studies, 
in combination with experimental in vitro and in vivo studies, have provided consistent 
evidence that neutrophils and human pulmonary carcinogenesis might be causally 
related by the capacity of neutrophils, via the release of MPO, to promote bioactiva-
tion of environmental carcinogens like PAH. Nonetheless, a lot of work needs to be 
done to provide a deeper insight into the role of PMN in pulmonary DNA damage and 
mutagenesis and whether this could trigger pulmonary carcinogenicity. Such know-
ledge may eventually lead to new approaches for inflammatory cancer prevention. 
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Figure 3. Simplified overview of the pathways by which neutrophils may impact on pulmonary genotoxicity. 
PMN cause oxidative DNA damage through generation of diffusible H2O2. In addition, PMN are able to 
enhance metabolic activation of inhaled chemical carcinogens, mainly by release of MPO. This may lead to 
increased DNA adduct formation. Both pathways of DNA damage induction, in combination with ROS 
induced cell signalling may ultimately lead to target cell mutagenesis and increased cell proliferation. 
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Abstract 
Chronic inflammation has been recognised as a contributing factor in the pathogene-
sis of lung cancer. In this process, reactive oxygen species (ROS) released by neu-
trophils may play an important role. The aim of the present study was to investigate 
the capacity of the major neutrophilic oxidant hypochlorous acid (HOCl), which is 
formed by myeloperoxidase (MPO), to induce DNA damage and mutagenicity in lung 
cells. HOCl was mutagenic in lung epithelial A549 cells in vitro, showing at physiologi-
cal concentrations a significant induction of mutations in the HPRT gene. We studied 
three major types of DNA lesions that could be relevant for this HOCl induced muta-
genicity. Single strand DNA breakage and 8-hydroxydeoxyguanosine were not found 
to be increased following HOCl treatment. On the other hand, HOCl caused a signifi-
cant increase in the formation of 3-(2-Deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-
α]purin-10(3H)-one (M1dG), which can be formed by either malondialdehyde (MDA) or 
base propenals. We observed an increased MDA formation upon exposure of A549 
cells to HOCl, but a role of base propenals cannot be excluded. In line with this, we 
observed 4- fold increased M1dG adduct levels in mice that were intratracheally in-
stilled with lipopolysaccharide to induce a pulmonary inflammation with neutrophil 
influx. Depletion of circulating neutrophils significantly reduced pulmonary MPO activi-
ty as well as M1dG adducts levels, thereby providing a causal link between neutro-
phils/HOCl and pulmonary genotoxicity in vivo. Taken together, these data indicate 
that myeloperoxidase catalysed formation of hypochlorous acid during lung inflamma-
tion should be considered as a significant source of neutrophil induced genotoxicity. 
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Introduction 
A significant fraction of the global cancer burden is attributable to chronic inflamma-
tion [1]. For instance, pulmonary inflammation linked to smoking is widely recognised 
as a risk factor for lung cancer development. For the respiratory tract however, the 
mechanism of carcinogenesis associated with chronic inflammation has not yet been 
fully elucidated. Alveolar and bronchial epithelial cells are exposed to a variety of 
reactive oxygen species (ROS) from both exogenous (e.g. cigarette smoke) and en-
dogenous sources, such as the phagocytic respiratory burst. With regard to tumour 
formation, it has been postulated that ROS, produced by the prolonged activation of 
inflammatory polymorphonuclear neutrophils (PMN), play a role in lung tumour forma-
tion [2]. But also in later stages of the carcinogenic process, during tumour progres-
sion, neutrophil infiltration and associated release of ROS in tumours provide a growth 
advantage [3]. Upon activation, neutrophils induce various oxidant generating en-
zymes, such as NADPH oxidase, superoxide dismutase and myeloperoxidase (MPO). 
As a result, high concentrations of a variety of reactive oxygen species (ROS) are 
generated, including superoxide (O2·-), hydrogen peroxide (H2O2) and the MPO cata-
lysed production of hypochlorous acid (HOCl), which are produced to attack invading 
infectious agents [4]. However, excess amounts of ROS generated in inflamed tissues 
can also damage DNA in target cells, leading to increased mutation load and poten-
tially carcinogenesis [5-8]. 
In rats, chronic exposure to particles, inducing a massive recruitment of neutro-
phils, is associated with tumour formation, and neutrophil induced genetic alterations 
and mutagenic effects in lung epithelial cells are thought to be key factors in this 
process [9, 10]. In vitro coincubation of rat lung epithelial cells with bronchoalveolar 
lavage (BAL) cells, isolated from particle treated rats, increased mutation frequency in 
the hypoxanthine guanine phosphoribosyl transferase (Hprt) gene [11]. Previously 
reported studies, using similar in vitro coincubation models of target cells with acti-
vated neutrophils, demonstrated that neutrophils are able to induce sister chromatid 
exchanges [5], strand breaks [12] and mutations in neighbouring target cells [re-
viewed in 8], suggesting a role of neutrophil derived ROS. In a previous study, we 
demonstrated that activated neutrophils cause induction of 8-hydroxydeoxyguanosine 
(8-oxo-dG) in alveolar cells in vitro, suggesting involvement of hydroxyl radicals (·OH) 
[13]. Altogether, these studies suggested that H2O2 generated by neutrophils is one of 
the essential mediators of the genotoxic effects, as it serves as latent form of hydroxyl 
radicals. Hydrogen peroxide is very stable and can cross cellular membranes, and is 
at the same time able to penetrate the nucleus where ·OH can be generated in the 
vicinity of the DNA molecule via the Fenton reaction with localised transition metals 
[14]. However, under physiological conditions, up to 70% of H2O2 is consumed by the 
neutrophil derived enzyme MPO to generate the strong oxidant HOCl [15]. Interesting-
ly, MPO has been implicated in the pathogenesis of inflammation related carcinoge-
nesis, with reference to the -463G→A polymorphism in the promoter region of the 
MPO gene, which is associated with a reduced risk of cancer in the lung [16, 17]. 
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Nevertheless, there are only limited data available on a potential role of HOCl in the 
pathophysiology of inflammation related lung cancer development. 
The aim of the present study was to assess the DNA damaging and mutagenic 
effects of neutrophil derived HOCl. First, we assessed three different types of HOCl 
induced DNA damage (DNA single strand breakage (ssDNA), 8-oxo-dG and 3-(2-
Deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3H)-one (M1dG), as well 
as HPRT mutations in human alveolar epithelial lung cells (A549). Secondly, based 
on initial in vitro findings revealing M1dG adducts as the most significant HOCl in-
duced DNA damaging effect in vitro, we assessed this promutagenic DNA adduct 
formation in the mouse lung following acute LPS instillation. The causal role of neu-
trophils in this in vivo genotoxic effect was addressed by depleting the animals of 
circulating neutrophils. 
Materials and Methods 
Cell treatment with HOCl 
Human epithelial lung adenoma carcinoma cell line (A549) (American Tissue Culture 
Collection) were cultured in DMEM (Sigma, Zwijndrecht, the Netherlands) supple-
mented with 10% heat inactivated foetal calf serum (FCS, Gibco Invitrogen, Breda, 
the Netherlands) and 1% penicillin/streptomycin (Sigma) under humidified atmos-
phere containing 5% CO2 at 37ºC. Cell passages between 25 and 40 were used for 
experiments described in this study. 
The concentration of HOCl stock solution (Sigma) was measured spectrophoto-
metrically, immediately before use, at 293 nm, using the extinction coefficient of hy-
pochlorite ε293 = 349.2 M-1cm-1 at pH 10-12. For comet assay and DNA isolation, near-
ly confluent monolayers of A549 cells grown in 75 cm2 culture flasks were used. Me-
dium was discarded and cells were exposed to increasing concentrations of HOCl (0-
100 µM) suspended in HBSS. After 15 min, cells were harvested by trypsinisation. 
Acute cytotoxicity of HOCl in A549 cells was tested using trypan blue dye exclusion. 
For the lipid peroxidation assay, A549 cells were cultivated in 100 mm dishes and 
treated at near confluency as described above. After the 15 min incubation period, 
medium was removed and the dishes were kept on ice. Cell monolayers were washed 
with ice-cold PBS and scraped from the dishes with 500 µl of fresh PBS per dish. 
Cells were sonicated briefly (15 sec) and the lysate was stored at -20ºC and used for 
malondialdehyde (MDA) measurement by thiobarbituric acid reactive substances 
(TBARS) formation. 
Hydrogen peroxide (250 µM) was used as a positive control for ssDNA, 8-oxo-dG 
and M1dG. Positive control for MDA measurement was Fe2+ (10 µM). Benzo[a]pyrene-
diol-epoxide (BPDE, 1 µM) was used as positive control for HPRT mutation analysis. 
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Single cell gel electrophoresis 
DNA single strand breakage in A549 cells was determined by alkaline comet assay 
[18], implemented according to recent guidelines [19]. After the incubation, cells were 
washed once, harvested and resuspended in HBSS at a cell concentration of 2 x 106 
cells/ml. The cell suspension was mixed with low melting point agarose (Sigma), 
reaching a final concentration of 0.65% LMP agarose and positioned on 1.5% aga-
rose coated slides. Further procedures were as described earlier [20]. Comets were 
stained with ethidium bromide (10 µg/ml) for fluorescence microscopy: per blindly 
scored slide, a total of 50 cells were scored using the software program Comet Assay 
III (Perceptive Instruments Ltd, Haverhill, UK). DNA strand breakage data were ex-
pressed as Tail Moment (TM), which is defined as the product of DNA content in the 
tail and the mean distance of migration in the tail. 
DNA isolation 
DNA was isolated using standard phenol extraction [21]. The DNA extraction proce-
dure was optimised to minimise artificial induction of 8-oxo-dG by using radical-free 
phenol, minimising exposure to oxygen and by adding 1 mM deferoxamine mesylate 
and 20 mM TEMPO (2,2,6,6-tetramethylpiperidine-N-oxyl), according to the European 
Standards Committee on Oxidative DNA Damage (ESCODD) [22]. DNA concentra-
tions were quantified by NanoDrop (Isogen-Lifescience, De Meern, the Netherlands) 
and samples were frozen at -20ºC until further analysis. 
Quantification of 8-oxo-dG 
High pressure liquid chromatography with electrochemical detection (HPLC-ECD) of 
8-oxo-dG was based on a method as described earlier [23]. Briefly, after extraction, 
DNA was digested into deoxyribonucleosides by treatment with nuclease P1 (1 U/µl) 
and alkaline phophatase (0.014 U/µl). The digest was then analysed by HPLC-ECD, 
using SupelcosilTM LC-18S column (250 x 4.6 mm) (Supelco Park, Bellefonte, PA, 
USA) and DECADE electrochemical detector (Antec, Leiden, the Netherlands). The 
mobile phase consisted of 10% aqueous methanol containing 94 mM KH2PO4, 13 mM 
K2HPO4, 26 mM KCl and 0.5 mM EDTA. Elution was performed at a flow rate of 1 
ml/min. 8-oxo-dG was detected at a potential of 400 mV and dG was simultaneously 
monitored by UV absorption at 260 nm. Results were expressed as the ratio of the 
determined 8-oxo-dG to dG. 
Quantification of M1dG 
The 32P-postlabelling technique was used to analyse the levels of 3-(2-Deoxy-β-D-
erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3H)-one (M1dG) adducts, as previous-
ly reported [24]. Briefly, a digestion method based on the DNA hydrolysis by micro-
coccal nuclease (Sigma) and a mixture of two spleen phosphodiesterases (Sigma) 
was applied. Hydrolysed samples, evaporated to dryness, were treated with nuclease 
P1 (Sigma). The modified nuclease P1 resistant nucleotides, evaporated to dryness, 
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were incubated with carrier-free [γ-32P]-ATP (Amersham, Buckinghamshire, UK) and 
T4-polynucleotide kinase (Epicentre Technologies, Madison, WI, USA) to generate 
32P-labelled adducts. M1dG adduct analysis was carried out by PEI-cellulose TLC 
chromatography according to published conditions [25]. Detection and quantification 
of M1dG adducts and total nucleotides were obtained by phosphor imaging technolo-
gy (Typhoon 9210, Amersham) and ImageQuant software (Molecular Dynamics, Sun-
nyvale, CA, USA). After background subtraction, the levels of DNA adducts were 
expressed as relative adduct labelling (RAL = adducted nucleotides/total nucleotides). 
Standard MDA modified [26] and unmodified DNA were routinely processed in the 
analysis as controls. 
Lipid peroxidation assay 
The thiobarbituric acid reactive substances (TBARS) were measured by means of 
HPLC according to Lepage et al. [27]. Briefly, 100 µl of cell lysate or MDA standard 
were mixed with 900 µl reagent composed of 10 parts of reagent A (0.012 M 2-
thiobarbituric acid (TBA), 0.32 M H3PO4 and 0.01% EDTA) and one part of reagent B 
(butylated hydroxytoluene in ethanol, 1.5 mg/ml). Standards were prepared using 0-
10 µM MDA solutions in PBS, which were derivatised in the same analytical mea-
surements as the samples. The tubes were covered with marbles and heated for 1 h 
at 99ºC. After cooling, the product was extracted in 500 µl butanol by vigorous shak-
ing and the tubes were centrifuged for 5 min at 5000 g. 30 µl of the extract was in-
jected on to a NucleosilTM C18 column (150 mm x 3.2 mm) (Supelco Park, Bellefonte, 
PA, USA) and eluted with 65% water and 35% methanol + 0.05% trifluoroacetic acid. 
Fluorescence was recorded at λex 553 nm. The peak of TBA-MDA product was inte-
grated and the concentration of MDA was corrected for protein content of the lysates. 
The results were expressed as a percentage of TBARS formation, taking the control 
sample as 100%. 
Protein determination 
Protein concentrations were determined spectrophotometrically using the DC-protein 
assay Kit (BIORAD, Veenendaal, the Netherlands) as per manufacturers protocol. 
Clonogenic survival assay 
The sensitivity of A549 cells to HOCl was assayed by clonogenic survival. Briefly, 
cells were seeded at a density of 4 x 105 cells/60 mm dish and grown for 24 h before 
exposure to HOCl (0-100 µM) or BPDE (1 µM). Cells were treated for respectively 15 
min and 30 min at 37ºC with the indicated dosages, after which they were harvested 
and seeded in triplicate for each concentration. After ~14 days of growth, the medium 
was removed and colonies were fixed and stained with 2% bromophenolblue in 70% 
ethanol. Any groupings of cells containing 50 or more cells were counted as a colony. 
For each dose, survival was calculated from the relative colony forming ability of the 
HOCl exposed cells compared to control. 
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HPRT mutation analysis 
For the determination of HPRT mutant frequencies, A549 cells were seeded at 1 x 106 
cells/100 mm dish. The following day, cells were treated with the different doses of 
HOCl (15 min at 37ºC) or BPDE (30 min at 37ºC) and were subcultured for 1 week to 
allow phenotypic expression of the acquired mutations. Cells were then seeded in 
selective medium containing 6-thioguanine (6-TG) and incubated until colonies were 
formed (~3 weeks). 6-TG resistant colonies consisting of cells carrying HPRT muta-
tions were fixed, stained and counted. All experiments were normalised for plating 
efficiency. Finally, HPRT mutant frequency was defined after correcting for clonogenic 
survival. 
LPS induced acute lung inflammation mouse model 
Male Wt C57Bl6 mice (~12 weeks old) were obtained from Charles River Breeding 
Laboratories (Heidelberg, Germany). Mice were housed individually in standard la-
boratory cages and received food and water ad libitum throughout the experiments. 
The studies were carried out in accordance with an approved protocol by the institu-
tional Animal Care Committee of Maastricht University. 
 Mice were treated with LPS (Escherichia Coli, serotype O55:B5, Sigma) by intra-
tracheal instillation to induce an acute pulmonary inflammation. The dose of LPS was 
20µg/instillation/mouse. Intratracheal instillation was performed by a nonsurgical 
technique under anaesthesia as previously described [28]. Sham mice were instilled 
with sterile 0.9% NaCl. 
 Since a previous study [29] demonstrated that local LPS challenge in Wt C57Bl6 
mice results in a time dependent neutrophil accumulation peaking at day 3, mice (n = 
10) were sacrificed 3 days postexposure by 115 mg/kg sodium pentobarbital (Ceva 
Sante Animale, Maassluis, the Netherlands) and bronchoalveolar lavage (BAL) (3x 
with 1 ml sterile 0.9% NaCl) was performed to remove as much as possible inflamma-
tory cells from the airways. After centrifugation, the cell-free BAL fluid (BALF) was 
stored at -80ºC for MPO activity measurement. Lavaged lungs were snapfrozen in 
liquid nitrogen and pulverised using mortar and pestle. The pulverised lung tissue was 
stored at -80ºC until DNA isolation. 
 To unravel the direct role of neutrophils in pulmonary genotoxicity/mutagenicity, 
depletion of circulating neutrophils in mice (n = 5) was achieved by intraperitoneal 
injection of 0.5 mg of the monoclonal rat anti-mouse neutrophil antibody NIMP-R14 
(Hbt, Maastricht, the Netherlands), 24 h before i.t. LPS instillation. NIMP-R14 has 
been shown to selectively deplete mouse neutrophils in vivo for up to 6 days [30, 31]. 
In our study, a lack of MPO activity in the lung was used as a verification of this neu-
trophil absence. IgG (eBioscience, San Diego, CA, USA) was used as control mAb in 
the sham group. Again, 3 days after instillation, mice were sacrificed, and lungs were 
lavaged and isolated as described above. 
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MPO activity measurement 
Only activated neutrophils, which undergo an oxidative burst with associated release 
of MPO and subsequent formation of HOCl, can induce genotoxic effects in pulmo-
nary epithelial tissue. Therefore, extracellular MPO activity was measured in cell-free 
BALF as described by Klebanoff et al. [32], which is indicative for the presence of 
(activated) neutrophils in the lung [33]. 
Statistical analysis 
Data are expressed as mean ± standard error of the mean (SEM) of duplicate deter-
minations of at least two independent incubations concerning the in vitro experiments 
or of at least 5 in vivo samples per group. ANOVA with post hoc testing (Dunnett’s 
correction for multiple testing, two-sided) was applied to test differences between 
treatments and control. Statistical analysis was performed using SPSS v.15.0. In each 
case, a difference was considered statistically significant at P < 0.05. 
Results and Discussion 
Genotoxic effects of hypochlorous acid: use of an in vitro model 
In previous coincubation models of neutrophils and lung epithelial cells, we showed 
that activated neutrophils induce the formation of 8-oxo-dG and ssDNA breaks in 
epithelial cells, which could be mimicked by treatment of the cells with H2O2 [8, 20]. In 
the present study, we investigated the ability of the major oxidant derived from acti-
vated neutrophils, namely HOCl, to induce ssDNA breaks, 8-oxo-dG and M1dG in 
A549 cells. When A549 cells were exposed to increasing concentrations of HOCl, no 
acute cytototic effects were observed at physiological concentrations. The viability of 
the epithelial cells was > 90% after treatment with up to 200 µM of HOCl during 15 
min. These doses can be produced in vivo at sites of inflammation and also reflect the 
amount of HOCl produced in in vitro cocultures (1:1 ratio with activated neutrophils 
yields ~150 µM HOCl) [34]. 
 At physiological concentrations, no significant increase in ssDNA breaks or 8-oxo-
dG levels was detected compared to controls (Fig. 1A&B). It should be emphasised 
that HOCl is not considered to be a highly DNA reactive agent, and mainly targets 
proteins and lipids, before it reaches the nucleus [35]. Early studies have shown that 
stimulated neutrophils can cause lipid peroxidation [36, 37]. Lipid peroxidation gene-
rates a complex variety of products among which are reactive electrophiles, such as 
epoxides and aldehydes [38]. Malondialdehyde is a major product of lipid peroxida-
tion, capable of interacting with nucleic acid bases to form exocyclic DNA adducts, 
mainly M1dG [26]. M1dG adducts have been shown to be promutagenic in mammalian 
cells and to induce frameshift mutations and base pair substitutions [39]. In this way, 
HOCl may exert mutagenic effects indirectly via its attack on lipids. As a third geno-
toxic effect, we assessed the capacity of HOCl to induce M1dG adducts in A549 cells 
in vitro, being one of the major adducts resulting from lipid peroxidation [40]. Results 
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showed a significant (up to 3-fold, P < 0.01) induction of M1dG by HOCl at 50 µM (Fig. 
1C), independent from acute cytotoxicity. Clearly, such a rise in exocyclic M1dG ad-
ducts could be due to increased levels of MDA, but also to a decreased repair of 
these adducts, via the nucleotide excision repair pathway [41]. The latter is in line with 
recent data from our laboratory, showing that neutrophil derived HOCl inhibits nucleo-
tide excision repair [42]. 
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Figure 1. DNA damage in A549 cells induced by HOCl in vitro. A549 cells were exposed to increasing 
concentrations of HOCl (0-100 µM) for 15 min at 37ºC. (A) ssDNA breaks in A549 cells were monitored 
by comet assay and are expressed as mean ± SEM % of control of duplicate determinations from 2 
independent incubations. 250 µM H2O2 was assessed as positive control (5873 ± 3053 % to control, 
data not shown). (B) 8-oxo-dG was measured using HPLC-ECD and is expressed as mean ± SEM % 
of control of duplicate determinations from 2 independent incubations. 250 µM H2O2 was used as 
positive control (398 ± 2 % of control, data not shown). (C) M1dG adducts were detected using 32P-
postlabeling and expressed as mean ± SEM % of control of triplicate determinations from 2 indepen-
dent incubations. Cell treatment with 250 µM H2O2 gave 345 ± 9 % of M1dG adducts compared to 
control and was used as positive control (data not shown). * P < 0.05, ** P < 0.01 vs. control. 
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To support the M1dG adduct data and to clarify if HOCl can induce aldehyde formation 
in lung epithelial cells, we measured MDA in A549 cells exposed to HOCl in terms of 
its reaction with thiobarbituric acid. Figure 2 illustrates higher MDA levels in cells 
treated with HOCl as measured by TBAR formation (P = 0.07 at 50 µM HOCl). This 
increase in MDA formation can be assigned to HOCl induced lipid peroxidation. It 
should be noted, however, that also another pathway for aldehyde formation, inde-
pendent of lipid peroxidation, may be important in the observed generation of MDA 
and associated M1dG adducts. Hazen et al. [43] have demonstrated that HOCl oxidis-
es amino acids to chloramines. The latter derivatises lose of chloride and CO2 to form 
imines; imines subsequently hydrolyse to aldehydes. Furthermore, M1dG adducts can 
also arise from the reaction of 2-deoxyguanosine with a DNA peroxidation product, 
namely base propenal, which is formed by oxidative attack of the sugar phosphate 
backbone. However, since we did not observe an increase of 8-oxo-dG, it is not clear 
whether direct oxidation of DNA by HOCl occurs in sufficient amounts to induce this 
alternative pathway leading to M1dG adduct formation. 
 In general, based on the genotoxic endpoints addressed in this study, these in 
vitro data suggest that the DNA damaging effect induced by HOCl is mainly second-
ary via an oxidative attack on lipids and/or proteins. 
 
 
 
Figure 2. HOCl induced lipid peroxidation in A549 cells. A549 cells were treated with increasing doses 
of HOCl (0-100 µM) for 15 min and formed TBARs were used as a measure for lipid peroxidation. Data 
are corrected for protein content in the lysate and are expressed as % to control. Fe2+ (10 µM) was 
used as positive control and values were 281 % of MDA compared to control incubation (data not 
shown). 
 
Mutagenic effects of hypochlorous acid 
To reveal whether M1dG adducts caused by HOCl are relevant to mutagenesis, the 
ability of HOCl to form mutations at the HPRT locus was investigated in A549 cells. 
First, long term survival after HOCl treatment was studied by determination of the 
clone forming ability. Cells counted with dye exclusion method and plated a few hours 
after treatment with increasing concentrations of HOCl showed a relative survival 
going from 100% to 25% at 100 µM (Fig. 3A). Figure 3B illustrates the mutant fre-
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quency corrected for this cloning efficiency after the expression time, showing a dose 
dependent and statistically significant increase of the HPRT mutant frequency (P = 
0.01 at 25 µM HOCl). The decrease in mutation frequency at 100 µM HOCl is proba-
bly due to HOCl induced cytotoxicity on a long term as observed by the clonogenic 
survival assay. 
 This is the first study to report on mutagenic effects of HOCl in mammalian cells. 
Both an increase in DNA lesions and the inhibition of DNA repair induced by HOCl 
may play a role in the process of HPRT gene mutation. 
 
A 
 
 
B 
 
 
Figure 3. Mutagenicity of HOCl. (A) Clonogenic survival assays were used to determine the sensitivity 
to 15 min acute treatment with HOCl in A549 cells. The mean values of 3 independent experiments are 
shown with SEM. (B) The number of HPRT mutants was determined via selection in medium contain-
ing 6-TG. Mutations were corrected for survival and HOCl induced mutation frequencies are expressed 
as mean ± SEM of 3 independent experiments. BPDE, a well known mutagen, was assessed as posi-
tive control (data not shown). As only 25% of the A549 cells exposed to 100 µM HOCl survived after 
one week of culturing, the associated mutation frequency data point was left out statistical analysis, 
thus only the HOCl doses ranging from  
0-50 µM were taken in consideration. * P < 0.05 vs. control (P = 0.06 at 50 µM HOCl). 
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Neutrophil induced DNA damage in epithelial cells: an in vivo mouse 
model of acute lung inflammation 
Although the above in vitro findings may suggest M1dG adducts as being the most 
significant lesion underlying HOCl induced mutagenicity in lung epithelial cells, the 
relevance with respect to the mechanism of HOCl induced genotoxicity by neutrophils 
in vivo is unclear. Therefore, an LPS induced acute lung inflammation mouse model 
expanded with a systemic depletion of neutrophils was used to elucidate the involve-
ment of neutrophils and associated HOCl production in the induction of DNA damage 
in respiratory tract epithelial cells in vivo. 
 As extracellular MPO activity is indicative for the presence of activated neutro-
phils and serves as a surrogate marker for HOCl formation in the lung [33], MPO was 
assessed in BALF to verify neutrophil activation. Significant MPO activity was ob-
served in the LPS instilled mice (81.4 ± 20.5 mU/ml), whereas no MPO activity was 
detected in the sham group. Absent MPO activity in the neutrophil depletion group 
indicates absence of HOCl in these animals. 
 To reveal whether our in vitro observation, showing HOCl induced M1dG adduct 
formation in alveolar epithelial cells, corresponds with the in vivo situation, we ex-
amined the DNA damaging effects of neutrophils in pulmonary tissue of mice after i.t. 
LPS instillation. Similar as the in vitro finding on direct HOCl induced genotoxicity, no 
direct oxidative DNA damage was found by 8-oxo-dG measurement in LPS instilled 
mice (31.9 ± 6.9 8-oxo-dG/106 nucleotides) as compared to sham mice (25.3 ± 4.3 8-
oxo-dG/106 nucleotides). This is in line with previous studies in which we were not 
able to find increased 8-oxo-dG levels in lungs from rats intratracheally treated with 
crystalline silica at dose levels that caused massive neutrophil influx into the airways 
[44]. In contrast, LPS treatment caused a significant increase in the formation of M1dG 
adducts in the mouse lung (~4-fold, P < 0.01) (Fig. 4). Moreover, a significant correla-
tion was found between MPO activity in BALF and M1dG levels in epithelial cells 
(Pearson correlation = 0.67, P = 0.001). This finding is in line with the above in vitro 
observations and suggests a link between neutrophil influx, MPO mediated formation 
of HOCl and formation of M1dG adducts in vivo. The causal role of neutrophils and 
HOCl in this effect is further substantiated by the observation that depletion of circulat-
ing neutrophils causes a significant reduction in M1dG adduct levels in the LPS 
treated mice.  
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Figure 4. M1dG adduct levels in lung tissue after LPS exposure. Data are expressed as mean ± SEM 
of M1dG adducts/108 nucleotides (n = 5-10). ** P < 0.01 vs. sham animals. 
Conclusions 
It has been proposed that ROS generated by activated inflammatory neutrophils may 
be involved in mutagenic processes and, hence, play a pivotal role in carcinogenesis. 
Focussing on HOCl as the major oxidant produced by neutrophils, this study is the 
first to report that HOCl induces mutations in lung epithelial cells indicating mainly an 
indirect genotoxic hazard of neutrophil derived HOCl, by its attack on lipids and/or 
proteins producing MDA and forming M1dG adducts. Altogether, our data indicate that 
MPO catalysed formation of HOCl should be considered as a significant source of 
neutrophil induced DNA damage and possibly mutagenesis. These data support re-
cent molecular epidemiology studies, reporting a protective effect of an MPO poly-
morphism on lung cancer risk in smokers, and hence suggesting the involvement of 
the myeloperoxidase product hypochlorous acid in inflammation related lung cancer 
development. Moreover, with regard to neutrophil infiltration in tumours, the release of 
HOCl may also contribute to genetic instability in tumour cells, thereby further stimu-
lating tumour progression. 
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Abstract 
Neutrophils are thought to affect pulmonary carcinogenesis by promoting the metabol-
ism of inhaled chemical carcinogens, causing enhanced formation of promutagenic 
DNA adducts. We hypothesised that neutrophils interfere with the removal of such 
DNA adducts by inhibiting nucleotide excision repair (NER) in target cells. Human 
alveolar epithelial cells (A549) were cocultured with activated neutrophils and we 
observed a significant reduction of NER in the A549 cells, which was abrogated upon 
addition of the myeloperoxidase (MPO) inhibitor 4-ABAH. The inhibitory effect of neu-
trophils could be mimicked by the MPO product HOCl, which caused an acute, dose 
dependent inhibition of NER in A549 cells. This was independent of cytotoxicity or 
ATP loss, and persisted up to 24 h. These data were supported by showing that HOCl 
caused a delayed removal of DNA adducts in benzo[a]pyrene-diol-epoxide exposed 
A549 cells. The acute HOCl induced inhibition of NER can only be explained partly by 
oxidative modification of repair proteins. To explain the more persistent effects of 
HOCl, we analysed the expression of NER genes and found that HOCl significantly 
reduced XPC expression. In conclusion, these data indicate that neutrophils are po-
tent inhibitors of nucleotide excision repair. This may provide a further biological ex-
planation for the association between inflammation and lung cancer development. 
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Introduction 
Chronic inflammation is considered to be a risk factor for the development of epithelial 
cell derived malignancies [1, 2]. However, the underlying processes have not yet been 
fully defined at the biochemical and molecular level. Within the lung, many inflamma-
tory agents may play a part in accelerating carcinogenesis, including inhaled combus-
tion derived particles, such as cigarette smoke, fine particulate matter (PM) and diesel 
exhaust particles [3]. Inhalation of such particles causes a local pulmonary inflamma-
tory response that is characterised by the influx of polymorphonuclear neutrophils 
(PMN) into the airways. These inflammatory PMN are involved in the pathogenesis of 
various pulmonary diseases, such as chronic obstructive pulmonary disease (COPD) 
[4], fibrosis [5] and cancer [6]. 
 Upon entering the lung, neutrophils are activated to release reactive oxygen spe-
cies (ROS), as well as an array of proteins, such as myeloperoxidase (MPO). MPO 
catalyses the conversion of H2O2 into the bactericidal compound hypochlorous acid 
(HOCl) [7]. Under physiological conditions, the concentration of HOCl ranges from 10 
to 100 µM [8], although concentrations up to 200 µM have been reported in some 
tissues [9]. Even though HOCl formation has been linked to the induction of DNA 
damage [10], the primary cellular targets for HOCl appear to be proteins [11]. HOCl-
protein interactions result in side-chain modification, backbone fragmentation and 
crosslinking [12], which may ultimately lead to disturbed enzyme function. In vitro 
studies indeed have identified HOCl as a potent inhibitor of acetylcholinesterase [13] 
and glutathione S-transferase P1-1 [14]. In addition, HOCl has also been demonstrat-
ed to be an inhibitor of DNA strand break repair [15], as well as of poly (ADP-ribose) 
polymerase (PARP) activity, which is involved in base excision repair [16]. 
 Epidemiological studies have indicated that neutrophils are involved in pulmonary 
carcinogenicity by releasing MPO in the cellular environment. For instance, there is 
evidence that a polymorphism in the promotor region of the MPO gene (-463G→A 
transition) is associated with a decreased risk of developing lung cancer in smokers 
[17]. At present, the most widely accepted explanation for this association is the role 
of MPO in the bioactivation of inhaled carcinogens, such as polycyclic aromatic hy-
drocarbons (PAH). For example, MPO has been demonstrated to enhance the trans-
formation of the prototype PAH benzo[a]pyrene (B[a]P) into DNA binding metabolites 
[e.g. B[a]P diolepoxide (BPDE)] [18-21]. If these helix distorting DNA lesions escape 
from specific DNA repair (i.e. nucleotide excision repair), they may cause replication 
fork blocks, ultimately leading to mutagenesis and carcinogenesis [22-24]. 
 Recent data have revealed that oxidising species, such as 4-hydroxynonenal (4-
HNE) [25], malondialdehyde (MDA) [26] and nitric oxide [27] are endogenous inhibi-
tors of nucleotide excision repair (NER). A comparable effect of the potent oxidising 
MPO product HOCl could, thus, provide an additional explanation for the observed 
association between neutrophils and lung cancer risk in subjects exposed to DNA 
adduct forming chemicals. In the present study, we investigated the effect of activated 
neutrophils on the NER capacity of pulmonary epithelial cells. We hypothesised that 
neutrophils, by virtue of their capacity to release HOCl, are potent inhibitors of NER, 
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thereby causing a disturbed removal of promutagenic PAH-DNA adducts. To test this 
hypothesis, activated neutrophils were cocultured with human epithelial lung cells. We 
found that neutrophils significantly reduced the NER capacity of the cocultured epi-
thelial cells, leading to a delayed removal of bulky BPDE-DNA adducts. This effect 
appeared to be mediated by MPO derived HOCl. We propose that these effects of 
neutrophils may provide an additional biological explanation for the observed associa-
tion between inflammation and lung cancer risk [6]. 
Materials and methods 
Cell culture 
A549 cells (human epithelial lung carcinoma cells), purchased from the American 
Tissue Culture Collection (ATCC), were cultured in DMEM (Sigma, Zwijndrecht, the 
Netherlands) supplemented with 10% heat inactivated foetal calf serum (FCS, Gibco 
Invitrogen, Breda, the Netherlands) and 1% penicillin/streptomycin (Sigma, 
Zwijndrecht, the Netherlands). Cells were maintained at 37°C in a 5% CO2 atmos-
phere. Cells were routinely grown in 75 cm2 cell-culture flasks and were passaged 
twice a week. 
Cocultures of neutrophils and epithelial lung cells 
Coincubation experiments were performed as described by Knaapen et al. [28]. Brief-
ly, neutrophils were freshly isolated from the blood of healthy, non-smoking volunteers 
by gradient centrifugation (800x g, 20 min, 4°C), using lymphoprep (Axis-Shields, 
Oslo, Norway). Lymphocytes were removed and the remaining erythrocytes were 
lysed using cold (4°C) lysis buffer (155 mM NH4Cl, 10 mM KHCO3, 10 mM EDTA, pH 
7.4). PMN were washed and resuspended in Hanks’ balanced salt solution (HBSS, 
Gibco Invitrogen, Breda, the Netherlands) at 10 x 106 cells/ml. This method consis-
tently yielded PMN with a viability > 95%, as assessed by trypan blue dye exclusion 
(Sigma, Zwijndrecht, the Netherlands). During all the stages of the isolation proce-
dure, PMN and solutions were kept on ice to prevent premature activation. 
 Neutrophils were cocultured with confluent A549 cells grown in 75 cm2 culture 
flasks. The final volume of the incubations was always 10 ml with a total neutrophil 
number of 5 x 106 or 10 x 106, yielding a final neutrophil:A549 ratio of 1:2 and 1:1 
respectively. Neutrophils were subsequently activated with phorbol 12-myristate 13-
acetate (100 ng/ml) (PMA, Sigma) to elicit the respiratory burst. Cells were then coin-
cubated during 1 h in HBSS (37°C, 5% CO2). Control incubations were without PMN 
and/or without PMA. Following incubation, the neutrophils were removed using two 
repetitive washings with 10 ml of cold (4°C) HBSS. The A549 cells were harvested by 
trypsination for analyses of toxicity and NER capacity. Cytotoxicity of PMA and/or 
PMN in A549 was tested using trypan blue dye exclusion. All studies were performed 
at pH 7.4. To investigate the role of MPO, 100 µM of the highly specific MPO inhibitor 
4-aminobenzoic hydrazide (4-ABAH, Sigma) [29] was added to coincubations of A549 
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with PMA activated PMN (1:1 ratio). Coincubations were then performed as described 
above. 
Measurement of myeloperoxidase activity 
MPO activity in the supernatant of the neutrophil-A549 coincubations was assayed 
according to the method described by Klebanoff et al. [30]. Therefore, 100 µl of su-
pernatant was mixed with 400 µl MPO assay solution, which comprised 26.9 ml H2O, 
3 ml sodium phosphate buffer (0.1 M, pH 7.0), 48 µl guaiacol and 100 µl H2O2 (0.1 M) 
(all these chemicals were purchased from Merck, Darmstadt, Germany). The genera-
tion of tetra-guaiacol was measured spectrophotometrically (Beckman) at 470 nm. 
MPO activity was calculated using the formula: U/ml = ΔOD/min x 0.7518 and was 
expressed as mU/ml. One unit is defined as the amount of the enzyme that consumes 
1 µmol H2O2/min. 
Cell treatment with HOCl 
The concentration of the HOCl stock solution (Sigma) was measured spectrophoto-
metrically, immediately before use at 293 nm, using the extinction coefficient of hy-
pochlorite ε293 = 349.2 M-1.cm-1 at pH 10-12. HOCl was diluted in HBSS to final, phy-
siological concentrations ranging from 0 to 200 µM. Confluent A549 cells were 
washed twice with HBSS of 37°C. Fresh HBSS was then added followed by the addi-
tion of HOCl. After 15 min of incubation at 37°C, cells were harvested as described 
above. To assess prolonged effects of HOCl exposure, cells were treated with HOCl 
during 15 min, followed by washing and continued incubation in DMEM for up to 24 h. 
Addition of HOCl did not alter the pH of the reaction mixture. Cytotoxicity of HOCl in 
A549 was tested using trypan blue dye exclusion. 
Repair assay: modified comet assay to assess phenotypically nucleo-
tide excision repair 
Phenotypical assessment of NER capacity of the A549 cells was performed using a 
modified comet assay developed in our own laboratory [31]. This assay is based on a 
method described by Collins et al. [32] and is specifically designed to test the ability of 
cell lysates to detect and excise benzo[a]pyrene-diol-epoxide (BPDE-)DNA adducts in 
gel-embedded nucleoids. Briefly, nucleoids are prepared by embedding untreated 
A549 cells in low melting point agarose (Sigma, Zwijndrecht, the Netherlands) on 
microscopic slides and subsequently lysing these cells overnight in cold (4°C) lysis 
buffer (2.5 M NaCl, 0.1 M EDTA, 10 mM Tris, 0.25 M NaOH, pH 10, 10% dimethylsul-
foxide (DMSO) and 1% Triton X-100). The resulting nucleoids were then exposed to 
either 1 µM BPDE (NCI Chemical Carcinogen Reference Standard Repository, Mid-
west Research Institute, Kansas City, MO, USA) or DMSO during 30 min on ice. 
 In parallel, cell extracts were prepared from the cocultured A549 cells or the A549 
cells treated with HOCl, based on the method developed by Redaelli et al. [33], with 
minor modifications [31]. In some experiments, lysates were first isolated from un-
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treated A549 cells and then exposed to HOCl in vitro, to investigate the conse-
quences of the direct interaction of HOCl with the repair proteins. Protein concentra-
tions of the cell lysates were determined by the BIO-RAD DC Protein Assay Kit (BIO-
RAD, Veenendaal, the Netherlands), using bovine serum albumine (BSA) as external 
standard, and protein extracts were diluted to 1 mg/ml. To assess the ‘ex vivo’ repair 
capacity, each protein extract was finally added onto DMSO exposed as well as 
BPDE exposed gel-embedded nucleoids and incubated during 10 min at 37°C. Sub-
sequently, the slides were processed according to the conventional comet assay as 
described previously [34]. Comets were visualised using a Zeiss Axioskop fluores-
cence microscope and quantified as tail moment. Samples were tested in two inde-
pendent incubations within each single experiment. On every slide, 50 cells were 
analysed randomly using the Comet assay III software program (Perspective Instru-
ments, Haverhill, UK). The increased DNA strand breakage (tail moment) in the BPDE 
modified nucleoids versus the DMSO treated nucleoids is indicative for the NER ca-
pacity of the cell extracts. The final repair capacity was calculated according to Langie 
et al. [31], and is expressed as percentage of control. 
 This sensitive method has the advantage that it can be performed without the use 
of radioisotopically labelled probes. In addition, instead of using circular plasmids or 
probes containing a specific DNA lesion, this assay applies whole cell derived nucle-
oids which are treated with BPDE, inducing BPDE-DNA adducts that are targets for 
the repair proteins. These nucleoids retain the normal structure of the mammalian 
nucleus and are, thus, a more physiological substrate for studying the efficiency of cell 
lysates to repair eukaryotic DNA. Our assay was validated by showing that lysates 
obtained from Xeroderma Pigmentosum complementation group A and C deficient 
fibroblasts (Xpa and Xpc respectively) were unable to recognise and excise the 
BPDE-DNA adducts in the nucleoids, whereas fusion of both lysates fully restored the 
NER capacity [31]. 
32P-postlabelling of BPDE-DNA adducts 
As an additional approach to reveal the effects of HOCl on NER capacity in target 
cells, we studied the influence of HOCl on the kinetics of BPDE adduct removal in 
proliferating A549 cells. Therefore, A549 cells were exposed to 0.1 µM BPDE during 
30 min on ice, followed by treatment with HOCl (100 µM, in HBSS) during 15 min. 
After treatment with HOCl, the medium was replaced by DMEM (37 ºC) to allow re-
covery of the cells. Cells were harvested by trypsination at different time points post-
exposure (0 to 4 h) to assess the kinetics of DNA adduct removal using 32P-
postlabelling. Standard high salt extraction was used to obtain genomic DNA. 32P-
postlabelling was carried out using the nuclease P1 enrichment technique as de-
scribed by Reddy and Randerath [35] with some modifications [36]. In all experiments, 
three BPDE-DNA standards with known adduct levels (1 adduct/106, 1 adduct/107 and 
1 adduct/108 normal nucleotides) were analysed in parallel for quantification purpos-
es. Quantification was performed using Phosphor-Imaging technology (Fujifilm FLA-
3000). Part of the digest was used to determine the final amount of DNA in the assay 
by HPLC-UV, and the BPDE-DNA adduct levels were corrected accordingly. 
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ATP measurement 
To assess the effects of HOCl on ATP levels in A549 cells, cells were seeded in 24-
well plates. At confluency, cells were washed twice with HBSS, followed by the addi-
tion of 500 µl of HOCl containing HBSS. After 15 min, cells were washed twice with 
cold HBSS to remove any residual HOCl. Cells were lysed by adding 1x Reporter 
Lysis Buffer (125 µl) (Promega, Leiden, the Netherlands) to the wells and incubation 
on ice for 10 min. Cell lysates were centrifuged (13,000x g, 1 min), and supernatants 
were placed on ice for immediate analysis. Protein concentrations were determined 
by the BIO-RAD DC Protein Assay Kit. ATP levels in the cells were assessed with a 
Molecular Probes kit (Molecular Probes Invitrogen, Leiden, the Netherlands), using 
luciferase and luciferin according to the instructions of the manufacturer. Biolumines-
cence was measured during 20 seconds by using a Lumat LB 9507 luminometer 
(Berthold Technologies, Belgium). Concentrations of ATP were determined by com-
paring the values obtained with a freshly prepared standard curve of ATP and were 
corrected for protein content. 
Measurement of protein carbonyls 
Measurement of protein carbonyls was used as an indicator of HOCl induced oxida-
tion of cellular proteins. Therefore, cells were exposed to HOCl and proteins were 
extracted by the method used for the repair assay. Briefly, the cell pellets (5 x 106 
cells) were resuspended in 50 µl extraction Buffer A (45 mM HEPES, 0.4 M KCl, 1 
mM EDTA, 10% glycerol, adjusted to pH 7.8 using KOH) [31]. Since DTT is able to 
react quickly with α,β-unsaturated carbonyl compounds, it was omitted from the origi-
nal extraction buffer. Before analysis of protein carbonyl levels by ELISA, total protein 
concentration was determined, using the BIO-RAD DC Protein Assay kit. To load 
equal amounts of 20 µg protein in the ELISA procedure, the protein samples were 
concentrated by mixing a volume containing 20 µg proteins with 0.8 vol of 28% TCA, 
centrifugation at 10,000x g and discarding the supernatant. Protein carbonyl concen-
trations were finally determined by a Zentech PC ELISA test (Zentech Alexis, Lausen, 
Switzerland), which involves a derivatisation reaction of the isolated proteins with 
dinitrophenylhydrazine and subsequent detection of the derivatised proteins with an 
anti-dinitrophenylhydrazine antibody, according to the manufacturer’s instructions. 
Samples were calibrated against a standard curve constructed using reduced and 
HOCl oxidised albumin. 
Quantitative real-time PCR 
Quantitative real-time PCR was applied to assess the effects of HOCl on the expres-
sion of relevant NER genes. A549 cells were seeded in 28 cm2 dishes and treated 
with 100 μM HOCl. After 15 min, HOCl was removed and cells were washed with 
HBSS, followed by a further incubation of the cells in DMEM for 0 to 24 h. After incu-
bation, A549 cells were lysed in 1 ml Trizol® (Gibco Invitrogen, Breda, the Nether-
lands). Total RNA was isolated and purified using the RNeasy® Mini Kit (Qiagen 
Westburg, Leusden, the Netherlands) in combination with a DNase treatment (Qia-
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gen), according to the manufacturer’s instructions. The quantity and quality of each 
RNA sample were measured spectrophotometrically. First strand cDNA was generat-
ed according to the iScriptTM cDNA synthesis kit protocol (BIO-RAD, Veenendaal, the 
Netherlands) using 1 μg total RNA. The following NER genes were tested: XPA, XPC, 
ERCC-1, XPF (= ERCC-4) and XPG (= ERCC-5), using primers purchased from Ope-
ron (Leiden, the Netherlands) (see Table 1 for primer sequences). Real-time PCR 
was performed with a MyiQ Single Colour real-time PCR detection system (BioRad, 
Veenendaal, the Netherlands) using SYBR© Green Supermix (BIO-RAD), 5 µl diluted 
cDNA and 0.3 µM primers in a total volume of 25 µl. PCR was conducted in the fol-
lowing manner: denaturation at 95ºC for 3 min, followed by 40 cycles of 95ºC for 15 
seconds and 60ºC for 45 seconds. After PCR, a melt curve (60-95ºC) was produced 
for product identification and purity. PCR efficiency of all primer sets, as assessed by 
the use of cDNA dilution curves, was approximately 100%. Data were analysed using 
the MyiQ Software system (BIO-RAD) and were expressed as relative gene expres-
sion (fold increase), using the 2-ΔΔCt method and employing both β-actin and GAPDH 
as housekeeping genes [37]. 
 
 
 
 
Statistical analysis 
Data are represented as mean ± standard error of the mean (SEM) from 3 indepen-
dent experiments, unless stated otherwise. Statistical analysis was performed using 
SPSS version 11.5 for Windows. ANOVA with post hoc testing (Dunnett’s correction 
for multiple, two-sided) was applied to test differences between treatments and con-
trol. Differences were considered to be statistically significant when P < 0.05. 
 
 
Gene
β-actin Forward primer: CCTGGCACCCAGCACAAT
Reverse primer: GCCGATCCACACGGAGTACT
GAPDH Forward primer: GCACCACCAACTGCTTAGCA
Reverse primer: TGGCAGTGATGGCATGGA
ERCC-1 Forward primer: ACCCCTCGACGAGGATGAG
Reverse primer: CAGTGGGAAGGCTCTGTGTAGA
XPA Forward primer: CCGACAGGAAAACCGAGAAA
Reverse primer: TTCCACACGCTGCTTCTTACTG
XPC Forward primer: CCCAGCCCGCTTTACCA
Reverse primer: TGCATTAACTGTAAATGTTCCAATGA
XPF (ERCC-4) Forward primer: CACCTCCCTCGCCGTGTA
Reverse primer: CGCAAATATAACACCACCTTGTG
XPG (ERCC-5) Forward primer: GCATGAAATCTTGACTGATATGAAAGA
Reverse primer: TAAGCAAGCCTTTGAGTTGGTACTG
Table 1: Primer sequences used for real-time PCR
Sequence 5‘→ 3’
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Results 
Inhibition of NER in A549 cells coincubated with neutrophils is MPO 
dependent 
PMA activated neutrophils caused a significant decrease in NER capacity of lysates 
obtained from the cocultured A549 cells. This effect enhanced with increasing PMN 
numbers (Fig. 1A). In the absence of PMA, neutrophils were unable to inhibit NER in 
the coincubated A549 cells. The A549 cells coincubated with equal amounts of PMA 
activated PMN (1:1 ratio) showed a significant reduction in NER capacity up to 60 % 
(P < 0.05). The supernatant of the A549-neutrophil cocultures was analysed for MPO 
activity. As shown in Figure 1B, MPO activity was only detected in the incubations 
containing PMA activated neutrophils. No MPO activity could be detected in the cocul-
ture supernatants, in the absence of PMA. 
 In order to evaluate the role of MPO in NER inhibition, coculture experiments 
were performed using the specific MPO inhibitor 4-ABAH. We applied 4-ABAH be-
cause it is known to be one of the most potent inhibitors of MPO, functioning as a 
suicide substrate that promotes irreversible inactivation of the enzyme and thereby 
fully inactivating the production of MPO derived HOCl. Significantly, 4-ABAH does not 
affect neutrophil induced NADPH-oxidase and does not inhibit catalase and glutha-
tione peroxidase, unlike many other MPO inhibitors [29]. MPO activity was completely 
inhibited at a concentration of 100 µM 4-ABAH (Fig. 1D). This MPO inhibition by 4-
ABAH resulted in a complete abrogation of the NER inhibition induced by activated 
PMN (Fig. 1C). In fact, Figure 1 indicates a clear inverse relation between neutrophilic 
MPO activity and NER capacity. Incubation of A549 cells with 4-ABAH alone did not 
affect NER capacity. In addition, all effects observed in the cocultures were not re-
lated to toxicity, because viability of the A549 cells was always above 95%. 
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Figure 1. Effect of activated neutrophils on NER capacity in A549 cells. (A) Phenotypical NER capacity 
in the A549 cells coincubated for 1 h with PMA activated neutrophils at a 2:1 and a 1:1 ratio. *P < 0.05 
for 1:1 ratio vs. control (‘A549’; i.e. without neutrophils, with PMA). (B) MPO activity in the supernatant 
of the coincubations. No MPO activity was detected in the supernatant from A549 cells only. *P < 0.05, 
1:1 ratio vs. control (‘A549’; i.e. without neutrophils, with PMA). Data are expressed as mean ± SEM of 
three independent cell cultures. (C) NER capacity in the A549 cells cocultured with neutrophils at a 1:1 
ratio (10 x 106 neutrophils/ml) in the presence of PMA (100 ng/ml) and/or 4-ABAH (100 μM). *P < 0.05 
vs. control (‘A549’; i.e. without neutrophils, with PMA) and 4-ABAH condition. (D) Supernatants of the 
coincubations were used to assess the MPO activity (expressed as mU/ml). *P < 0.05 vs. control 
(‘A549’; i.e. without neutrophils, with PMA) and 4-ABAH condition. Values expressed as mean ± SEM 
(n = 4). 
 
 
NER inhibition by PMN is mediated by the MPO product HOCl 
The data obtained from the coculture experiments suggest a crucial role of MPO in 
the NER inhibitory action of neutrophils. As MPO catalyses the formation of HOCl, it is 
likely that the inhibition of NER in the cocultured epithelial cells is mediated by MPO 
catalysed HOCl formation. To investigate the role of HOCl as a mediator of the PMN 
induced NER inhibition, A549 cells were exposed to increasing concentrations of 
HOCl (0 to 200 µM). These doses can easily be produced in vivo at sites of inflamma-
tion and also reflect the amount of HOCl produced in the in vitro cocultures (1:1 ratio 
with activated neutrophils yields ~150 µM HOCl). 
 Initially, we determined the cytotoxicity of HOCl in the A549 cells and found that 
the viability of the epithelial cells was more than 90% after treatment with up to 200 
µM of HOCl during 15 min. At higher doses, viability of the A549 cells declined to 40% 
at 1000 μM HOCl (data not shown). We observed an acute dose dependent reduction 
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of NER capacity (within 15 min) in the lysates obtained from A549 cells treated with 
nontoxic, physiological doses of HOCl (0 – 200 μM), with an inhibition up to 60-80% in 
cells treated with 100 to 200 µM HOCl (P < 0.05) (Fig. 2A). The IC 50 value for HOCl 
was 52.9 µM, calculated using the least square fit method by fitting data points from 
Figure 2A to the inhibition formula using the equation Ix = 100 e-k*[x]. To investigate the 
persistency of this inhibiting effect, cells were incubated for 0 to 24 h in DMEM after 
an initial acute treatment (15 min) with 100 µM HOCl. The data are shown in Figure 
2B, indicating that the NER inhibitory effect of acute exposures to HOCl persists for 
up to 24 h (P < 0.05). This effect was also observed in the absence of cytotoxicity. 
 
A 
 
 
B 
 
 
Figure 2. (A) Acute effects of HOCl on NER. A549 cells were treated with increasing concentrations of 
HOCl during 15 min at 37°C. Data are expressed as means ± SEM of 6 separate experiments. *P < 
0.05, **P < 0.01 compared to control condition without HOCl treatment. (B) Persistent HOCl mediated 
inhibition of NER. A549 cells were treated with HOCl during 15 min, washed and reincubated in com-
plete medium for 0 to 24 h. NER capacity of A549 cells was determined at the indicated time points and 
is expressed as percentage of control cells (mean ± SEM, n = 4). *P < 0.05. 
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HOCl delays the removal of BPDE-DNA adducts in proliferating A549 
cells 
The results shown in Figures 2A and 2B reflect the NER capacity (i.e. recognition and 
excision of bulky DNA adducts) of lysates isolated from epithelial cells, following ex-
posure to HOCl. To evaluate the implication of this effect on the kinetics of bulky DNA 
adduct removal in proliferating epithelial cells, cultured A549 cells were exposed to 
0.1 μM BPDE during 30 min followed by HOCl exposure (100 µM during 15 min). 
Cells were harvested at 0 to 4 h postexposure, and BPDE-DNA adduct levels were 
analysed by 32P-postlabelling. HOCl treatment significantly delays the removal of 
BPDE adducts from the DNA of BPDE-treated A549 cells, further validating the NER 
inhibitory effect of HOCl (see Fig. 3). 
 
 
 
Figure 3. BPDE-DNA adduct removal in cells treated with HOCl. A549 cells were exposed to 0.1 µM 
BPDE followed by treatment with 100 µM HOCl. The removal of BPDE-DNA adducts in HOCl treated 
and untreated cells was measured using 32P-postlabelling. The data are expressed as percentage of 
control incubations (n = 3, mean ± SEM). *P < 0.05 (Mann-Whitney U test) 
 
HOCl exposure does not affect intracellular ATP levels in A549 cells 
Exposure to HOCl is known to deplete acutely cellular ATP levels in a variety of target 
cells [38]. ATP is a crucial cofactor for the NER process. Therefore, we tested the 
possibility that the effects of HOCl on NER inhibition could be explained by a loss of 
epithelial cell ATP. However, after a 15 min treatment with concentrations of HOCl for 
up to 200 µM, no loss of ATP was observed in the A549 cells (Fig. 4). 
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Figure 4. Effect of HOCl on intracellular ATP levels. HOCl (0 – 200 µM) was added to A549 cells in 
HBSS for a duration of 15 min. Cells were washed in HBSS, and cellular ATP was measured by using 
bioluminescence. Results are expressed as percentage of control cells without HOCl treatment (mean 
± SEM of 5 separate experiments). 
Role of direct NER protein oxidation by HOCl 
OCl is a potent oxidising molecule that specifically attacks proteins [11]. Direct oxida-
tive modification of NER proteins could, therefore, explain the acute inhibitory effects 
of HOCl. To study this possibility, cell extracts were isolated from unexposed A549 
cells as described above and then treated in vitro with increasing concentrations of 
HOCl during 15 min. These modified extracts were subsequently evaluated for their 
NER capacity (Fig. 5A). We again observed a dose dependent NER inhibition in the 
HOCl exposed extracts, but this inhibitory effect was less pronounced compared to 
the extracts obtained from HOCl treated A549 cells (cf. Fig. 2A). To further reveal 
direct HOCl-protein interactions as a possible explanation for the observed effects, we 
analysed the formation of protein carbonyls in the A549 cells, as this is a sensitive 
indicator of HOCl induced protein oxidation in target cells [39], which is associated 
with disturbed enzyme function [40]. However, HOCl treatment did not significantly 
increase the protein carbonyl content in A549 cells exposed to NER inhibiting doses 
of HOCl (Fig. 5B). 
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Figure 5. (A) Direct effect of HOCl on NER capacity of A549 lysates. Cell extracts, isolated from unex-
posed A549 cells, were treated with increasing concentrations of HOCl during 15 min at room tempera-
ture. Values are expressed as mean ± SEM. *P < 0.05. (B) Protein carbonyl formation in A549 cells, 
treated with HOCl (0 – 500 µM) during 15 min. The data are expressed as percentage of control incu-
bations (n = 4, mean ± SEM). *P < 0.05. 
Effect of HOCl on expression of NER genes 
Figure 2B indicates that the NER inhibition persisted for up to 24 h, suggesting a 
disturbance in gene expression and/or de-novo synthesis of repair enzymes involved 
in the recognition and removal of BPDE-DNA lesions. To test this possibility, direct 
effects of HOCl on the expression of NER genes were studied. The phenotypical 
repair assay described above reflects the capacity of lysates to perform the recogni-
tion and incision phase of the NER process. Therefore, we here focussed on genes 
that are crucially involved in these specific phases of NER, namely XPA and XPC for 
damage recognition; ERCC-1 and XPF as 5’endonucleases and XPG as 
3’endonuclease. A549 cells were treated during 15 min with 100 µM HOCl followed by 
a recovery period for up to 24 h in complete medium. As shown in Table 2, HOCl was 
found to cause a time dependent inhibition of XPC mRNA expression, with a maximal 
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effect at 8 h postexposure (~50%). No further significant effects of HOCl were found 
for the expression of ERCC-1, XPA, XPF and XPG. 
 
 
Discussion 
It is suggested that the influx of inflammatory polymorphonuclear neutrophils into the 
airways contributes to lung tumour development [6]. In this study, we demonstrated 
that activated neutrophils are potent inhibitors of the nucleotide excision repair capaci-
ty of lung target cells, most likely mediated by the formation of MPO catalysed HOCl. 
Considering the widespread exposure to inhaled DNA adduct forming carcinogens, 
such as PAH, as well as the simultaneous presence of neutrophils in the inflamed 
lung, we propose that this neutrophil induced reduction of NER may be a significant 
contributory factor in the development of inflammation related pulmonary mutagenesis 
and carcinogenesis. 
 MPO consumes up to 40-70% of neutrophil derived H2O2 to generate HOCl [7]. 
HOCl is a relatively stable and membrane diffusible molecule which can pass through 
subcellular compartments and, presumably, can reach the cell nucleus [10]. As such, 
it has the potential to interact with many different cellular proteins, including DNA 
repair proteins. We indeed demonstrated that neutrophil induced inhibition of NER is 
mediated by the MPO product HOCl, by using coincubations in the presence of the 
MPO inhibitor 4-ABAH as well as by treating A549 cells with the MPO derived product 
HOCl. This effect was persistent for up to 24 h and observed at physiologically rele-
vant concentrations of HOCl, as HOCl levels in the vicinity of activated neutrophils are 
at or above 100 µM [8]. In general, these data are in line with other studies showing 
that NER inhibition can be caused by oxidants, such as trans-4-hydroxy-nonenal (4-
HNE) [25] and nitric oxide [27]. Moreover, our data are in accordance with studies by 
Pero et al., who described an HOCl induced inhibition of unscheduled DNA synthesis 
(UDS), which can be considered as an indicator of nucleotide excision repair [15]. 
However, it needs to be stressed that the latter observations were in contrast with 
other studies that reported an induction of UDS by activated neutrophils, with no ap-
parent role for HOCl [41]. 
The present study showed an HOCl-induced inhibition of the NER capacity after a 
15 min during treatment. In order to find an explanation for this profound and acute 
effect, we initially focussed on the possible role of HOCl in depleting ATP in lung epi-
thelial cells [38]. In the initial steps of the NER pathway, ATP is a crucial cofactor, 
 
Time 0 h 4 h 8 h 24 h
XPC 0.98 ± 0.13 0.73 ±0.13 0.47 ± 0.07 * 0.68 ± 0.08
XPA 1.17 ± 0.18 1.69 ± 0.18 1.19 ± 0.41 1.86 ± 0.28
ERCC-1 1.10 ± 0.03 1.01 ± 0.03 0.99 ± 0.05 0.92 ± 0.03
XPF 0.97 ± 0.10 1.03 ±0.10 1.01 ± 0.08 0.99 ± 0.06
XPG 1.29 ± 0.15 0.83 ± 0.15 0.67 ± 0.19 0.97 ± 0.14
Table 2: Relative NER gene expression in A549 cells treated during 15 min with 100 µM HOCl followed
by incubation in normal medium for 0 to 24 h
Data are presented as mean ± SEM of 4 independent experiments. 
*P < 0.05 vs. control condition without HOCl treatment (=1.00 fold).
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facilitating the helicase activity of XPB and XPD [24]. Nevertheless, we did not find 
any loss of cellular ATP in A549 cells treated with physiological NER inhibiting doses 
of HOCl (0 – 200 µM). This is in contrast with other studies showing a significant dep-
letion of ATP at similar HOCl doses in various other cell types [42, 43] and is most 
likely explained by the relatively high level of antioxidant protection of the A549 cells 
compared with other (lung) epithelial cell lines (unpublished own observations). 
Proteins are the major molecular target for HOCl. Of primary importance among 
the HOCl mediated protein modifications are tyrosine chlorination, formation of chlo-
ramines and carbonyls [39] and in some cases crosslinking [12]. This study focused 
on carbonyls as a biomarker of oxidative HOCl attacks on proteins. In the inflamed 
lung, for instance, a high correlation between protein carbonyl concentration and MPO 
activity was observed [44]. Carbonyl groups represent an irreversible protein modifica-
tion, often leading to the inactivation of these proteins [13, 14, 40]. We, therefore, 
hypothesised that a loss of function of NER enzymes, originating from direct HOCl-
protein interactions, is a possible mechanism explaining the observed acute HOCl 
induced inhibition of NER. However, less effective NER inhibition was observed in 
direct HOCl treated cell lysates compared to lysates obtained from HOCl exposed 
whole A549 cells. In addition, we were unable to show protein carbonyls in the A549 
cells treated with NER inhibiting doses of HOCl. Together, this would suggest that 
direct oxidative inactivation of repair proteins may only partly explain the acute inhibi-
tory effects of HOCl, and indicates that other intracellular factors, for instance the 
formation of protein-DNA crosslinks, may be involved in mediating HOCl induced 
inhibition of NER in the target cells [45]. 
We demonstrated that HOCl induced repression of NER capacity persisted for up 
to 24 h. As a possible explanation for this long-term effect, we addressed the effect of 
HOCl on the transcription of relevant NER genes. Our repair assay is based on the 
capacity of cell extracts to perform the initial steps of NER, i.e. damage recognition 
and incision of DNA containing BPDE adducts. Thus, we only focused on the expres-
sion of genes coding for crucial enzymes involved in these specific phases of the NER 
process, namely ERCC-1, XPA, XPC, XPF and XPG. Our data showed a significant 
suppression of XPC gene expression upon incubation with HOCl. XPC is crucially 
involved in damage recognition [24]. Therefore, although additional studies are 
needed to assess the significance of this finding, our data indicate that HOCl expo-
sure may affect the ability of cells to recognise lesion containing DNA. 
NER is the most important repair pathway to remove large helix distorting DNA 
adducts that are produced upon inhalation of chemical carcinogens, such as PAH [23, 
24]. The formation of these promutagenic PAH-DNA adducts has been implicated as 
a causal process in lung cancer development in smokers [46]. As studies with NER 
deficient mice showed that effective DNA repair is crucial to prevent the carcinogenic 
effects of PAH induced DNA damage [47], it can be speculated that processes lead-
ing to the suppression of the relevant DNA repair pathways may have a detrimental 
effect on the cancer susceptibility of individuals exposed to such chemicals. Epide-
miological studies have indeed shown that polymorphisms in NER genes, leading to a 
(hypothetically) decreased NER capacity, are associated with increased risk of lung 
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carcinogenesis [48, 49]. Our present results indicate that neutrophilic inflammation, by 
causing inhibition of NER, might be another important factor determining susceptibility 
to cancer. For instance, our findings could provide an additional explanation for the 
association between MPO polymorphisms and risk of pulmonary DNA adduct forma-
tion and carcinogenesis in PAH exposed subjects [17, 21]. Evidently, although the 
present paper is focused on the lung, it needs to be emphasised that our findings may 
also be of importance for other organs where bulky DNA adduct forming agents and 
neutrophils are simultaneously present. 
In conclusion, in this study we demonstrated that neutrophils are potent inhibitors 
of NER in human pulmonary epithelial cells. Previous studies have already shown that 
neutrophils, by releasing MPO, are involved in the carcinogenic process by promoting 
the activation of precarcinogens, such as B[a]P into DNA damaging metabolites. In 
the present study, we extended these observations by showing that MPO, via genera-
tion of HOCl, inhibits the repair of such promutagenic DNA adducts. We propose that 
these two detrimental effects of activated PMN at sites of inflammation may contribute 
synergistically to human inflammation related carcinogenesis. Therefore, our observa-
tions may provide a further explanation for the observed association between neutro-
philic inflammation, MPO and lung cancer risk. 
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Abstract 
Chronic pulmonary inflammation is associated with increased lung cancer risk, but the 
underlying process remains unknown. Recently, we showed that activated neutrophils 
inhibit nucleotide excision repair (NER) in pulmonary epithelial cells in vitro via the 
release of myeloperoxidase (MPO). To evaluate the effect of neutrophils on NER in 
vivo, mice were intratracheally instilled with lipopolysaccharide (LPS), causing acute 
lung inflammation and associated neutrophil influx into the airways. Three days post 
exposure, phenotypical NER capacity was assessed in lung tissue. LPS exposure 
inhibited pulmonary NER by approximately 50%. This finding was corroborated by 
downregulation of the NER associated genes Xpa and Xpf. To further elicit the role of 
neutrophils and MPO in this process, we utilised MPO deficient mice as well as mice 
in which circulating neutrophils were depleted by antibody treatment. LPS induced 
inhibition of pulmonary NER was not affected by either Mpo-/- nor by depletion of cir-
culating neutrophils. This contrasts with our previous in vitro observations, suggesting 
that inhibition of pulmonary NER following acute dosing with LPS is not fully mediated 
by neutrophils and/or MPO. In conclusion, these data show that LPS induced pulmo-
nary inflammation is associated with a reduction of NER function in the mouse lung. 
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Introduction 
Chronic inhalation of combustion derived particles (e.g. cigarette smoke) is a major 
determinant in the development of lung cancer, one of the most lethal types of cancer 
worldwide. A generally accepted explanation for this relationship is the ability of such 
particles to transport chemical carcinogens into the lung. However, another important 
characteristic is that the particles elicit an influx of polymorphonuclear neutrophils 
(PMN) into the lung, which is most evident in smokers who developed chronic ob-
structive pulmonary disease (COPD) [1]. COPD encompasses a local chronic inflam-
mation in the airways [2, 3], dominated by invasion of neutrophils, macrophages and 
T cells [4]. Interestingly, smokers diagnosed with COPD have an increased risk of 
developing lung cancer (3-10 fold) even after having quit smoking [5, 6]. The promi-
nent presence of neutrophils associated with COPD [4, 7] suggests a significant role 
of the ongoing neutrophilic inflammation in this carcinogenic response [8]. 
Neutrophils have been implicated in (pulmonary) carcinogenicity by their genotox-
ic capacity. This is thought to occur through the release of mutagenic reactive oxygen 
species (ROS) leading to oxidative DNA damage, as well as by promoting the meta-
bolic activation of environmental chemical carcinogens via the enzyme myeloperox-
idase (MPO), resulting in promutagenic DNA adducts [9]. Moreover, we have shown 
recently that neutrophils, via the MPO catalysed formation of hypochlorous acid 
(HOCl), are potent inhibitors of the nucleotide excision repair (NER) pathway in cul-
tured pulmonary epithelial cells, causing a delayed removal of promutagenic bulky 
DNA adducts [10]. 
To date, evidence of a role of neutrophils in pulmonary carcinogenicity has been 
largely derived from in vitro studies using cocultures of neutrophils and pulmonary 
epithelial target cells to study neutrophil induced genotoxicity [9]. Evidence from in 
vivo studies is, however, primarily circumstantial and additional animal studies are 
necessary to substantiate causality. The aim of the present study was to assess the in 
vivo effect of neutrophilic inflammation on NER in the mouse lung. Therefore, mice 
were intratracheally instilled with LPS, followed by the assessment of neutrophil infil-
tration, MPO activity and NER capacity in pulmonary tissues. In order to characterise 
the role of MPO, mice deficient in this enzyme were also subjected to LPS and similar 
analyses were performed. Furthermore, neutrophils were depleted by treatment with 
neutrophil specific antibodies to provide direct evidence for the relation between neu-
trophils and NER inhibition in vivo. Our results suggest that LPS induced acute lung 
inflammation is associated with a suppression of pulmonary NER, which is not me-
diated by neutrophil influx and the subsequent release of the enzyme MPO. 
 
 
Chapter 5 
 88 
Materials and methods 
Animals 
Male Wt C57Bl6 mice (~12 weeks old) were obtained from Charles River Breeding 
Laboratories (Heidelberg, Germany). Mpo-/- mice were generated by Y. Aratani [11] 
and bred into the C57Bl6 background. Mice were housed individually in standard 
laboratory cages and allowed food and water ad libitum throughout the experiments. 
The studies were carried out in accordance with an approved protocol by the Institu-
tional Animal Care Committee of Maastricht University. 
LPS induced acute lung inflammation mouse model 
Mice were treated with LPS (Escherichia Coli, serotype O55:B5, Sigma, St.Louis, MO, 
USA) by intratracheal instillation to induce an acute pulmonary inflammation. The 
dose of LPS was 20 µg/instillation/mouse. No signs of overall toxic effects with the 
employed dose of LPS were histopathologically observed in the trachea, airways and 
lungs, either in this study or those executed by others [12]. Intratracheal instillation 
was performed by a nonsurgical technique under anaesthesia as previously described 
[12]. Sham mice were instilled with sterile 0.9% NaCl. 
 Since a previous study [13] demonstrated that local LPS challenge in Wt mice 
results in a time dependent neutrophil accumulation peaking at day 3, Wt mice (n = 6) 
were sacrificed 3 days post exposure by 115 mg/kg sodium pentobarbital (Ceva 
Sante Animale, Maassluis, the Netherlands). After thoracotomy, the lungs were pre-
pared for histological evaluation (as described below) to characterise the LPS induced 
inflammatory cell influx. In satellite Wt mice (n = 10), bronchoalveolar lavage (BAL) 
(3x with 1 ml sterile 0.9% NaCl) was performed 3 days post instillation to remove as 
much as possible inflammatory cells from the airways. After centrifugation at 1,500 
rpm during 10 min at 4ºC, the cell-free BAL fluid (BALF) was stored at -80ºC for MPO 
activity measurement. Lavaged lungs were snapfrozen and pulverised using a mortar 
and pestle. The pulverised lung tissue was stored at -80°C for RNA isolation and 
protein extraction for assessment of NER capacity. 
 To characterise the role of MPO, Mpo-/- mice were dosed with LPS, followed by 
histological evaluation of inflammatory cell influx (n = 6) and BAL (n = 5) with subse-
quent similar analyses on lung tissue as in Wt animals. 
 Furthermore, to study the direct relation between neutrophils and NER inhibition, 
depletion of circulating neutrophils in Wt mice (n = 5) was achieved by intraperitoneal 
injection of 0.5 mg of the monoclonal rat anti-mouse neutrophil antibody NIMP-R14 
(Hbt, Maastricht, the Netherlands), 24 hours before i.t. LPS instillation. NIMP-R14 has 
been shown to selectively deplete mouse neutrophils in vivo for up to 6 days [14, 15]. 
IgG (eBioscience, San Diego, USA) was used as control mAb in the sham group (n = 
5). Again, 3 days after instillation, mice were sacrificed, and lungs were lavaged and 
isolated as described above. 
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Histopathology and quantification of cellular influx in lung tissue 
After thoracotomy, lungs were inflated through the trachea with 10% zinc buffered 
formalin (pH 5.5) at a pressure of 20 cm H2O and subsequently placed in 10% zinc 
buffered formalin during 24 hours for fixation of the tissue. After paraffin embedding, 
lung sections were cut at a thickness of 4 µm and mounted on slides. H&E stained 
sections were used to quantify infiltration of neutrophils and macrophages into the 
lungs. At a magnification of 200x, random fields were selected and the number of 
infiltrated, still intact cells was counted. At least 5 fields per section were analysed. 
MPO activity measurement 
MPO packaged in neutrophils will have no effect on NER in pulmonary epithelial tis-
sue, because MPO must be released extracellularly during the oxidative burst of neu-
trophils. Therefore, extracellular MPO activity was measured in cell-free BALF, as 
described by Klebanoff et al. [16], and is indicative for the presence of activated neu-
trophils in the lung [17]. 
Protein extraction 
The preparation of lung tissue protein extracts for NER capacity measurement and 
Western Blot analysis is based on the method developed by Redaelli et al. [18]. Pul-
verised frozen lung tissue was resuspended in lysis buffer (45 mM HEPES, 0.4 mM 
KCl, 1mM EDTA, 0.1 mM DTT, 10% glycerol, adjusted to pH 7.8 using KOH), snap-
frozen and thawed again to complete lysis by adding 1% Triton X-100. The lysate was 
centrifuged at 11,000 rpm for 5 min at 4ºC. Protein concentrations were determined 
by the DC-protein assay KT (BIORAD, Veenendaal, the Netherlands). 
Measurement of NER capacity 
To phenotypically assess the NER capacity in lung tissue, we applied a modified 
comet assay recently developed and validated in our laboratory [19]. This assay 
measures the ability of NER related enzymes, present in the prepared lung tissue 
extracts (250 µg/ml), to detect and incise benzo[a]pyrene-diolepoxide (BPDE)-DNA 
adducts in substrate DNA. The increase in DNA breaks, leading to increased tail in-
tensities, is indicative for the NER capacity of the tissue extracts. After subtracting 
background levels from all data, the final repair capacity was calculated as previously 
reported by Langie et al. [19]. 
NER gene expression analysis by quantitative PCR 
Total RNA was isolated and purified from snapfrozen, pulverised lung tissue (same 
tissue that was used for the NER capacity measurement), using the RNeasy® Mini Kit 
(Qiagen Westburg, Leusden, the Netherlands) in combination with a DNase treat-
ment, according to the manufacturer’s instructions. First strand cDNA was generated, 
using the iScriptTM cDNA synthesis kit protocol (BIO-RAD) on 1 μg total RNA. Aliquots 
were used for quantitative PCR on the BioRad MyiQ iCycler Single Colour quantitative 
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detection system, using iQ SYBR Green Supermix. Reactions were initiated for 3 min 
at 95°C, followed by 40 cycles of 15 sec at 95°C and 45 sec at 60°C. After each run, a 
melting curve was analysed starting at 60°C with stepwise temperature elevations of 
0.5°C every 10 sec to check for non-specific products. The following NER genes were 
tested: Xpa, Xpc, Ercc-1, Xpf and Xpg, using primers purchased from Operon (Lei-
den, the Netherlands) (see Table 1 for primer sequences). Data were analysed, using 
the MyiQ Software system (BIO-RAD) and were expressed as relative gene expres-
sion, using the 2-ΔΔCt method and employing Hprt as housekeeping gene [20]. 
 
 
 
 
Determination of XPA levels by Western Blot Analysis 
XPA protein abundance was evaluated in the lung protein extracts (which were also 
used for the NER capacity measurement) by Western Blotting. Samples were diluted 
1:4 in Laemmli sample buffer and boiled for 5 min at 95ºC. Equal amounts of protein 
(40 µl/well) were loaded and separated on a polyacrylamide gel (12%) (Mini-
PROTEAN 3 System (BIO-RAD)). Subsequently, proteins were transferred to Hy-
bond-C-membrane (Amersham Pharmacia Biotech, Diegem, Belgium) and blocked 
for 1 hour with 5% skim milk powder in PBS/0.1% Tween-20. Nitrocellulose blots were 
washed (PBS/0.1% Tween-20), followed by overnight incubation with the polyclonal 
anti-XPA antibody (XPA [FL-273]); sc-853, Santa Cruz Biotechnology Inc., Santa 
Cruz, CA, USA). After washing, blots were incubated for 1 hour with a goat anti-rabbit 
horseradish peroxidase conjugated IgG (Dako Cytomation, Glostrup, Denmark) and 
visualised by means of enhanced chemiluminescence (Amersham Pharmacia Bio-
tech) with the LAS-3000 (Fuji). Band intensity was determined by using a GS700 
densitometer and MOLECULAR ANALYST software (BIO-RAD) and given as mean ± 
SEM. The expected size of the band is 40 kDa, which was further identified by using 
protein samples from mice that do not express the XPA protein (XPA-/- mice; a gener-
ous gift from the Laboratory for Health Protection Research, National Institute for 
Public Health and the Environment (RIVM), Bilthoven, the Netherlands), which was 
analysed together with the samples. A reference sample was included in every blot to 
correct blot to blot variation. 
 
mRNA of interest
Hprt Sense: AAGACTTGCTCGAGATGTCATGAA
Antisense: AAAGAACTTATAGCCCCCCTTGA
Ercc-1 Sense: TGGAGACCTACAAGGCGTATGA
Antisense: GGCCCGTGATAGGAAGTTCTG
Xpa Sense: CCAAAGGTGGCTTCATTTTAGAA
Antisense: CATGACGGGCCCTGGTT
Xpc Sense: TGAAGGCGGTGGAGATTGA
Antisense: CTCCATCTTTATCTTCTCACTTCTTTCC
Xpf (Ercc-4) Sense: TGTCACAACCCGTCACTTGAA
Antisense: GGCGGATTGTCTTGTCGAAT
Xpg (Ercc-5) Sense: TGCCTTCTCTTTGCCAAGGT
Antisense: TTCGTATCCGCCCTATTTTTGT
Table 1: Primer sequences used for Real Time RT-PCR
Sequences 5‘→ 3’
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Statistical analysis 
Data are expressed as mean ± standard error of the mean (SEM) and statistical anal-
ysis was conducted using the independent samples T-test. Values of P ≤ 0.05 were 
taken to denote statistical significance. 
Results 
LPS induced acute lung inflammation 
To characterise the LPS induced acute lung inflammation, infiltration of inflammatory 
cells was histologically quantified in the lung tissue of Wt mice, which revealed that 
LPS challenge resulted in a massive recruitment of neutrophils in the alveolar spaces 
(650 ± 190/mm2). Furthermore, LPS instillation resulted in an increase of infiltrating 
macrophages (40 ± 10/mm2). In the sham treated group, neither significant neutrophil 
nor macrophage influx was observed. To verify neutrophil activation in Wt animals, 
extracellular pulmonary MPO activity was determined in BALF of all mice. In agree-
ment with the histological assessment of neutrophil infiltration, a significant MPO 
activity after LPS instillation in Wt animals was observed (81.4 ± 20.5 mU/ml), whe-
reas no MPO activity was detected in the sham group. 
Also in Mpo-/- mice, neutrophil (60 ± 10/mm2) and macrophage (10 ± 1/mm2) numbers 
were assessed, showing unexpected lower neutrophil, but comparable macrophage 
infiltration as in Wt mice. The absence of MPO activity in the BALF confirmed the 
Mpo-/- status. As MPO activity is indicative for the presence of activated neutrophils in 
the lung [17], MPO was also assessed in BALF of neutrophil depleted mice, and no 
MPO activity was detected. 
Intratracheal LPS instillation results in pulmonary NER inhibition 
To reveal whether our previous in vitro observation, showing MPO/neutrophil depen-
dent NER inhibition in cocultured epithelial cells [10], corresponds with the in vivo 
situation, we examined the role of neutrophils on NER of pulmonary tissue in mice 
after i.t. LPS instillation using an MPO knockout approach and a neutrophil depletion 
model. As shown in Figure 1, LPS treatment indeed decreased the pulmonary NER 
capacity in Wt mice approximately 2-fold (P = 0.05). In contrast to our previous in vitro 
experiments, however, we found that lack of MPO or depletion of neutrophils did not 
result in a significant abrogation of the pulmonary NER inhibition induced by LPS 
instillation (Fig. 1). 
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Figure 1. Effect of LPS induced neutrophil influx in the lung on phenotypical NER capacity of lung cells. 
Phenotypical NER capacity was determined using protein extracts from the lavaged lungs of Wt, Mpo-/- 
and neutrophil depleted mice, 3 days after LPS instillation. Data are expressed as mean ± SEM of 4-9 
mice per group. *P ≤ 0.05 versus sham mice. 
Intratracheal LPS exposure decreases expression of NER associated 
genes 
To address whether the observed LPS induced NER inhibition in the mouse lung was 
mediated by a reduction of the corresponding mRNA, we examined pulmonary mRNA 
expression of NER genes after local LPS exposure in vivo. We focused on those 
enzymes of the NER machinery that are crucially involved in the recognition and inci-
sion phase of the NER process, because the phenotypical NER assay described 
above reflects these processes; XPA and XPC for damage recognition, ERCC-1 and 
XPF as 5’endonucleases and XPG as 3’endonuclease [21]. 
 As shown in Figure 2, almost all of the genes exhibited a reduction in expression 
upon LPS exposure to a very similar degree (~50 to 75%), irrespective of genetic 
background. However, the regulation of Xpa and Xpf seemed to be neutrophil depen-
dent as these genes were not downregulated in the LPS exposed neutrophil depleted 
mice. This shift in NER gene downregulation in the LPS exposed neutrophil depleted 
mice did, however, not result in a different phenotypical effect. 
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Figure 2. Relative gene expression profiles of a) Xpa, b) Xpc, c) Xpf, d) Xpg and e) Ercc-1 in lung 
tissue at 3 days after i.t. LPS exposure. Data are presented as mean ± SEM for the LPS treated Wt 
mice (n = 8) and Mpo-/- mice and neutrophil depleted mice (n = 5 per group). Gene expression in the 
resp. sham groups is represented as a 100% line. *P ≤ 0.05 versus sham mice.  
LPS induced down regulation of XPA protein 
XPA protein is the core factor for the assembly of the NER complex, and is the only 
factor in which disruption completely obliterates NER [21, 22]. Since Xpa gene ex-
pression was found to be neutrophil dependently downregulated after LPS exposure 
in Wt mice, we sought to determine whether this also occurs at the protein level. 
Quantification of band intensities indicated differences (about 50% decrease, P = 
0.09) in XPA protein levels between LPS instilled Wt mice and sham Wt mice, but not 
between LPS treated Mpo-/- mice compared to their respective sham group (see Fig. 
3). These data resemble the transcriptional effect of LPS instillation on XPA expres-
sion. 
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Figure 3. Western Blot analysis of XPA protein in the lung after LPS instillation. Proteins were ex-
tracted from lung tissue of sham and LPS exposed Wt and Mpo-/- mice, 3 days after exposure. XPA 
protein levels were analysed using Western Blots. a) Each column represent mean ± SEM (n = 5 mice 
per group). P = 0.09 versus sham mice. b) Blots of representative animals for each group are shown. 
 
Discussion 
Chronic inflammatory diseases of the lung are associated with lung cancer develop-
ment. Over the past years, evidence has accumulated that the influx of innate immune 
cells, including polymorphonuclear neutrophils, into the airways contributes to inflam-
mation associated carcinogenesis [7, 8]. Our study demonstrated an association be-
tween LPS induced pulmonary inflammation and inhibition of nucleotide excision 
repair in the mouse lung in vivo. Considering the exposure to inhaled carcinogens, as 
well as the simultaneous presence of inflammatory cells in the inflamed lung of 
smokers for example, we propose that this inflammation associated reduction of NER 
may represent a significant and previously unrecognised contributory factor in the 
development of inflammation related pulmonary cancer. 
Neutrophilia plays a prominent role in host defence against pathogens, but is also 
responsible for pulmonary injury due to the release of several toxic compounds (e.g. 
proteases), reactive oxygen species and the enzyme MPO. MPO consumes up to 40-
70% of neutrophil derived H2O2 to generate HOCl [23]. HOCl is a relative stable and 
membrane diffusible molecule that can pass through subcellular compartments and, 
presumably, can reach the cell nucleus [24]. Therefore, it has the potential to interact 
with many different cellular proteins, including DNA repair proteins. In fact, we have 
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previously shown that activated neutrophils are potent inhibitors of the NER pathway 
in pulmonary epithelial cells via the MPO catalysed formation of HOCl in vitro [10]. 
To investigate the association between neutrophil infiltration and NER in the lung 
in vivo, we applied a mouse model of LPS induced acute pulmonary neutrophil influx 
in the airways [12], expanded with a MPO knockout approach for studying the contri-
bution of MPO, and a systemic depletion of neutrophils to reveal the role of neutro-
phils. We observed that intratracheal administration of LPS in Wt mice induces lung 
neutrophilia and associated MPO activation that peaks 3 days after instillation. How-
ever, a lack of MPO (as in Mpo-/- mice) significantly attenuated the acute inflammatory 
response induced by airway administration of LPS. This decreased neutrophilia can 
predominantly be assigned to a decreased extravasation of Mpo-/- neutrophils, as 
MPO plays a role in the activation of neutrophil adherence before extravasation [25], 
with a decreased chemokine production as a result [13]. 
The present in vivo results show that i.t. LPS instillation indeed induces a pulmo-
nary suppression of NER capacity. However, in contrast to the in vitro findings, we 
were not able to show a distinct role of either MPO or neutrophils in the present in 
vivo study as LPS instillation in Mpo-/- and neutrophil depleted animals caused a simi-
lar decrease in NER. Although data obtained in the Mpo-/- animals cannot directly be 
compared with the Wt animals because of the unexpected lower neutrophil influx, the 
observed NER inhibiting effect in Mpo-/- mice is nevertheless in line with the depletion 
model, indicating that lower MPO and a lower number of neutrophils are not affecting 
LPS induced NER inhibition. 
As a possible explanation of the observed LPS induced NER inhibition, we ad-
dressed the effect of LPS associated lung inflammation on the transcriptional level of 
relevant NER genes. Our data showed a suppression of several NER genes in lung 
tissue after LPS induced acute lung inflammation, mainly Xpa, Xpc and Xpf in Wt 
mice. Since XPC is the earliest distortion recognition factor [21], our data imply that 
LPS instillation affects the ability of lung cells to recognise damaged DNA, which 
corresponds with our in vitro observations [10]. However, there was no clear trend 
suggestive of differences in the way different types of mice respond to LPS instillation, 
except for the neutrophil mediated downregulation of Xpa and Xpf. XPA is the only 
crucial core factor in the NER complex configuration showing affinity for damaged 
DNA and key interactions with the other NER enzymes, which disruption completely 
obliterates NER [22]. From this point of view, XPA seems to be a neutrophil specific 
target for inflammation associated NER disruption by downregulating and possibly 
inhibiting its function. Although Xpa was not downregulated in Mpo-/- mice and neutro-
phil depleted animals, the downregulation of the other relevant NER related genes 
may be responsible for the decreased phenotypical NER capacity seen in these 
mouse models, as probably all XP factors of the NER repair complex are needed for 
effective DNA repair. Interestingly, the in vivo finding on Xpa downregulation was 
corroborated by decreased XPA protein in the inflamed lungs, further explaining the 
distortion of the NER process seen in the LPS exposed Wt animals. Referring to our 
previous in vitro observations [10], this reduced XPA protein expression implicates 
also a role for HOCl mediated oxidative inactivation of repair enzymes or other HOCl-
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NER protein interactions in neutrophil induced NER inhibition, although additional 
studies are needed to assess this. 
A clarification for the differing findings on MPO dependency in vivo and in vitro 
can possibly be found in a study of Aratani and colleagues [26], comparing Mpo-/-, 
Nadph oxidase-/- and double (Mpo/Nadph-/-) knock out mice in a model of pulmonary 
infection. They reported that H2O2 used by MPO is solely produced by NADPH oxi-
dase. It is therefore likely that Mpo-/- mice, which are incapable of inverting H2O2 to 
HOCl, build up H2O2. Since H2O2 is a very potent oxidant, just like HOCl, increased 
H2O2 levels in the Mpo-/- mice could exert some NER suppressive effects by oxidative 
modulation of NER related genes (especially Ercc-1 expressional downregulation) on 
the lung target cells, which is in line with studies from our own laboratory [27] and Hu 
et al. [28]. 
Moreover, the in vivo versus in vitro discrepancy with respect of the role of neu-
trophils in the observed NER inhibition, may be due to the presence of resident alveo-
lar macrophages in the in vivo situation. Alveolar macrophages are also involved in 
the lung inflammatory response, more specifically by neutralising pathogens and 
recruiting neutrophils in the initiation phase, and apoptotic/cell debris cleanup at a 
later stage. Additionally, (LPS) activated alveolar macrophages generate large 
amounts of reactive nitrogen species (by activation of iNOS), which are originally 
released for bacterial cell killing, but are known to be involved in DNA repair inhibition 
[29] and may explain the observed neutrophil independent NER inhibiting effect of 
lung inflammation. 
In conclusion, our study is the first to show that LPS induced acute pulmonary in-
flammation is associated with reduced nucleotide excision repair in the mouse lung. 
This effect appears not to be mediated by the infiltration of neutrophils and the asso-
ciated release of the enzyme myeloperoxidase. Nevertheless, these data may provide 
a further mechanism underlying the association between pulmonary inflammation and 
lung carcinogenesis. 
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Abstract 
Lung cancer often develops in association with chronic pulmonary inflammatory dis-
eases with an influx of neutrophils. More detailed information on inflammatory path-
ways and the role of neutrophils herein is a prerequisite for understanding the me-
chanism of inflammation associated cancer. In the present study, we used microar-
rays to gain a global view of the transcriptional responses of the lung to LPS in mice. 
This treatment mimics an acute lung inflammatory response. To investigate the influ-
ence of neutrophils in this process, we depleted mice from circulating neutrophils 
treatment with anti-PMN antibodies prior to LPS exposure. A total of 514 genes were 
greater than 1.5-fold differentially expressed in the LPS induced lung inflammation 
model. 394 of the 514 were upregulated genes mostly involved in cell cycle and im-
mune/inflammation related processes, such as cytokine/chemokine activity and sig-
nalling. Downregulated genes represented nonimmune processes, such as develop-
ment, metabolism and transport. Notably, the number of genes and pathways that 
were differentially expressed was reduced when animals were depleted from circulat-
ing neutrophils, confirming the central role of neutrophils in the inflammatory re-
sponse. Furthermore, there was a significant correlation between the differentially 
expressed gene list and the promutagenic DNA lesion M1dG, suggesting that it is the 
extent of the immune response which drives genetic instability in the inflamed lung. 
Several neutrophil specific genes could be identified and these were mostly involved 
in interferon signalling, the oxidative stress response and cell cycle progression. The 
latter refers possibly to a higher rate of cell turnover in the inflamed lung with neutro-
phils, suggesting that the neutrophil influx is associated with a higher risk for the ac-
cumulation and fixation of mutations. Gene expression profiling identified specific 
genes and pathways that are related to neutrophilic inflammation and could be asso-
ciated to cancer development and indicate an active role of neutrophils in mediating 
the LPS induced inflammatory response in the mouse lung. 
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Introduction 
Inflammation is often considered as a critical component of tumourigenesis, since 
many cancers arise at sites of infection, chronic irritation and inflammation [1, 2]. Also 
subjects suffering from inflammatory pulmonary diseases, such as chronic obstructive 
pulmonary disease (COPD)/emphysema, have an increased risk for developing lung 
cancer [3]. One common characteristic of many inflammatory lung disorders is the 
influx of polymorphonuclear neutrophils (PMN), which are highly specialised members 
of the innate immune system. Neutrophils are often the first immune cells to arrive at 
sites of infection and their primary function is to phagocytise and destroy invading 
microorganisms and/or foreign material. Under normal conditions, neutrophils circu-
late through the bloodstream, having a half life span of about 7 hours. However, dur-
ing an invasion of pathogens, neutrophils are recruited to the site of inflammation and 
their life span is increased up to 4 days [4]. It has been suggested that the accumula-
tion of these neutrophils in the lumen of the lung is related to lung cancer risk [5], 
implying a significant role of the neutrophilic inflammation in the carcinogenic re-
sponse [6]. 
 Inflammation is thought to initiate and promote lung cancer development via the 
continuous formation of reactive oxygen or nitrogen species (ROS/RNS) that can bind 
to DNA, and thus lead to promutagenic DNA alterations [7, 8]. Furthermore, the re-
lease of ROS by neutrophils is also believed to cause a cell proliferative response, 
which may contribute significantly to the carcinogenic response following chronic 
inflammation. We have previously reported two distinct pathways of neutrophil in-
duced genotoxicity and mutagenicity via their capacity to release the oxidant hypoch-
lorous acid (HOCl). Exposure of lung epithelial cells to HOCl leads to: (i) indirect DNA 
disturbances by attack of HOCl on lipids/proteins, resulting in the formation of promu-
tagenic DNA adducts [unpublished results: 9] and (ii) impaired removal of bulky DNA 
lesions due to inhibition of nucleotide excision repair (NER) [10, unpublished results: 
11]. Although both processes are thought to play an important role in tumourigenesis, 
additional processes may be involved to create a microenvironment that facilitates 
tumour formation and progression. Thus, a better understanding of biochemical path-
ways in the lung elicited by inflammatory stimuli, and the role of neutrophils herein, is 
required to further unravel mechanisms of inflammation related lung carcinogenesis. 
 In this report, we determined the transcriptional response upon neutrophilic lung 
inflammation in lung cells of mice treated intratracheally with lipopolysaccharide 
(LPS), by identifying genes that are differentially expressed. The well characterised 
component of gram-negative bacterial cell walls LPS was used, as it is a potent endo-
toxin capable of inducing a strong inflammatory response by recruiting circulating 
PMN to the lungs [12]. Indeed, intratracheal instillation of experimental animals with 
LPS induces an acute lung inflammation associated with a neutrophil influx into the 
alveoli [13]. We further demonstrated the specific role of neutrophils by antibody dep-
letion of circulating neutrophils from the animals. In this report, we present the profiles 
of differentially expressed genes in lung tissue due to neutrophilic inflammation and 
investigated whether neutrophil induced genes are associated with induction of geno-
Chapter 6 
 104 
toxicity. Moreover, we related the biological networks/pathways including these genes 
to the potential role of neutrophils in pulmonary inflammation related carcinogenesis. 
Materials and Methods 
Animals 
Male C57Bl6 mice (~12 weeks old) were obtained from Charles River Breeding La-
boratories (Heidelberg, Germany). Mice were housed individually in standard labora-
tory cages and allowed food and water ad libitum throughout the experiments. The 
studies were carried out in accordance with an approved protocol by the Institutional 
Animal Care Committee of Maastricht University. 
LPS induced acute lung inflammation mouse model 
Mice were exposed to LPS (Escherichia Coli, serotype O55:B5, Sigma, St. Louis, MO, 
USA) by intratracheal instillation to induce an acute pulmonary inflammation. The 
dose of LPS used was 20 µg/instillation/mouse. Intratracheal instillation was per-
formed by a nonsurgical technique under anaesthesia as previously described [14]. 
Sham mice (n = 5) were instilled with sterile 0.9% NaCl. Since a previous study [13] 
demonstrated that local LPS challenge in C57Bl6 mice results in a time dependent 
neutrophil accumulation peaking at day 3, mice (n = 5) were sacrificed 3 days postex-
posure by 115 mg/kg sodium pentobarbital (Ceva Sante Animale, Maassluis, the 
Netherlands) and bronchoalveolar lavage (BAL) (3x with 1 ml sterile 0.9% NaCl) was 
performed to remove inflammatory cells from the airways. After centrifugation at 1,500 
rpm during 10 min at 4ºC, the cell-free BAL fluid (BALF) was stored at -80ºC for MPO 
activity measurement. Lavaged lungs were snapfrozen and pulverised using a mortar 
and pestle. The pulverised lung tissue was stored at -80°C for DNA, RNA and protein 
isolation. 
To unravel the role of neutrophils in the inflammatory airway transcriptome, deple-
tion of circulating neutrophils in mice (n = 5) was achieved by intraperitoneal injection 
of 0.5 mg of the monoclonal rat anti-mouse neutrophil antibody NIMP-R14 (Hbt, Uden, 
the Netherlands), 24 h before i.t. LPS instillation. NIMP-R14 selectively depletes 
mouse neutrophils in vivo for up to 6 days [15, 16]. Again, 3 days after instillation, 
mice were sacrificed, and lungs were lavaged and isolated as described above. In our 
study, a lack of MPO activity in the lung was used as a verification of the absence of 
neutrophils. IgG (eBioscience, San Diego, CA, USA) was used as control mAb in the 
sham group and LPS group without neutrophil depletion. 
MPO activity measurement 
MPO packaged in neutrophils will have no effect on pulmonary epithelial tissue, be-
cause MPO must be released extracellularly during the oxidative burst of neutrophils. 
Therefore, extracellular MPO activity was measured in cell-free BALF as described by 
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Klebanoff et al. [17] and is indicative for the presence of activated neutrophils in the 
lung [18]. 
MPO ELISA 
The presence of residual inflammatory neutrophils in the lavaged lung may affect the 
analysis of the transcriptome of lung epithelial cells. Therefore, to evaluate the degree 
of contamination of the lavaged lungs with resident neutrophils, proteins were ex-
tracted and MPO protein levels were determined quantitatively in lung homogenates, 
using a mouse MPO ELISA kit (Hbt, Uden, the Netherlands) according to the manu-
facturer’s instructions. Protein concentrations were determined spectrophotometrical-
ly, using the DC-protein Assay Kit (BIORAD, Veenendaal, the Netherlands). The 
amount of MPO in the lung tissue was expressed as ng MPO/mg protein. 
DNA isolation 
DNA was isolated using standard phenol extraction [19]. DNA concentrations were 
quantified by NanoDrop (Isogen-Lifescience, De Meern, the Netherlands) and sam-
ples were frozen at -20ºC until further analysis. 
 
Quantification of M1dG 
The 32P-postlabelling technique was used to analyse the levels of 3-(2-Deoxy-β-D-
erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3H)-one (M1dG) adducts, as previous-
ly reported [20]. M1dG adduct analysis was carried out by PEI-cellulose TLC chroma-
tography according to published conditions [21]. Detection and quantification of M1dG 
adducts and total nucleotides were obtained by phosphor imaging technology (Ty-
phoon 9210, Amersham) and ImageQuant software (Molecular Dynamics, Sunnyvale, 
CA, USA). After background subtraction, the levels of DNA adducts were expressed 
as relative adduct labelling (RAL = adducted nucleotides/total nucleotides). Standard 
MDA modified [22] and unmodified DNA were routinely processed in the analysis as 
controls. 
RNA isolation and purification 
After lungs were pulverised using a liquid nitrogen cooled mortar and pestle, TRIzol® 
Reagent (Invitrogen, Breda, the Netherlands) was added and RNA was isolated by 
using an RNeasy Mini kit (Qiagen, Venlo, the Netherlands) with DNase treatment, 
according to the manufacturer’s protocol. RNA quantity was determined by NanoDrop 
(Isogen-Lifescience, De Meern, the Netherlands) and RNA quality was assessed by 
automated gel electrophoresis on an Agilent 2100 Bioanalyser (Agilent Technologies, 
Amstelveen, the Netherlands). All RNA samples analysed were pure and free of RNA 
degradation. 
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RNA labelling and microarray hybridisation 
Cyanine labelled cRNA was generated by using the Two-Colour Microarray based 
Gene Expression Analysis kit from Agilent Technologies. All samples were labelled 
with Cy5 and a pool of Cy3 labelled sham group samples was used as reference. Dye 
incorporation rates were used to put appropriate amounts of Cy5 and Cy3 labelled 
samples (10 pmol each) together for hybridisation on Agilent 4x 44K Mouse Microar-
rays (Agilent Technologies). After hybridisation, slides were washed and dried with N2 
gas before scanning. 
Image analysis 
Slides were scanned on a GenePix® 4000B Microarray Scanner (Molecular Devices, 
Sunnyvale, CA, USA). Cy5 and Cy3 were excited at wavelengths of 635 and 532 nm 
respectively. Laser power was set to 100%. The photo multiplier was set to a satura-
tion tolerance of 0.02% to minimise background and saturated spots. The images 
obtained (resolution 5 micron, 16 bit tiff images) were processed with Imagene 8.0.1 
software (Biodiscovery, El Segundo, CA, USA) to measure median Cy3 and Cy5 
signal intensities for spots and local backgrounds. Quality control was performed by 
means of visual inspection of the scanned images, raw data scatter plots, MA plots 
and normal probability plots to assess signal distribution. Positive and negative con-
trols were used for quality control, but subsequently excluded from the further norma-
lisation and analysis. 
Normalisation and data preparation 
Raw microarray signal data were normalised in R (http://www.r-project.org), using the 
four step approach as described by Baken et al. [23]: (1) natural log-transformation, 
(2) quantile normalisation of all scans, (3) correcting the sample spot signal for differ-
ences in the corresponding reference spot signal between arrays and (4) averaging 
data from spots annotated with an identical gene symbol. Normalised data for the 
resulting 25,696 genes were visualised by Principal Component Analysis (PCA) for 
additional quality control. Further analyses were carried out in R and Microsoft Excel. 
As PCA analysis showed heterogeneity within groups, for each gene, median expres-
sion values per group were calculated and compared between the 3 experimental 
groups. Genes with a more than 1.5-fold difference between experimental groups 
were considered differentially expressed. It has been described by Guo et al. [24] that 
for such strong effects, analyses of such gene lists showed good and internal consis-
tency on the Gene Ontology and pathway level. 
Data analysis 
Functional Annotation and Gene Ontology (GO) term enrichment were examined with 
DAVID Bioinformatics Resource (http://david.abcc.ncifcrf.gov/) [25]. Additionally, Me-
taCore (GeneGO, San Diego, CA) was used for additional pathway enrichment analy-
sis, as well as visualisation of differentially expressed genes in cellular pathways. To 
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provide a sample specific measure for the gene expression response over the diffe-
rentially expressed genes, their value was adjusted for the median of the control 
(sham) group, followed by calculation of the root mean square. Correlation between 
the gene expression response and M1dG DNA adduct lesions were compared be-
tween samples using the Spearman’s rank correlation coefficient. 
Results 
Neutrophil infiltration in lung tissue 
To determine the influx of neutrophils and to verify neutrophil activation, we assessed 
MPO activity in the BALF. Extracellular MPO is indicative of the presence of activated 
neutrophils [18]. Intratracheal instillation of mice with LPS indeed increased the mean 
MPO activity in BALF (81.4 ± 20.5 mU/ml), as compared to the sham group (MPO 
activity < detection limit, P < 0.05). MPO activity was absent in animals depleted of 
circulating neutrophils, thereby confirming their depletion status. 
 Furthermore, MPO protein concentrations in lung tissue homogenates, prepared 
after BAL lavage, were determined to check the efficiency of the BAL and the possible 
contamination of the lavaged lungs with resident neutrophils and hence neutrophil 
RNA. MPO protein values in the lavaged lung tissues of LPS exposed mice 
with/without PMN (resp. 334.0 ± 94.8 and 188.0 ± 51.3 ng MPO/mg protein) indicated 
no significant neutrophilic contamination compared to background levels in sham mice 
(246.2 ± 77.3 ng MPO/mg tissue). MPO protein contents of lung samples of LPS 
exposed mice with/without PMN that were not lavaged (obtained from another study) 
were resp. 875.2 ± 284.6 and 328.7 ± 82.3 ng MPO/mg protein compared to back-
ground levels in control mice (309.4 ± 43.4 ng MPO/mg protein), which indicates that 
the lavages were successful, washing away most of the neutrophils / inflammatory 
cells and the microarray analysis will thus not be disturbed by remaining infiltrated 
neutrophils cells. 
Differentially expressed genes 
PCA analysis on all normalised data showed that LPS exposed groups were more 
heterogeneous than the sham group. This was also the case in a PCA using only the 
383 commonly lung inflammation genes that were described, by Pennings et al., to be 
induced in multiple lung inflammatory models [26], indicating that also the inflammato-
ry response, which is the main expected response, is subjected to relatively large 
inter-animal variation following LPS exposure. This observation is also reflected by 
the heterogeneity in MPO activity levels measured in BALF and is probably due to 
differences in the acute phase response of individual mice upon intratracheal LPS 
instillation. To make the gene expression data analysis robust against this hetero-
geneity and outliers within groups, we based our further analysis on the median val-
ues for each group and focussed on the genes with highest fold change ranking only. 
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 This data analysis approach revealed 621 genes that were differentially ex-
pressed between all experimental groups with a ≥ 1.5-fold change (Gene list can be 
found at http://www.grat.nl/media/file/exchange/N_Gungor_appendix_proefschrift.pdf), 
of which 179 were 2-fold differentially expressed. The distribution of the number of 
differentially regulated genes over the experimental groups is presented in a Venn 
diagram (Fig. 1). The expression of 514 genes was changed in the LPS group in the 
presence of PMN, of which 394 showed increased expression and 120 decreased 
expression as compared to sham control. The greatest increase was 15-fold (serum 
amyloid A 3) and the greatest decrease was 2.6-fold (paraoxonase 1). In total, 360 
genes were differentially expressed in the LPS group that was depleted of PMN (287 
upregulated and 73 downregulated). The greatest increase in this list is 7.7-fold, again 
for serum amyloid A 3, and the greatest decrease was 2.7-fold (keratin complex 1, 
acidic gene 15). As demonstrated in Figure 1, there were overlaps between the gene 
lists obtained from LPS exposed animals with and without PMN depletion. Among the 
differentially expressed genes compared to sham mice, 265 were overlapping both 
groups, showing differential regulation upon LPS induced lung inflammation, irrespec-
tive of the neutrophil influx status. A correlation (R = 0.68) was observed between the 
expression of these genes in animals that were exposed to LPS with or without deple-
tion of PMN. The slope of the regression line was 0.6, indicating that the extent of the 
response was less strong in animals that were PMN depleted. Comparison of the 2 
LPS exposed groups with/without PMN depletion resulted in 107 differentially ex-
pressed genes, mostly overlapping the lists of differentially expressed genes of the 
separate LPS groups compared to the sham group, but different in the extent of 
change. Only 12 genes were differentially expressed by PMN depletion and not by 
LPS instillation, of which only 1 gene was 2-fold changed (i.e. resistin like gamma). 
 
 
 
Figure 1: Venn diagram showing the distribution of the 1.5-fold differentially expressed genes over the 
3 groups: LPS exposed mice compared to sham mice (LPS + PMN), LPS exposed neutrophil depleted 
mice compared to sham mice (LPS – PMN) and LPS exposed mice compared to LPS exposed neutro-
phil depleted mice (+ PMN vs. – PMN).  
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Pathway regulation 
To assign functions to differentially expressed genes, we classified them according to 
GO categories. Subsequently, enrichment of GO categories in the list of 1.5-fold diffe-
rentially expressed genes was assessed to identify pathophysiological processes 
involved in the acute phase response in the lung upon LPS induced lung inflammation 
and the role of neutrophils herein. As expected, this GO term enrichment analysis 
showed that among the 514 genes differentially expressed in the LPS exposed group 
in the presence of PMN, a considerable number of the 394 upregulated genes be-
longed to the GO categories “immune response” (74 genes) and “inflammatory re-
sponse (41 genes). The functional classes of genes that were most prominently upre-
gulated consisted of cytokines and chemokines, several genes involved in the com-
plement cascade and a few known inflammation markers (e.g. Lcn2, Saa1, Saa3). 
Apart from genes involved in immune or inflammation related processes, also a sub-
stantial number of differentially regulated genes (46 genes) is involved in cell cycle 
regulation. GO-categories belonging to the 120 downregulated genes mostly 
represented nonimmune processes, such as development, metabolism and transport. 
Depleting the mice from circulating neutrophils resulted in a comparable but weaker 
immune/inflammatory response upon LPS exposure. Moreover, the number of genes 
belonging to the GO categories “immune response” and “inflammatory response” was 
reduced from 74 to 59 and 41 to 29 genes, respectively, due to PMN depletion. Also 
the number of genes belonging to the GO category cell cycle was reduced to 36 
genes in PMN depleted mice. 
 To reveal intergene relations, we performed MetaCore analysis on the 1.5-fold 
regulated genes upon LPS exposure in the combined group with or without PMN 
depletion. The significant pathways are presented in Table 1. This analysis revealed a 
common significance of pathways involved in cell cycle for both LPS exposed groups, 
although cell cycle effects were more pronounced in the presence of neutrophils. 
Further, a large number of pathways involved in immune response were modulated 
upon LPS exposure. High ranking MetaCore pathways in both LPS groups were “Al-
ternative complement pathway” and “Antigen presentation by MHC class II”. Interes-
tingly, several immune response pathways, including the classic and lectin induced 
complement cascade, interferon and IL-10 signalling, were only significantly induced 
in the LPS exposed group without PMN depletion. Whereas the transcriptional regula-
tion of myeloid progenitor cell differentiation into neutrophils was only modulated in 
the LPS exposed group with PMN depletion, as indicated by higher Mpo expression in 
this group. The rest of the differentially expressed inflammation associated transcripts 
upon LPS exposure in depleted and undepleted mice were categorised into the fol-
lowing cellular processes: oxidative stress, apoptosis, G protein signalling, cytoskele-
ton remodelling and metabolism. As shown in Table 1, the overall response is rather 
similar in both LPS groups compared to sham group, but generally less extensive in 
the group in which PMN were depleted, as indicated by fewer modulated pathways 
and fewer genes involved in these pathways. 
 Biological processes and pathways for differentially regulated genes between the 
PMN depleted and undepleted group (both with LPS exposure) were also identified by 
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querying the MetaCore database. The significant pathways, listed in Table 2, reveal 
mainly a role of inflammatory neutrophil influx in immune response processes, such 
as interferon, IL-3 and Oncostatin M signalling. 
 
 
 
 
 
 
Correlation of genes with phenotypic markers of effects; M1dG adducts 
Because the pathway analysis tool MetaCore identified only significant modulation of 
oxidative stress related pathways upon LPS instillation in the group without PMN 
Main cellular process Modulated pathways
total
+ PMN - PMN + PMN - PMN
Cell cycle Role of APC in cell cycle regulation 1.040E-09 8.149E-08 15 12 32
Chromosome condensation in prometaphase 4.131E-06 8.392E-11 9 12 20
The metaphase checkpoint 4.423E-06 1.474E-04 12 9 36
Spindle assembly and chromosome separation 3.170E-04 1.937E-03 9 7 32
Start of DNA replication in early S phase 1.284E-03 3.115E-02 8 5 31
Initiation of mitosis 1.544E-03 2.483E-03 7 6 25
Sister chromatid cohesion 1.530E-02 5 21
Transition and termination of DNA replication 1.523E-02 5 26
Role of Nek in cell cycle regulation 2.390E-02 5 29
Nucleocytoplasmic transport of CDK/Cyclins 4.386E-02 3 14
Immune response Alternative complement pathway 4.539E-07 2.737E-02 12 5 30
Fc gamma R-mediated phagocytosis 1.606E-03 9.058E-03 8 6 32
Antigen presentation by MHC class II 6.046E-03 2.644E-03 4 4 11
Classic complement pathway 1.517E-05 12 40
Antiviral actions of Interferons 2.431E-04 9 31
CCR3 signalling 8.728E-04 12 59
Lectin Induced complement pathway 1.251E-03 9 38
Lipoxin inhibitory action on Superoxide production 1.544E-03 2.483E-03 7 6 25
IFN alpha/beta signalling pathway 6.214E-03 6 24
IL-10 signalling pathway 2.245E-02 5 23
Antigen presentation by MHC class I 3.675E-02 5 26
Transcription regulation of granulocyte development 3.115E-02 5 31
Oxidative stress ROS production 8.932E-04 4.113E-02 7 4 23
Apoptosis Inhibition of ROS induced apoptosis 3.675E-02 5 26
G protein signalling Rac2 regulation pathway 4.957E-03 4.113E-02 6 4 23
RAC1 in cellular process 1.361E-02 6 28
Cytoskeleton remodelling Regulation of actin cytoskeleton by Rho GTPases 8.972E-03 5 23
Alpha-1A adrenergic receptor-dependent inhibition of PI3K 2.887E-02 3 12
Metabolic process Lipoprotein metabolism I. Chylomicron, VLDL and LDL metabolism 1.630E-02 9.007E-07 3 6 8
Lipoprotein metabolism II. HDL metabolism 1.630E-02 9.007E-07 3 6 8
G-alpha(q) regulation of lipid metabolism 2.245E-02 5 23
Urea cycle 3.675E-02 5 26
LDL metabolism during development of fatty streak lesion 1.870E-02 2 4
Table 1: Pathways significantly modulated by LPS induced lung inflammation as found in MetaCore
Note: Significantly modulated 1.5-fold changed genes (P value < 0.05) versus total number of genes in pathway
P value Genes in pathway
expressed
Main cellular process Modulated pathways P value
expressed total
Cell cycle Role of APC in cell cycle regulation 1.012E-02 4 32
Spindle assembly and chromosome separation 1.012E-02 4 32
Immune response IFN alpha/beta signalling pathway 2.740E-05 6 24
Alternative complement pathway 8.024E-03 4 30
Oncostatin M signaling via MAPK 1.683E-02 4 35
NKG2D signalling 4.297E-02 3 29
IL-3 activation and signallng pathway 4.685E-02 3 30
Response to extracellular stimulus Angiotensin signalling via STATs 2.917E-02 3 25
Ligand dependent activation of the ESR-1/AP-1 pathway 4.756E-02 2 13
Other Mucin expression in CF via IL-6, IL-17 signalling pathways 3.926E-02 3 28
Note: Significantly modulated 1.5-fold changed genes (P value < 0.05) versus total number of genes in pathway
Genes in pathway
Table 2: Pathways significantly modulated by neutrophil depletion as found in MetaCore
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depletion (see Table 1), we sought to link neutrophil induced gene expression 
changes with phenotypic genotoxic effects of neutrophil derived ROS. As a previous 
study indicated that neutrophils are possibly mutagenic via an indirect genotoxic ha-
zard of neutrophil derived HOCl, by its attack on lipids and/or proteins producing MDA 
and forming M1dG adducts [unpublished results: 9], we measured M1dG levels in the 
mouse lung as a phenotypic marker of neutrophil induced genotoxicity. LPS treatment 
caused a significant increase in the formation of M1dG adducts in the mouse lung 
(13.6 ± 2.8 M1dG/108 nt) compared to sham mice (5.1 ± 0.2 M1dG/108 nt) (~4-fold, P = 
0.01). Reduced M1dG levels in LPS instilled neutrophil depleted mice (10.6 ± 2.5 
M1dG/108 nt), and a significant correlation between MPO activity in BALF and M1dG 
levels in lung cells (Pearson correlation = 0.67, P = 0.001) suggest a link between 
neutrophil influx, MPO mediated formation of HOCl and formation of M1dG adducts in 
vivo. Therefore, we calculated Spearman’s rank correlation coefficient between gene 
expression response values and M1dG adduct data, indicating a significant correlation 
with P = 0.01 for R = 0.64 using the 1.5-fold changed gene lists. 
Discussion 
Gene expression changes usually occur in early stages of disease development and 
can provide additional information on the pathogenesis of that particular disease. The 
present study makes use of the ability of microarray technology to define the expres-
sion of inflammation related genes in lungs, by using LPS in a mouse model com-
bined with systemic neutrophil depletion. In this way, we were able to extend the un-
derstanding of the role of neutrophils in pulmonary inflammation and identify genes 
and pathways that can be related to mechanisms of inflammation related carcinoge-
nesis. 
 As LPS induced pulmonary inflammation involves a massive recruitment of neu-
trophils into the alveoli, it raises the question whether the observed transcriptional 
responses in sessile lung cell can actually be attributed to the fact that the lung sam-
ples are contaminated with resident inflammatory neutrophils. However, inflammatory 
cells were removed from the lungs prior to expression analysis, and similar MPO 
protein levels in sham and LPS exposed animals indicated efficient BAL and neglect-
able levels of resident neutrophils. Thus, the changes in gene expression described 
here can predominantly be attributed to sessile pulmonary epithelial cells. 
 Of the 1.5-fold differentially expressed genes between all groups, the number of 
differentially expressed genes in the group of LPS exposure without neutrophil deple-
tion was larger then those in the LPS group with neutrophil depletion, indicating a 
more pronounced response when LPS induced lung inflammation is associated with 
neutrophil influx in terms of changes of gene expression (Fig. 1). The reduced acute 
inflammatory response in the neutrophil depleted animals was also confirmed by 
lower expression levels of the serum amyloid genes Saa1 and Saa3, which are acute 
phase systemic inflammation markers known to be induced by LPS treatment [27]. 
Overall, there is consistency of changed gene expression profiles between LPS ex-
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posed animals with or without neutrophil depletion, which is reflected by the fact that 
74% of the > 1.5-fold changed genes in the LPS group with neutrophil depletion were 
overlapping the LPS group without neutrophil depletion. In comparison, a high percen-
tage of differentially expressed genes between PMN depleted and undepleted group 
(89%) were also found in the gene sets of which the expression changed in the ex-
posed groups as compared to sham, indicating that neutrophil specific gene profile 
changes in the lung were almost only noticeable after LPS exposure. 
 The shared response of undepleted mice and neutrophil depleted mice upon LPS 
exposure involves predominantly increased expression of cell cycle related genes. 
There is apparently a rapid turnover or proliferation of cells due to increased lung 
epithelial renewal, which is actually often seen during acute lung inflammation [26]. As 
expected, besides this modulation of cell cycle, most upregulated genes are involved 
in immune and inflammation related processes, such as cytokine/chemokine activity 
and signalling, complement cascade and antigen presentation. Other modulated 
processes include oxidative stress response, apoptosis, cytoskeleton remodelling and 
lipid metabolism. Most of the genes that were downregulated by LPS exposure in-
volved nonimmune processes, such as development, metabolism and transport. It is 
tempting to speculate that downregulation of these processes shifts the energy bal-
ance in favour of the immune response, which suggests that the induction of the in-
flammatory response goes at the expense of normally activated processes in lung 
tissue. Comparison of our data to several reported lung inflammatory models indi-
cated a comparable trend for the regulation of the set of commonly lung inflammation 
genes, described by Pennings et al. [26]. 
 Evidently, influx of inflammatory cells in the lung is likely to influence gene ex-
pression profiles. Pathway analysis revealed restrained cell cycle progression in the 
neutrophil depleted animals by modifications in cell cycle regulation, DNA replication 
and metaphase checkpoints, possibly referring to a higher rate of cell turnover in the 
undepleted LPS exposed group, suggesting that the neutrophil influx is associated 
with a higher risk for the accumulation and fixation of mutations. In addition, our data 
provide more information on the central role of PMN in the lung inflammatory re-
sponse. Pathogenesis of LPS induced acute lung inflammation is characterised by a 
profound neutrophil influx [12], as also confirmed by pathway analysis in this study, 
showing the most significant induction of relevant pathways in the LPS induced in-
flammatory response in the group without PMN depletion. The reduced amount of 
genes involved in inflammatory/immune processes in the LPS group with PMN deple-
tion can be related to the absence of neutrophils and consequently restrained lung 
inflammation. This suppressive effect of neutrophil depletion is most obvious in the 
expression of multiple genes involved in pathways related to interferon signalling, like 
the “IFNα/β signalling pathway” and the “NK62D signalling pathway”. By depleting 
neutrophils, the interferon signalling pathways are downregulated, indicating a re-
duced level of lung inflammation because interferon signalling is known to play a role 
in the regulation of the inflammatory response in the lower respiratory tract after LPS 
inhalation [28]. The expression of genes involved in the “NK62D signalling pathway”, 
resulting in GM-CSF and IFN-γ production, is, however, significantly upregulated in 
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neutrophil depleted mice. GM-CSF is a proinflammatory cytokine, also synthesised by 
lung epithelial cells, which promotes the growth and maturation of granulocyte proge-
nitors and the activation of mature neutrophils [29]. It primes neutrophils, making them 
more receptive to activation by secondary stimuli [30]. Knowing this role of GM-CSF, 
and the fact that several cytokines and chemokines are regulated by IFN-γ, it is con-
ceivable that in the absence of normal PMN recruitment, homeostatic mechanism 
may serve to promote differentiation of myeloid progenitor cells into mature neutro-
phils and to enhance the production and release of cytokines after inhalation of LPS. 
Among the differentially regulated genes in these pathways are Stat2 and some inter-
feron induced genes, such as Ifit2 and Isg15, but also genes involved in AP-1 signal-
ling, for instance the 1.5-fold upregulation of Fos expression upon neutrophil depletion 
of LPS treated mice. c-Fos levels regulate the transcriptional activity of the transcrip-
tion factor activator protein 1 (AP-1), which is a heterodimer of the proto-oncogene 
proteins c-FOS and c-JUN [31]. Interestingly, the promoter regions of many inflamma-
tory cytokines contain AP-1 binding sites [32], suggesting that AP-1 activation may be 
necessary for the induction of acute cytokine mediated inflammation. In this way, c-
Fos plays a role in more than one signalling process, interconnecting various signal-
ling routes and thereby extending the inflammatory response. For instance, the inter-
connection of FOS, AP-1 and STAT in the “Oncostatin M signalling pathway”, regu-
lates the expression of several acute phase proteins in response to oncostatin M 
secretion by neutrophils to reduce the local inflammation [33]. Also IL-3 activation 
involves AP-1; linking the previous mentioned upregulated NK62D signalling pathway 
to increased production of IL-3 in neutrophil depleted mice upon LPS induced lung 
inflammation. IL-3 stimulates the differentiation of multipotent haematopoietic stem 
cells into myeloid progenitor cells, as well as the proliferation of all cells in the myeloid 
lineage, including granulocytes, as is confirmed by the observed upregulation of the 
Mpo gene, which is only expressed in neutrophil precursor cells and not in mature 
neutrophils [34], indicating increased amounts of progenitor cells in the lungs of neu-
trophil depleted mice. Additionally, the chemoattractants S100a8 and S100a9, whose 
expression was induced in LPS exposed neutrophil depleted mice and are known to 
attract haematopoietic mac1+ myeloid progenitor cells in the lungs [35], may explain 
this observed accumulation of mac1+/gr1+ granulocyte precursors in the lungs of neu-
trophil depleted mice. Altogether, these modulated pathways in the PMN depleted 
mice upon LPS exposure can act cooperatively to stimulate the PMN recruitment, 
suggesting that the organism tries to compensate for the absence of neutrophils. 
 Furthermore, our study provides evidence that neutrophil influx is involved in 
transcriptional regulation of oxidative stress during lung inflammation. A network con-
sisting of Gp91-phox, P67-phox, P47-phox, P22-phox and Cytochrome b-558, was 
more expressed in LPS group with PMN. Gp91-phox and p22-phox are 2 subunits 
forming the core heterodimer of NAD(P)H oxidase. NAD(P)H oxidase is one of the 
major oxidant generating enzymes present in the lung and is induced during an in-
flammatory status. Imbalance of oxidants/antioxidants has long been hypothesised to 
play an important role in the pathogenesis of chronic lung inflammation (including 
COPD) [36] and is associated with cancer development [37]. Moreover, inspection of 
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individual genes in the differentially expressed gene lists showed the upregulation of 
Noxo1 in the LPS group without PMN depletion. NOXO1 is an organiser protein that 
activates NADPH oxidase (NOX1) [38, 39] and increased Noxo1 expression may be a 
marker for oxidative stress during lung inflammation. Together with the neutrophil 
associated “Inhibition of ROS induced apoptosis”, this indicates the important role for 
neutrophil derived ROS in the induction of DNA damage during acute lung inflamma-
tion, which plays a significant part in the carcinogenic process. This was further con-
firmed by a positive correlation between gene expression changes and the DNA le-
sion M1dG induced by neutrophils during lung inflammation, suggesting that the extent 
of the inflammatory response is representative for genotoxicity. M1dG adducts are 
efficient promutagenic lesions that induce mutations in genes involved in carcinoge-
nesis [40] and evidence has accumulated that such M1dG-DNA adducts play a role in 
several cancers, notably those with an inflammatory component in their ethiopathoge-
nesis [41]. Thus, this correlation indicates a possible link between neutrophil induced 
genotoxicity, gene expression changes and inflammation related cancer. 
Conclusions 
We used the microarray technology to demonstrate the upregulation of inflammation 
associated genes in an acute lung inflammation mouse model induced by LPS. Most 
neutrophil dependent gene expression changes were involved in immune and inflam-
mation related processes. A substantial amount of modulated genes and pathways 
provided more information on the central role of neutrophils in the inflammatory re-
sponse to LPS and can impact a variety of seemingly unrelated pathological condi-
tions. For example, sequence changes in innate immune receptors and their signal-
ling molecules are known to alter the risk of developing not only inflammation, but also 
atherosclerosis and asthma [42]. Thus, the neutrophil associated profiles of the in-
flammatory response merit further attention, as some of these genes may increase 
susceptibility to inflammatory lung disease and perhaps cancer [43]. Furthermore, the 
positive correlation of neutrophil induced genes and the promutagenic DNA lesion 
M1dG, combined with the neutrophil induced upregulation of genes in oxidative stress 
and cell cycle progression related pathways, suggest that the extent of the inflamma-
tory response drives genetic instability, indicating an active role of neutrophils in tu-
mour initiation and progression. 
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Inflammation has been recognised as an important factor in cancer development [1]. 
In some types of cancer, an oncogenic change induces and inflammatory microenvi-
ronment that promotes the development of tumours (extrinsic pathway). Regardless of 
its origin, ‘smouldering’ inflammation in the tumour microenvironment has many tu-
mour promoting effects. It aids in the proliferation and survival of malignant cells, and 
promotes angiogenesis and metastasis. Conversely, in other types of cancer, inflam-
matory conditions are present before a malignant change occurs and augment the 
risk of developing cancer (intrinsic pathway). The two pathways converge in the acti-
vation of transcription factors (mainly NF-κB, STAT-3 and HIF1α), which coordinate 
the production of inflammatory mediators (cytokines and chemokines), which in their 
turn recruit and activate inflammatory cells (e.g. neutrophils), resulting in inflamma-
tion. These mediators and effectors of inflammation are important constituents of the 
local environment of tumours [2]. Although the connection between inflammation and 
cancer is now generally accepted, it remains unclear whether inflammation is suffi-
cient for cancer development. This thesis focuses on one candidate for endogenous 
‘inflammatory carcinogen’, namely reactive oxygen species released by inflammatory 
neutrophils. 
 For the lung, experimental studies with rats, as well as molecular epidemiological 
studies in humans, have provided evidence that the influx of neutrophils into the air-
ways may be an important process linking inflammation with carcinogenesis. Never-
theless, the mechanisms involved in inflammation (neutrophil) related carcinogenesis 
have only partly been elucidated. Carcinogenesis is a complicated multistep process 
and specifically in the initiation stage, genotoxic events are thought to play a crucial 
role. It is suggested that the genotoxic capacity of neutrophils may be a crucial etio-
logical factor in this carcinogenic response. Neutrophils are a major source of oxi-
dants in the inflamed lung, and the constant release of reactive oxygen species (ROS) 
by these cells provides a plausible mechanism by which inflammatory cells and pul-
monary carcinogenesis might be related; ROS cause genetic alterations in the lung 
epithelium, which may induce/promote cancer development [3]. In vitro studies, using 
cocultures of activated neutrophils and target cells, indeed indicated oxidative DNA 
disturbances induced by neutrophils, which seems mainly driven by the release of 
hydrogen peroxide (H2O2). However, the major neutrophil derived oxidant is the mye-
loperoxidase (MPO) catalysed hypochlorous acid (HOCl) [4]. Interestingly, there is 
only limited data available on the potential role of this ROS in inflammation related 
carcinogenesis. 
In addition to the direct genotoxic effects of ROS, neutrophils are also implicated 
in pulmonary genotoxicity via the promotion of metabolic activation of inhaled chemi-
cals carcinogens, thereby generating highly DNA reactive and mutagenic compounds. 
The most relevant pathway by which neutrophils may enhance biological activation of 
chemical carcinogenesis is probably a MPO mediated peroxidative metabolism, acti-
vating carcinogenic polycyclic aromatic hydrocarbons (PAH), such as benzo[a]pyrene 
[5, 6]. In this way, MPO has been implicated in the pathogenesis of inflammation 
related carcinogenesis by epidemiological studies, with reference to the -463G→A 
polymorphism in the promoter region of the MPO gene, which is associated with a 
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reduced risk of lung cancer [7, 8]. Considering the role of MPO in the generation of 
HOCl, it could also be assumed that the possible protective effect of the -463A allele 
is mediated through a reduced production of HOCl. 
Nevertheless, the causal role of neutrophils in ROS mediated DNA damage and 
mutagenesis is still primarily described by in vitro experiments. In vivo experiments, 
using experimental animals, have mainly provided indirect evidence implying that 
additional research is needed to further test the relation between neutro-
phils/MPO/HOCl and genotoxicity in the respiratory tract. The aim of the present the-
sis was to investigate the role of neutrophils in inflammation related carcinogenesis, 
focussing on three major pathways of neutrophil induced genotoxicity using both in 
vitro and in vivo models. In the first part of the thesis (chapter 3), we specifically fo-
cussed on mechanisms involved in primary genotoxicity induced by neutrophils and 
HOCl, whereas in chapters 4 & 5, a possible inhibitory effect of neutrophil derived 
HOCl on nucleotide excision repair is described, as an additional contribution of neu-
trophil derived oxidants to the genotoxic environment of lung inflammation. In the final 
chapter 6, a broader characterisation of the neutrophil induced effects in the mouse 
lung is presented by using gene expression profiling. 
Genotoxic effects of neutrophils and HOCl 
At this moment, it is generally accepted that the genotoxic capacity of neutrophils is at 
least partly attributable to the generation of DNA damaging and mutagenic ROS. In 
the past, the major focus was on H2O2 generated by neutrophils as being the pre-
sumed primary mediator of genotoxic effects, because it serves as a latent form of 
hydroxyl radical, the most reactive ROS towards DNA [9]. However, under physiologi-
cal conditions, up to 70% of H2O2 is consumed by the neutrophil derived enzyme 
MPO to generate the strong oxidant HOCl [4], of which the genotoxic capacity is still 
unclear. 
In chapter 3, the DNA damaging and mutagenic effects of HOCl on lung cells 
have been described. This study is the first to report that HOCl induces mutations in 
the HPRT gene of lung epithelial cells, suggesting an indirect genotoxic effect of HOCl 
by its attack on lipid and/or proteins producing malondialdehyde (MDA) and subse-
quent formation of 3-(2-Deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-
10(3H)-one (M1dG) adducts. An LPS induced acute lung inflammation mouse model, 
using depletion of circulating neutrophils, confirmed the link between pulmonary neu-
trophil influx, HOCl and formation of M1dG adducts in vivo. Taken together, these data 
indicate that the MPO catalysed formation of HOCl during pulmonary inflammation 
should be considered as a significant source of neutrophil induced genotoxicity and 
possibly mutagenesis. These data support findings from recent molecular epidemio-
logical studies, reporting a protective effect of a 463G→A polymorphism in the promo-
ter region of the MPO gene on the lung cancer risk in smokers [7, 8]. However, as the 
in our studies used A549 cells present an adenomacarcinoma cell line and are in fact 
not a progenitor cell type, these may not be the ideal cells to explore genotoxic influ-
Chapter 7 
 122 
ence of HOCl relevant for tumour initiation. Therefore, further investigation of muta-
genic effects of HOCl in primary lung epithelial cells may be more relevant for the 
initial genotoxic events that may occur during cancer development. While it is certainly 
possible that neutrophils are involved in the initiation events of pulmonary carcinoge-
nesis, our data on HOCl induced genomic instability may also add to the known fact 
that neutrophil infiltration into tumours stimulates tumour progression [10]. 
DNA repair inhibition by neutrophils and HOCl 
Although HOCl formation has been linked to induction of DNA damage, as described 
above, there is growing evidence that the protective effect of the A allele for lung 
cancer is predominantly observed in smokers, mainly suggesting an interaction be-
tween neutrophils, MPO and cigarette smoke constituents [11, 12]. The initial expla-
nation for this association was sought in the role of MPO in the bioactivation of in-
haled carcinogens. For example, MPO has been demonstrated to enhance the trans-
formation of the prototype PAH benzo[a]pyrene into DNA binding metabolites (e.g. 
benzo[a]pyrene-diol-epoxide) [6, 13]. If these helix distorting DNA lesions escape from 
specific DNA repair (i.e. nucleotide excision repair (NER)), they may cause replication 
fork blocks, ultimately leading to mutagenesis and carcinogenesis [14]. 
As recent data have revealed that oxidising species, such as 4-hydroxynonenal 
[15], MDA [16] and nitric oxide [17], are endogenous inhibitors of NER and consider-
ing the potent protein oxidising effect of HOCl, the second hypothesis of the thesis 
focussed on the potential of HOCl to modulate DNA repair capacity in lung epithelial 
cells. Chapter 4 demonstrated that neutrophils are potent inhibitors of NER in human 
pulmonary epithelial cells in vitro, via the MPO mediated generation of HOCl. A loss of 
function of NER enzymes, originating from direct HOCl induced oxidative attack on 
proteins, could only partly explain the NER inhibitory effects of HOCl on target cells, 
indicating that other mechanisms, like the formation of protein-DNA crosslinks [18], 
may be involved. Also the HOCl induced lipid peroxidation/protein oxidation product 
MDA, such as reported in chapter 3, has been shown to directly interact with repair 
enzymes [16], providing an additional possible mechanism for the observed HOCl 
induced NER inhibition. The relevance of this in vitro finding for DNA repair in vivo has 
been described in chapter 5, demonstrating an association between LPS induced 
pulmonary inflammation and reduced NER in the mouse lung. The effect of neutro-
phils was revealed by the use of an MPO knockout mouse model and the systemic 
depletion of circulating neutrophils with specific antibodies. However, in contrast to the 
in vitro findings, no distinct role of either MPO (and hence HOCl) or neutrophils was 
shown, suggesting that other factors are mediating inhibition of NER in the inflamed 
mouse lung. It is suggested that resident alveolar macrophages, by generating reac-
tive nitrogen species (RNS), including nitric oxide, may be causing DNA repair inhibi-
tion [17]. 
 Nonetheless, the results of chapter 4 & 5 together indicate an inflammation asso-
ciated reduction of NER as a significant and previously unrecognised potential contri-
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butory factor in the development of inflammation related pulmonary cancer. This effect 
may be most significant in subjects that are exposed to chemical carcinogens, for 
instance by chronic inhalation of cigarette smoke, and showing a concomitant pulmo-
nary inflammatory response. NER is the most important repair pathway to remove 
large helix distorting DNA adducts that are produced following inhalation of such 
chemical carcinogens (e.g. PAH) [19, 20], and the formation of these promutagenic 
PAH-DNA adducts have been implicated as a causal process in lung cancer devel-
opment in smokers [21]. As studies with NER deficient mice showed that effective 
DNA repair is crucial to prevent the carcinogenic effects of PAH induced DNA dam-
age [22], it can be speculated that processes leading to suppression of the relevant 
DNA repair pathways may have a detrimental effect on the cancer susceptibility of 
individuals exposed to such chemicals. Epidemiological studies have indeed shown 
that polymorphisms in NER genes, leading to (hypothetically) decreased phenotypical 
NER capacity, are associated with increased risk of lung carcinogenesis [23, 24]. In a 
wider perspective, the present finding further supports the notion that (chronic) in-
flammation may be an important factor determining susceptibility to cancer following 
exposure to environmental chemicals, and could provide an additional explanation for 
the association between MPO polymorphisms and risk of pulmonary DNA adducts 
formation and carcinogenesis in PAH exposed subjects [25, 26]. 
Neutrophil induced inflammatory pathways and gene expression 
changes in the lung microenvironment 
It should be realised, however, that induction of DNA damage and mutagenesis alone 
does not cause cancer and that neutrophils, for instance by generating an inflammato-
ry prooxidant environment, may have an impact on the initiation and progression of 
carcinogenesis. In this way, the release of ROS by neutrophils is also believed to 
cause a cell proliferative response, which may contribute significantly to the carcino-
genic response following chronic inflammation. 
 As gene expression changes usually occur in early stages of disease develop-
ment, the expression of inflammation associated genes and the identification of path-
ways related to mechanisms of inflammation related carcinogenesis, is studied in 
chapter 6. However, no significant effect of neutrophils was observed on genes in-
volved in carcinogenic processes, as most gene expression changes were related to 
immune and inflammation related processes providing more information on the central 
role of neutrophils in the inflammatory response. Nonetheless, these neutrophil asso-
ciated profiles of the inflammatory response merit further attention, as they may in-
crease susceptibility to inflammatory lung disease and may also impact on seemingly 
unrelated pathological conditions and perhaps cancer, regarding the involvement of 
inflammatory mediators (chemokines and cytokines) in cancer related inflammation. 
Another finding is the neutrophil induced upregulation of multiple genes involved in 
oxidative stress related biological processes and, moreover, a positive correlation 
between the neutrophil induced gene expression response and the promutagenic 
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DNA lesion M1dG, as reported in chapter 3. Additionally, lung inflammation revealed 
neutrophil dependent upregulation of cell cycle progression related pathways, possi-
bly referring to a higher cell turnover rate, suggesting that neutrophil influx is asso-
ciated with a higher risk of accumulation and fixation of mutations. These results, in 
combination with the role of impaired DNA repair pathways as part of cancer ethiopa-
thogenesis (chapter 4 & 5), provide a further confirmation for the link between inflam-
mation and pulmonary genotoxicity and suggest that it is indeed the extent of the 
inflammatory response which could drive genetic instability in the genesis but also 
perpetuation of carcinogenesis. 
Closing remarks 
The emphasis of the present thesis was to investigate the role of neutrophils in in-
flammation related carcinogenesis. At present, there is accumulating in vivo evidence 
that neutrophils are an important factor in later stages of the carcinogenic process. 
PMN infiltration into tumours might stimulate tumour progression by contributing to 
genetic instability of the tumour cells through release of ROS [10]. In line with this, it 
has been shown that tumour growth can be inhibited by the elimination of circulating 
PMN [27]. However, experimental evidence on more upstream events on tumour 
initiation, such as DNA damage and mutagenesis, is limited. Additionally to in vitro 
coculture models, the use of an MPO knockout mouse model and the systemic deple-
tion of circulating neutrophils with specific antibodies is a promising approach to fur-
ther reveal the effect of neutrophils in animals acutely exposed to inflammatory 
agents. By using these models, this thesis described that MPO catalysed HOCl in-
creases DNA damage and inhibits the repair of promutagenic bulky lesions, possibly 
inducing mutagenesis. However, it should be emphasised that genotoxicity only re-
lates to DNA reactivity, which means that is essentially not the same as carcinogenici-
ty. A major challenge would thus be to investigate if the in vitro HOCl induced muta-
genesis, as discussed in this thesis, can be extrapolated to a neutrophil influx in the in 
vivo situation. 
 A following question that rises is whether the in vitro and in vivo mechanisms of 
inflammation related carcinogenesis and the role of neutrophils herein, as discussed 
in this thesis, can be extrapolated to humans. So far, it is still unclear whether neutro-
phils really cause ROS induced genotoxicity in the inflamed human respiratory tract. 
On the other hand, recent molecular epidemiological studies, in combination with 
experimental in vitro and in vivo studies, have provided consistent evidence that neu-
trophils and human pulmonary carcinogenesis might be causally related by the capac-
ity of neutrophils, via the release of MPO, to promote biological activation of environ-
mental carcinogens, like PAH, into DNA damaging metabolites [28]. Whereas data 
presented in this thesis extended these observations by showing that inflammatory 
neutrophils, via MPO catalysed HOCl, increase DNA lesions and inhibit the repair of 
such promutagenic DNA adducts, possibly inducing mutagenesis in target cells rele-
vant for tumourigenic outcomes, still a lot of work needs to be done to provide deeper 
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insight in the implication of these processes in pulmonary carcinogenesis and formal 
proof that inflammation causes cancer is still required. Such knowledge may eventual-
ly lead to new approaches for inflammatory cancer prevention. Evidently, although the 
present study focussed on the lung, it needs to be emphasised that our findings may 
also be of importance for other organs where cancer development is associated with 
pre-existing neutrophilic inflammation. 
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Ontsteking wordt beschouwd als een belangrijke factor bij de ontwikkeling van kanker 
[1]. Kanker en ontstekingen zijn met elkaar verbonden door twee pathways: de extrin-
sieke en de intrinsieke pathway. Bij sommige kankersoorten leidt een oncogene ver-
andering tot een ontstoken micro-omgeving die de ontwikkeling van tumoren bevor-
dert (extrinsieke pathway). Een dergelijke ‘sluimerende’ ontsteking in de micro-
omgeving van de tumor heeft, ongeacht de oorsprong ervan, verschillende tumorbe-
vorderende effecten. Het draagt bij tot de proliferatie en de overleving van kwaadaar-
dige cellen en bevordert de angiogenese en de metastase. Bij andere kankersoorten 
daarentegen, bestaat er vóór de kwaadaardige ontwikkeling reeds een ontsteking die 
het risico op de ontwikkeling van kanker verhoogt (intrinsieke pathway). Deze twee 
pathways komen samen in de activering van transcriptiefactoren (voornamelijk NF-κB, 
STAT-3 en HIF1α) die de productie van inflammatoire mediatoren, zoals cytokines en 
chemokines, coördineren. Deze stoffen produceren en activeren op hun beurt inflam-
matoire cellen (bijv. neutrofielen) en dit volledige proces resulteert uiteindelijk in een 
ontsteking. De inflammatoire mediatoren en effectoren zijn belangrijke onderdelen 
van de tumormicro-omgeving [2]. Hoewel het verband tussen ontstekingen en kanker 
tegenwoordig algemeen aanvaard is, blijft het echter onduidelijk of een ontsteking 
alleen volstaat om kanker te ontwikkelen. In dit proefschrift ligt de nadruk op reactieve 
zuurstofradicalen, vrijgegeven door inflammatoire neutrofielen, als mogelijke endoge-
ne ‘inflammatoire carcinogenen’. 
Wat betreft de long, bewezen zowel experimentele onderzoeken op ratten, als mole-
culaire epidemiologische onderzoeken bij mensen dat de infiltratie van neutrofielen in 
de luchtwegen mogelijk een belangrijk proces is waardoor ontstekingen worden ge-
koppeld aan carcinogenese. Desondanks werden de betrokken mechanismen bij 
ontstekingsgerelateerde (neutrofiel-) carcinogenese slechts gedeeltelijk toegelicht. 
Carcinogenese is een complex, meerstaps proces waarin voornamelijk de genotoxi-
sche gebeurtenissen in de beginfase een zeer belangrijke rol te spelen. Met name de 
genotoxische capaciteit van neutrofielen blijkt hierin een cruciale etiologische factor te 
zijn. Neutrofielen vormen een zeer grote bron van oxidanten in de ontstoken long en 
de voortdurende afscheiding van reactieve zuurstofradicalen (ROS) vormt mogelijk de 
basis van de relatie tussen de inflammatoire cellen en de pulmonaire carcinogenese. 
ROS veroorzaken genetische wijzigingen in het longepitheel die kunnen leiden tot de 
ontwikkeling van kanker of deze kunnen bevorderen [3]. In vitro onderzoeken met co-
culturen van geactiveerde neutrofielen en doelcellen indiceerden inderdaad oxidatieve 
DNA-schade veroorzaakt door neutrofielen, hoofdzakelijk aangedreven door de af-
scheiding van waterstofperoxide (H2O2). De belangrijkste neutrofiel-afgeleide oxidant 
is echter myeloperoxidase (MPO-) gekatalyseerd waterstofhypochloriet (HOCl) [4]. 
Opvallend is dat er slechts een beperkt aantal gegevens beschikbaar is over de po-
tentiële rol van deze oxidant in ontstekingsgerelateerde carcinogenese. 
 Naast de rechtstreekse genotoxische effecten van ROS, zijn neutrofielen ook 
betrokken bij de pulmonaire genotoxiciteit via de metabolische activering van geïnha-
leerde chemische carcinogenen. Als gevolg daarvan worden zeer DNA-reactieve en 
mutagene samenstellingen geproduceerd. De meest relevante pathway via dewelke 
neutrofielen de biologische activering van chemische carcinogenen bevorderen is 
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waarschijnlijk een MPO-gemedieerd peroxidatief metabolisme dat carcinogene poly-
cyclische aromatische koolwaterstoffen (PAK), zoals benzo[a]pyreen, activeert [5, 6]. 
Aldus toonden epidemiologische onderzoeken aan dat MPO betrokken is bij de pa-
thogenese van ontstekingsgerelateerde carcinogenese; het -463G→ polymorfisme in 
de promotorregio van het MPO-gen wordt geassocieerd met een verlaagd risico op 
longkanker [7, 8]. Rekening houdend met de rol van MPO bij de HOCl-productie kan 
ook worden verondersteld dat het mogelijke beschermende effect van het -463A-allel 
een gevolg is van een lagere productie van HOCl. 
 Desondanks wordt de causale rol van neutrofielen in door ROS-veroorzaakte 
DNA-schade en mutagenese voornamelijk beschreven door in vitro experimenten. In 
vivo experimenten op proefdieren leverden vooral indirecte bewijzen, vandaar dat 
bijkomende onderzoeken noodzakelijk zijn voor het verder bestuderen van de relatie 
tussen neutrofielen/MPO/HOCl en genotoxiciteit in de luchtwegen. Dit proefschrift 
heeft als doelstelling de rol van neutrofielen in ontstekingsgerelateerde carcinogenese 
te onderzoeken door gebruik te maken van zowel in vitro als in vivo modellen, met 
speciale aandacht voor de drie belangrijkste pathways van door neutrofiel veroor-
zaakte genotoxiteit. Het eerste onderdeel van het proefschrift (hoofdstuk 3) richt zich 
voornamelijk op de mechanismen betrokken bij de primaire genotoxiciteit veroorzaakt 
door neutrofielen en HOCl. Hoofdstukken 4 & 5 behandelen het mogelijke remmen-
de effect van neutrofiel-gederiveerd HOCl op nucleotide excisieherstel, wat mede 
bijdraagt tot de genotoxische omgeving van een longontsteking. In hoofdstuk 6 wordt 
tot slot een bredere karakterisering van de neutrofiel-afgeleide effecten in de muizen-
long geschetst door middel van genexpressieprofilering. 
Genotoxische effecten van neutrofielen en HOCl 
Op dit moment is het algemeen aanvaard dat de genotoxische capaciteit van neutro-
fielen tenminste gedeeltelijk is toe te schrijven aan de productie van DNA-
beschadigende en mutagene ROS. In het verleden lag de klemtoon voornamelijk op 
door neutrofielen geproduceerd H2O2. Deze oxidant werd beschouwd als de voor-
naamste mediator van de genotoxische effecten, aangezien ze fungeert als een laten-
te vorm van het hydroxylradicaal, de meest DNA-reactieve ROS [9]. Onder fysiologi-
sche omstandigheden wordt echter tot 70% van H2O2 verbruikt door het neutrofiel-
afgeleide enzym MPO om zo de sterke oxidant HOCl [4] te kunnen produceren waar-
van de genotoxische capaciteit nog steeds niet gekend is. 
 Hoofdstuk 3 beschrijft de DNA-beschadigende en mutagene effecten van HOCl 
op longcellen. Dit onderzoek toonde als eerste aan dat HOCl mutaties veroorzaakt in 
het HPRT-gen van longepitheelcellen en bijgevolg een indirect genotoxisch effect zou 
hebben door lipiden en/of proteïnen aan te vallen, waardoor malondialdehyde (MDA) 
en 3-(2-Deoxy-β-D-erythro-pentofuranosyl)pyrimido[1,2-α]purin-10(3H)-1 (M1dG)-
adducten worden gevormd. Dankzij depletie van circulerende neutrofielen slaagden 
we erin om in een muizenmodel met een LPS-geïnduceerde acute longontsteking het 
verband tussen de infiltratie van pulmonaire neutrofielen, HOCl en de vorming van 
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M1dG-adducten in vivo aan te tonen. Al deze resultaten indiceren dat de MPO-
gekatalyseerde vorming van HOCl tijdens een longontsteking dient te worden be-
schouwd als een belangrijke bron van neutrofiel-geïnduceerde genotoxiciteit en mo-
gelijk mutagenese. De resultaten onderbouwen eveneens bevindingen uit recente 
moleculaire epidemiologische onderzoeken waarin het beschermende effect wordt 
beschreven van een 463G→A-polymorfisme van het MPO-gen op longkanker bij 
rokers [7, 8]. Aangezien de in ons onderzoek gebruikte A549-cellen adenomacarci-
nomacellen zijn en dus niet behoren tot het progenitorceltype, zijn ze mogelijk niet 
ideaal geschikt voor het onderzoeken van de genotoxische invloed van HOCl op het 
ontstaan van tumoren. Daarom is verder onderzoek naar de mutagene effecten van 
HOCl in primaire longepitheelcellen waarschijnlijk veel relevanter voor de initiële ge-
notoxische effecten die mogelijk optreden tijdens de ontwikkeling van kanker. Hoewel 
de mogelijkheid zeker bestaat dat neutrofielen betrokken zijn bij de initiatiefase van 
pulmonaire carcinogenese, vormen onze gegevens over de HOCl-geïnduceerde ge-
nomische instabiliteit een toevoeging op het gekende feit dat de infiltratie van neutro-
fielen in tumoren de ontwikkeling van de tumor stimuleert [10]. 
Inhibitie van DNA-herstel door neutrofielen en HOCl 
Hoewel de vorming van HOCl werd geassocieerd met de inductie van DNA-schade, 
zoals hierboven beschreven, zijn er steeds meer bewijzen dat het beschermende 
effect van het A-allel op longkanker hoofdzakelijk wordt geobserveerd in rokers, wat 
een interactie tussen neutrofielen, MPO en sigarettenrookcomponenten suggereert 
[11, 12]. De eerste verklaring voor dit verband werd gezocht in de rol van MPO in de 
bio-activering van geïnhaleerde carcinogenen. Zo werd bijvoorbeeld aangetoond dat 
MPO de transformatie van het prototype PAK benzo[a]pyreen in DNA-bindende me-
tabolieten (bijv. benzo[a]pyreen-diol-epoxide) verhoogt [6, 13]. Als deze helixversto-
rende DNA-lesies ontglippen aan het specifieke DNA-herstel (i.e. nucleotide excisie-
herstel (NER)), blokkeren zij mogelijk de replicatievork, wat uiteindelijk resulteert in 
mutagenese en carcinogenese [14]. 
 Aangezien recent onderzoek heeft aangetoond dat oxiderende stoffen, zoals 4-
hydroxynonenal [15], MDA [16] en stikstofmonoxide [17], endogene remmers van 
NER zijn en gezien het mogelijke proteïne-oxiderende effect van HOCl, handelt de 
tweede hypothese van dit proefschrift voornamelijk over de capaciteit van HOCl om 
DNA-herstel in de longepitheelcellen te moduleren. In hoofdstuk 4 toonden we in 
menselijke longepitheelcellen in vitro aan dat neutrofielen mogelijke NER-remmers 
zijn door de MPO-geïnduceerde productie van HOCl. De NER-remmende effecten 
van HOCl op doelcellen konden slechts gedeeltelijk worden verklaard door de ver-
minderde werking van de NER-enzymen, veroorzaakt door een directe HOCl-
geïnduceerde oxidatieve aanval op proteïnen. Waarschijnlijk zijn ook andere mecha-
nismen, zoals de vorming van proteïne-DNA crosslinks, hierbij betrokken [18]. Er 
werd eveneens aangetoond dat het HOCl-geïnduceerde lipideperoxidatie-/proteïne-
oxidatieproduct MDA, zoals beschreven in hoofdstuk 3, rechtstreeks reageert op 
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herstelenzymes [16] en aldus een bijkomend mogelijk mechanisme vormt voor de 
geobserveerde HOCl-geïnduceerde NER-inhibitie. De relevantie van deze in vitro 
bevinding voor DNA-herstel in vivo werd beschreven in hoofdstuk 5, waarin een 
verband tussen LPS-geïnduceerde pulmonaire ontsteking en verminderde NER in de 
muizenlong wordt onderbouwd. Het effect van neutrofielen werd toegelicht door het 
gebruik van een MPO-knockout-muizenmodel en de systemische depletie van circule-
rende neutrofielen met specifieke antilichamen. In tegenstelling tot de in vitro bevin-
dingen, werd noch van MPO (en bijgevolg van HOCl), noch van neutrofielen een 
duidelijke rol bewezen, wat wijst op het feit dat andere factoren de inhibitie van NER 
tot stand brengen in de ontstoken muizenlong. We veronderstellen dat de residente 
alveolaire macrofagen mede aan de oorzaak liggen van de inhibitie van DNA-herstel 
[17] door het genereren van reactieve stikstofradicalen (RNS), waaronder stikstofmo-
noxide. 
 Niettemin duiden de resultaten van hoofdstuk 4 & 5 de ontstekingsgerelateerde 
reductie van NER aan als een belangrijke en niet eerder herkende potentiële mede-
bepalende factor in de ontwikkeling van ontstekingsgerelateerde longkanker. Dit ef-
fect is wellicht het meest doorslaggevend bij personen blootgesteld aan chemische 
carcinogenen (bijv. PAK), bijvoorbeeld door chronische inhalatie van sigarettenrook. 
NER is de belangrijkste herstelpathway voor de verwijdering van grote helixversto-
rende DNA-adducten die worden geproduceerd na inhalatie van dergelijke chemische 
carcinogenen, zoals PAK [19, 20]. De vorming van zulke promutagene PAK-DNA-
adducten werd beschouwd als een causaal proces in de ontwikkeling van longkanker 
bij rokers [21]. Aangezien uit studies met NER-deficiënte muizen is gebleken dat een 
efficiënt DNA-herstel van wezenlijk belang is voor het verhinderen van de carcinoge-
ne effecten van PAK-geïnduceerde DNA-schade [22], kan worden verondersteld dat 
de processen, die relevante DNA-herstelpathways onderdrukken, de personen die 
werden blootgesteld aan dergelijke chemische stoffen mogelijk vatbaarder maken 
voor kanker. Epidemiologische onderzoeken toonden inderdaad aan dat de polymor-
fismen in NER-genen, die leiden tot een (hypothetische) verminderde fenotypische 
NER-capaciteit, worden geassocieerd met een verhoogd risico op longkanker [23, 
24]. Bekeken vanuit een breder perspectief, onderbouwt deze bevinding de theorie 
die zegt dat een (chronische) ontsteking een belangrijke factor kan zijn bij de bepaling 
van de vatbaarheid op kanker na blootstelling aan chemische stoffen uit de omgeving. 
Dit biedt eventueel een bijkomende verklaring voor het verband tussen MPO-
polymorfismen en het risico op de vorming van pulmonaire DNA-adducten en carci-
nogenese in PAK blootgestelde mensen [25, 26]. 
Neutrofiel-geïnduceerde inflammatoire pathways en 
genexpressiewijzigingen in de micro-omgeving van de long 
Er moet echter ook rekening mee worden gehouden dat de inductie van DNA-schade 
en mutagenese alleen niet aan de oorzaak ligt van kanker en dat neutrofielen, bij-
voorbeeld door het generen van een inflammatoire pro-oxidantomgeving, een impact 
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kunnen hebben op de initiatie en de progressie van carcinogenese. De afscheiding 
van ROS door neutrofielen veroorzaakt mogelijkerwijs een celproliferatieve reactie, 
die een belangrijke bijdrage kan leveren aan de carcinogene respons volgend op een 
chronische ontsteking. 
 Aangezien genexpressiewijzigingen zich meestal voordoen tijdens de vroege 
ontwikkelingsstadia van een ziekte, werden de expressie van genen en de identifica-
tie van pathways, betrokken bij ontstekingsgerelateerde carcinogenese, bestudeerd in 
hoofdstuk 6. Er werd echter geen significant effect van neutrofielen geobserveerd in 
genen die betrokken zijn bij carcinogene processen, omdat het merendeel van de 
expressiewijzigingen verband hield met immuun- en ontstekingsgerelateerde proces-
sen die verdere informatie bieden over de centrale rol van neutrofielen in de inflam-
matoire reactie. Desalniettemin verdienen deze neutrofiel-geassocieerde profielen 
van de inflammatoire respons verdere aandacht, aangezien zij de vatbaarheid op een 
inflammatoire longziekte kunnen verhogen en mogelijk ook een invloed hebben op 
ogenschijnlijke niet verwante pathologische omstandigheden en zelfs kanker. Een 
andere bevinding is de neutrofiel-veroorzaakte up-regulatie van meervoudige genen 
betrokken bij oxidatieve stressgerelateerde biologische processen. Bovendien werd er 
een positieve correlatie ontdekt tussen het neutrofiel-veroorzaakte genexpressiepro-
ces en de promutagene DNA-lesie M1dG, zoals beschreven in hoofdstuk 3. Daarnaast 
bleek longontsteking ook geassocieerd met een neutrofiel-afhankelijke up-regulatie 
van celcyclusgerelateerde pathways, wat mogelijk wijst op een snellere celdeling. Dit 
alles doet vermoeden dat de infiltratie van neutrofielen zorgt voor een vermeerdering 
van en tevens versnelde fixatie van mutaties. Deze resultaten bevestigen nogmaals 
het verband tussen ontstekingen en pulmonaire genotoxiteit en suggereren dat de 
omvang van het inflammatoire proces inderdaad van wezenlijk belang is voor de 
genetische instabiliteit in carcinogenese. 
Slot 
In dit proefschrift lag de klemtoon op het onderzoeken van de rol van neutrofielen in 
ontstekingsgerelateerde carcinogenese. Tegenwoordig zijn er steeds meer in vivo 
bewijzen waaruit blijkt dat neutrofielen een belangrijke rol spelen in de latere stadia 
van het carcinogeneseproces. PMN-infiltratie in tumoren kan de ontwikkeling ervan 
stimuleren door de genetische instabiliteit van de tumorcellen te beïnvloeden via de 
afscheiding van ROS [10]. In het verlengde van deze bevinding werd aangetoond dat 
de tumorgroei kan worden verhinderd door eliminatie van de circulerende PMN [27]. 
Er is slechts beperkt experimenteel bewijs voor de rol van DNA-schade en mutagene-
se in de vroegste stadia van carcinogenese, met name de tumorinitiatie. Ter aanvul-
ling van de in vitro co-cultuurmodellen, is het gebruik van een MPO-knockout mui-
zenmodel en de systemische depletie van circulerende neutrofielen met specifieke 
antilichamen een veelbelovende aanpak om het effect van neutrofielen op dieren, die 
intens werden blootgesteld aan een inflammatoire agens, te verklaren. Door gebruik 
van deze modellen werd in dit proefschrift beschreven dat MPO-gekatalyseerd HOCl 
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de DNA-schade vergroot en het herstel van omvangrijke promutagene lesies verhin-
dert en zo mogelijk de aanzet vormt tot mutagenese. Wat echter benadrukt dient te 
worden is dat genotoxiteit enkel refereert naar DNA-reactiviteit, wat in essentie niet 
hetzelfde is als carcinogeniteit. Het is bijgevolg een heel grote uitdaging om te onder-
zoeken of in vitro HOCl-veroorzaakte mutagenese, zoals besproken in dit proefschrift, 
kan worden geëxtrapoleerd naar een neutrofielinfiltratie in vivo. 
 Het volgende vraagteken dat ontstaat is of de in vitro en in vivo mechanismen 
van ontstekingsgerelateerde carcinogenese en de rol van neutrofielen hierin, zoals 
beschreven in dit proefschrift, kunnen worden geëxtrapoleerd naar mensen. Tot dus-
ver blijft het nog steeds onzeker of neutrofielen daadwerkelijk ROS-geïnduceerde 
genotoxiteit veroorzaken in de ontstoken menselijke luchtwegen. Anderzijds hebben 
recente moleculaire epidemiologische onderzoeken, in combinatie met experimentele 
in vitro en in vivo onderzoeken, consistente bewijzen aangevoerd waaruit blijkt dat 
neutrofielen en menselijke pulmonaire carcinogenese mogelijk causaal gerelateerd 
zijn doordat neutrofielen, via de afscheiding van MPO, de biologische activering van 
omgevingscarcinogenen, zoals PAK, tot DNA-beschadigende metabolieten [28] sti-
muleren. Dit proefschrift toont nader aan dat inflammatoire neutrofielen, via MPO-
gekatalyseerd HOCl, de DNA-lesies vermeerderen en het herstel van dergelijke DNA-
adducten verhinderen, en aldus mogelijk leiden tot mutagenese in doelcellen met 
tumorverwekkende gevolgen. Toch dient er nog veel aandacht te worden besteed aan 
het uitdiepen van deze processen in pulmonaire carcinogenese, alsook aan het bie-
den van een definitief uitsluitsel dat ontstekingen inderdaad kanker veroorzaken. 
Dergelijke kennis kan uiteindelijk leiden tot nieuwe benaderingen voor de preventie 
van inflammatoire kanker. Hoewel deze studie zich beperkte tot de longen, spreekt 
het voor zich dat onze bevindingen ook van groot belang kunnen zijn voor andere 
organen waarin de ontwikkeling van kanker wordt geassocieerd met een vooraf be-
staande (neutrofiel-) ontsteking. 
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Een promotie is een schijnbaar onmogelijke berg om te beklimmen, het proefschrift is 
een uitdaging om te schrijven. Hoe moeilijk het soms ook was, ik voelde me gesteund 
door geweldige collega’s, vrienden en familie. Mede dankzij jullie kan ik tevreden 
terugblikken op een leerrijke ervaring en een  geslaagd proefschrift. Graag zou ik een 
aantal personen in het bijzonder willen bedanken. 
 
Beste (co-)promoteren, Frederik-Jan van Schooten, Ad Knaapen en Roger Gods-
chalk, jullie zou ik graag als eerste willen bedanken voor de gegeven kansen, jullie 
wetenschappelijk enthousiasme, jullie flexibiliteit en natuurlijk voor de begeleiding. Het 
promotietraject was voor mij niet enkel een periode van wetenschappelijke groei, 
maar ook een ontplooiing op persoonlijk vlak. Jullie positieve blik en overtuiging wa-
ren voor mij erg motiverend en hebben me steeds een stapje verder gebracht. 
Roland, thanks for your helpful comments and suggestions when reviewing my pa-
pers. 
 
De beoordelingscommissie, bestaande uit Prof. dr. E. Wouters, Prof. dr. F. Ramae-
kers en Dr. R Schins, wil ik graag bedanken voor het kritisch evalueren van mijn 
proefschrift. 
 
Many thanks to all co-authors of the manuscripts for the nice cooperation and their 
contributions. In het bijzonder: Astrid, bedankt voor je hulp bij de muizenstudie en al je 
antwoorden op mijn MPO-vragen. Jeroen, zonder jouw supersnelle micro-array ana-
lyses had ik hoofdstuk 6 nooit op tijd kunnen afwerken. Bedankt hiervoor! 
 
Niets is zo fijn als werken in een omgeving met toffe collega’s. Collega’s van GRAT, 
bedankt voor jullie hulp in het lab, de fijne samenwerking en de leuke tijd, tijdens en 
soms ook na werktijd! ‘Cool chicks’ van kamer 4.106, Sabine, Karen en Nicole, het 
was altijd leuk om het promovendi wel-en-wee, en alles daarbuiten, met elkaar te 
delen. Dankjewel voor de gezellige sfeer op ons kamertje! 
Ook mijn nieuwe collega’s van MAASTRO wil ik graag bedanken voor hun interesse 
en bovenal de prettige en collegiale werksfeer. 
 
Mijn liefste paranimfjes, Yonca en Veronique, bedankt voor jullie steun en vriend-
schap. Ik ben trots dat jullie op deze voor mij speciale dag aan mijn zijde staan! 
 
Familie, schoonfamilie en vrienden erg bedankt voor jullie enorme interesse. Eindelijk 
zien jullie een tastbaar resultaat van waar ik de afgelopen jaren (en zeker maanden) 
mee bezig ben geweest. Vanaf nu heb ik meer tijd voor jullie! 
 
Mijn zus(je), Yonca, super dat je mijn hele boekje hebt nagelezen. Ook de vertaling 
van de samenvatting heb ik aan jou te danken! Je hebt het zeker verdiend om mee te 
promoveren. Jouw vrolijkheid mag strakjes zeker niet ontbreken op de grote dag! 
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Lieve mama en papa, ik ben heel dankbaar voor de rustige en stimulerende omgeving 
die jullie voor me zijn. Bedankt voor de steun en de kansen die jullie me al heel mijn 
leven geven! Sizleri çok seviyorum, büyük bir öpücük! 
 
Wim, mijn liefje, jij weet als enige hoe moeilijk het is met een promoverende vriendin 
samen te leven. Toch ben je er nog altijd. Hoe kan ik je bedanken voor al je steun en 
hulp… Just to be with you is having the best day of my life. 
 
 
 
Nejla 
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